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Abstract
Abstract
T.b.brucei, T.b.rhodesiense and Tb.gambiense are all morphological identical and 
cannot be distinguished by microscopical observations. The original definition of 
these three subspecies was presented by Hoare (1970) taking into account their 
geographical distribution, their host specificity, their ability to infect humans and the 
pattern of disease they cause. By these criteria, T.b.brucei is defined as non-human 
infective and Tb.gambiense and T.b.rhodesiense as human infective since they have 
the ability to withstand lysis by human serum. The underlying mechanisms for 
human serum sensitivity/resistance are not yet fully understood and more than one 
factor in human serum may be involved. The overall aim of this thesis was to 
investigate the inlieritance and molecular basis for human serum 
resistance/sensitivity. Inheritance studies were made possible because of the 
availability of recombinant progeny from a cross between a human serum resistant 
and a human sermn sensitive trypanosome strain. A molecular approach based on 
differential display RT-PCR was also used to complement the more biochemical 
approaches adopted by others.
A range of variables were examined and optimised to develop a reliable in vitro 
bloodstream form human serum sensitivity assay but it was clear that cell viability 
could not be estimated from morphological appearance alone. A statistically 
significant difference in mean percentage lysis was observed between stocks that 
correlated with human serum sensitivity but the data varied too much between 
individual assays for the assay to provide unambiguous results. Instead, a reliable in 
vivo human serum resistance assay, which involved incubating bloodstream 
trypanosomes with human serum, injecting them into mice and screening of the mice 
for the development of parasitaemia, was optimised and adopted.
Genetic analysis and the heritability of human serum resistance/sensitivity was 
investigated with the aim of revealing the niunber of loci and alleles involved and 
determining the dominance relationships between alleles. From the pattern of 
inheritance a model for the inlieritance of human serum resistance is suggested and a
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number of models for inheritance which are incompatible with the results are refuted. 
As a result of detecting F, progeny clones of intermediate resistance, the simplest 
possible model is based on 3 alleles; codominant sensitive and resistant alleles and a 
recessive sensitive wild type allele, all at a single locus.
A candidate gene determining resistance to human serum has been previously 
described; the serum resistance associated (SRA) gene (De Greef & Hamers, 1994). 
To determine whether SRA expression was causing resistance in the present study, 
the presence of a genomic copy of the SRA gene was initially investigated by PCR in 
the cloned stocks STIB 386, STIB 247 and TRJEU 927. PCR products of the expected 
size were obtained from STIB 247 and TREU 927 but not from STIB 386. No PCR 
product could be amplified from STIB 386 whatever primer combination and PCR 
conditions were used implying that the SRA gene may be absent from this isolate. To 
further investigate the presence of a sequence related to SRA in STIB 386 and TREU 
927, Southern blots were performed. Hybridisation with fragments of similar, but not 
identical, sizes were noted in all of the clones indicating that sequences with 
homology are present but that sequence variation occurs within the SRA gene. The 
expression of the SRA gene and its correlation with a HSR phenotype was further 
examined but its expression does not coincide with HSR in the stocks used in this 
study.
A study was initiated to identify candidate genes determining resistance or 
sensitivity to human serum. To do this differential display RT-PCR was used in order 
to identify cDNA fragments expressed in either of the serum sensitive or serum 
resistant trypanosome lines. Nine differentially amplified products were identified, 
reamplified, cloned and sequenced and 16 clones obtained. Four of these clones 
showed expression patterns associated with human serum resistance or sensitivity, 
three were specifically expressed in human serum sensitive trypanosomes and one 
was specifically expressed in human serum resistant trypanosomes. Two of the 
sensitive specific clones were related to EST sequences from a cDNA library of a 
T. brucei bloodstream clone which have not been further characterised. The other 
sensitive specific clone was part of a gene for ribosomal RNA while the resistance
111
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specific clone was unrelated to any other sequences in the database. These data, talcen 
together, suggest that human serum sensitivity in trypanosomes is determined by 
both a lack of resistance and a specific expression of gene product(s) conferring 
sensitivity.
IV
Contents
Contents
Page
Declaration
Abstract
Contents
List of tables
List of figures
Abbreviations
Acknowledgements
1
ii
V
ix
xi
XV
xvii
Chapter 1 General Introduction 1
1.1 General Features of African trypanosomes 1
1.1.1 Lifecycle 1
1.1.2 African Trypanosomiasis-spread and disease 3
1.1.3 Diagnosis of African sleeping sicloiess 6
1.1.4 Treatment of African sleeping sickness 6
1.2 Stocks and sub-species of T. brucei 8
1.2.1 Methods for identifying trypanosome stocks 9
1.2.2 Animal reservoirs of sleeping sickness 10
1.2.3 Distinguishing T.b.gambiense from T.b.rhodesiense and
T.b.brucei 12
1.2.4 T.b.gambiense type II 13
1.2.5 Distinguishing T. b.rhodesiense from T. b. brucei 13
1.2.6 The origin of human infective trypanosomes 16
1.3 Antigenic variation in T. brucei 16
1.3.1 Expression of VS G genes 18
1.3.2 VSG switching during trypanosome infection 19
1.3.3 Surface receptors of T. brucei 20
1.4 Human infectivity 22
1.4.1 Sensitivity of African Trypanosomes to human serum 22
1.4.2 Methods for measuring HSS/HSR 25
1.4.3 Intermediate resistance to human serum 27
1.4.4 The trypanolytic effect of human serum on HSS
trypanosomes 28
1.4.5 Potential factors involved in human serum mediated
lysis 29
1.4.6 Possible mechanisms for the action of TLF 33
1.4.7 Individual differences in trypanolytic effect 35
1.4.8 Trypanocidal factors in non-human mammals 36
1.4.9 The serum resistance associated gene 37
Contents
Chapter 2
Chapter 3
1.5 Genetic organisation and genetic exchange 38
1.5.1 Ploidy and karyotype 38
1.5.2 Genetic exchange in laboratory crosses 40
1.5.3 Clmomosome and kinetoplast inheritance 42
1.5.4 Frequency and stage of mating 43
1.5.5 Genetic exchange in natuial populations 45
1.5.6 Proposed mechanisms of genetic exchange 48
1.6 Aims of study 49
Materials and methods 51
2.1 Trypanosome stocks 51
2.2 Trypanosome growth and isolation 52
2.3 In vitro hmnan serum sensitivity assay 54
2.4 In vivo human serum sensitivity assay 55
2.5 Conducting trypanosome crosses 56
2.6 Identifying hybrid progeny 57
2.7 DNA isolation 57
2.8 RNA preparation 58
2.9 First strand cDNA synthesis 60
2.10 Gel electrophoresis 61
2.11 Recovery of DNA from agarose gels 61
2.12 Restriction enzyme digests 62
2.13 Southern blotting and hybridisation 64
2.14 Northern blotting and hybridisation 66
2.15 PCR amplification of the SRA gene 68
2.16 RT-PCR amplification of the SRA gene 69
2.17 DNA sequencing 69
2.18 Analysis of sequence data 70
2.19 Indirect immunofluorescence 70
2.20 Antibody mediated complement lysis 71
2.21 Differential display RT-PCR 71
2.22 Production of recombinant DNA, transformation of
E.coli and cloning 75
2.23 Recombinant clone characterisation 76
2.24 5'RACE 77
Development of an assay for human serum
resistance/sensitivity 79
3.1 Introduction 79
3.2 Results 80
3.2.1 Development of an in vitro HSS-assay 80
VI
Contents
3.2.2 Viability stains and dyes for an in vitro HSS-assay 89
3.2.3 Lysis under optimal in vitro HSS-assay conditions 91
3.2.4 Development of an in vivo HSS-assay 94
3.2.5 Comparisons of potential variables for an in vivo HSS-
assay 94
3.2.6 The reliability of an in vivo HSS-assay under optimal
conditions 97
3.2.7 The effect of human serum compared with purified TLF 97
3.3 Discussion 99
Chapter 4 Genetic inheritance of human serum 
resistance/sensitivity 104
4.1 Introduction 104
4.2 Results 105
4.2.1 Human serum resistance in the F, progeny from crosses 105
4.2.2 Suggested models for inlieritance of human serum
resistance 109
4.2.3 Refuted inlieritance models 113
4.2.4 Application of the proposed inlieritance model 120
4.3 Discussion 123
Chapter 5
Chapter 6
SRA gene expression and its lack of correlation with 
resistance in T.brucei 130
5.1 Introduction 130
5.2 Results 132
5.2.1 Analysis of the SRA gene by PCR 132
5.2.2 Analysis of the SRA gene by Southern hybridisation 136
5.2.3 Sequencing analysis of the PCR products fi'om the SRA
locus 138
5.2.4 Analysis of the expression of SRA by Northern
hybridisation 140
5.2.5 Analysis of the SRA gene by RT-PCR 143
5.3 Discussion 145
Genes isolated by Differential display RT-PCR as 
potentially important in human serum resistance 149
6.1 Introduction 149
VI!
Contents
6.2
6 .2.1
6 .2.2
6.2.3
6.2.4
6.2.5
6 .2.6
Results 152
Selection of a trypanosome line expressing differences 
in human serum resistance whilst expressing the same 152
VAT
Preparation of starting material 153
Band separation and retrieval 155
Screening differentially displayed bands 158
Characterisation of differentially displayed fragments 161
Characterisation of genes potentially important in 
human serum resistance 176
6.2.7 Discussion 177
Chapter 7 
Bibliography
General discussion 182
190
Vlll
List o f  tables
List of tables
Table 1.1 Distinguishing features of the T.brucei group of trypanosomes
Table 2.1 Restriction endonucleases, buffers components and optimal
assay temperatures
Table 3.1 A comparison of the percentage lysis caused by human serum
of slender and stumpy form trypomastigotes
Table 3.2 A comparison of percentage lysis observed when counting
unfixed or fixed trypanosomes
Table 3.3 The number of mice that developed a patent parasitaemia
when injected i.p. with either 100 or 1000 trypanosomes 
which had been incubated with human serum
Table 3.4 The proportion of mice which developed parasitaemias after
injection with trypanosomes which had been incubated with 
human serum
Table 3.5 The lytic effect of purified TLF in vitro and in vivo
Table 4.1 The results of in vivo HSS-assays of hybrid progeny from a
cross between the human serum resistant STIB 386 and the 
human serum sensitive STIB 247
Table 4.2 The results of in vivo HSS-assays of hybrid progeny from a
cross between STIB 247 and TREU 927
Table 4.3 The results from in vivo HSS-assays of 7 hybrids from a
genetic cross between the human serum resistant STIB 386 
and the intermediate human serum resistant TREU 927
Table 4.4 Results of in vivo HSS-assays of recombinants produced after
self-fertilisation of STIB 247 and TREU 927
Table 4.5 Possible gametes, genotypes and phenotypes of parents and F,
progeny assuming three alleles with different dominance 
relationships between alleles
Table 5.1 Oligonucleotides used as primers for SRA gene analysis
Table 6.1 The generation of nine differentially displayed cDNA
fragments in a compaiison of human serum sensitive and 
resistant trypanosome lines
Page
9
63
87
95
96 
98
106
107
108 
109
119
132
155
IX
List o f  tables
Table 6.2 Summary of screening of clones originating from
differentially displayed fragments by Northern and Northern 
slot blot analysis 1 6 0
Table 6.3 Summary of data on clones derived from differential display 
RT-PCR products and from putative full length open reading 
frames 167
Table 6.4 List of primers used for RT-PCR amplification of 
differentially expressed cDNA fragments 168
List o f  figures
List of figures
Page
Figure 3.1 A comparison of the lytic effect of serum from five different 
individuals 81
Figure 3.2 Comparisons of the lytic effect of heat-inactivated and non
heat-inactivated human serum 82
Figure 3.3 Comparison of trypanosome lysis at room temperature and at
37°C 83
Figure 3.4 Different serum concentrations and their effect on percentage
trypanosome lysis 84
Figure 3.5 Comparisons of percentage lysis at different trypanosome 
concentrations 85
Figure 3.6 A comparison of guinea-pig serum and rabbit sermn as 
potential negative control sera
Figure 3.7 A comparison of percentage lysis in different incubation 
volumes
86
87
Figure 3.8 
Figure 3.9
Figure 4.1
Phase-contrast photomicrographs of 7! hrucei
The simplest possible model for inheritance of the human 
serum resistance trait
92
Percentage lysis after standard in vitro HSS-assay for each of 
the trypanosome stocks STIB 386, STIB 247 and TREU 927 93
110
Figure 4.2 Chi square test for the proposed inlieritance model
Figure 4.3 A schematic view of the proposed genetic model for the
inheritance of the human serum resistance trait
111
112
Figure 4.4 A second possible model for the inheritance of human serum
resistance trait 113
Figure 4.5 A genetic model for the cross between STIB 247 and STIB 
386 assuming that sensitivity to human serum is a dominant 
trait and that two alleles am involved at a single locus 114
XI
List o f  figures
Figure 4.6
Figure 4.7
Figure 4.8 
Figure 4.9 
Figure 4.10
Figure 5.1 
Figure 5.2
Figure 5.3 
Figure 5.4 
Figure 5.5 
Figure 5.6
The predicted genotypic and phenotypic outcome for a cross 
between STIB 247 and STIB 386 assuming codominance and 
a recessive resistant wild type allele 116
The possible genotypic and phenotypic outcome of a cross 
between STIB 247 and STIB 386 when assuming a recessive 
wild type (^ '"^  ) allele that is recessive in relation to the two 
codominant S^  and S^ alleles
Predicted model for the inlieritance of human serum resistance 
applied to a STIB 247 x TREU 927 cross
Application of a proposed model for inlieritance of human 
serum resistance with progeny from STIB 386 x TREU 927
Suggested approach for confirming the proposed genetic 
model by conducting a backcross between one of the parents 
and a hybrid offspring
The published SRA sequence for ETatl.2 and primers 
designed for PCR
PCR amplification using a range of annealing temperatui'es 
with primers MHS and MHT designed from sequences 
flanking the SRA gene
PCR amplification of the SRA gene locus using nested 
primers
PCR amplification of the SRA gene sequence using primers 
SRA5 and SRA6
Southern hybridisation of restriction digested genomic DNA 
from four trypanosome stocks with the SRA gene probe
117
121
122
127
133
134
135
136
137
Comparison of the published SRA gene sequence and the 
sequence of PCR derived SRA fragments horn ETatl.2, STIB 
247 and TREU 927 139
Figure 5.7 Northern hybridisation of inRNAs with the SRA gene probe 141
Figure 5.8 RT-PCR amplified VSG gene expressed in a passaged line of
STIB 247 142
Figure 5.9 Northern blot analysis of inRNAs probed with the SRA 
specific PCR probe lacking its C-terminal end 143
Xll
List o f  figures
Figure 5.10 Example of positive control of the quality of cDNA prior to
use in RT-PCR 144
Figure 5.11 RT-PCR amplification of the SRA locus from RNA isolated
from cloned stocks of trypanosomes 145
Figure 6.1 
Figure 6.2 
Figure 6.3 
Figure 6.4 
Figure 6.5 
Figure 6.6 
Figure 6.7 
Figure 6.8
Schematic representation of differential display RT-PCR used 
for identifying possible HSR/HSS genes 150
Selection of trypanosome stocks for differential display RT- 
PCR
Examples of differential display RT-PCR products including 
the nine differentially displayed bands
Recovered and reamplified differentially displayed DNA 
fragments
Different sized inserts identified in cloned fragments isolated 
from differential display
Screening of differentially displayed fr agments by Northern 
slot hybridisation
Southern blot analysis of DNA from trypanosome isolates 
probed with tliree differentially displayed fr agments
Sequence of clone 005E, clone 00IE, clone 004D and clone 
008F
Figure 6.9 Alignment of the insert of clone GO IE and a randomly 
sequenced EST from bloodstream T.brucei ILTatl.l
Figure 6.10 Sequence comparison of the insert of clone 004D and the 
T.brucei gene for large subunit ribosomal RNA
Figure 6.11 Sequence aligmnent of the insert of clone 008F and an EST 
identified in T.b.rhodesiense expressing M-VAT4
Figure 6.12 RT-PCR products amplified from RNA isolated from human 
serum sensitive or resistant trypanosomes
Figure 6.13 Sequence of the RT-PCR product of clone 005RT
Figure 6.14 Southern blot analysis of two extended differential display 
products
152
156
157
158 
161 
162
164
165
165
166
169
171
172
Ï
Xlll
Figure 6.15 Sequence of the RT-PCR product of clone OOIRT 173
Figure 6.16 Sequence comparison of the cloned insert OOIRT and a cDNA
from T.brucei ILTatl. 1 (T3554) 174
Figure 6.17 Sequence of the RT-PCR product 008RT 174
Figure 6.18 Sequence alignment of the cDNA produced from differential
display fragment 008 175
List o f  figures f
. . i :
XIV
Abbreviations
Abbreviations
BSA Bovine serum albumin
BLAST Basic Local Alignment Search Tool
CBSS Carter's balanced salt solution
CFLP Outbred strain of mice
CNS Central nervous system
CSF Cerebral spinal fluid
DAPI 4,6,"diamino-2-phenylindoie
DDRT-PCR Differential display reverse transcription PCR
DEPC Diethylpyrocarbonate
DMSO Dimethyl sulphoxide
DFMO a-difluoromethylornithine
DNA Deoxyribonucleic acid
EDTA Ethylene diaminetetraacetic acid
ETat Edinburgh Trypanozoon antigenic type
EATRO East African Trypanosomiasis Research Organisation
ES Expression site
ESAG Expression site associated gene
FI First filial generation
FITC Fluorescein isothiocyanate
g Acceleration due to gravity
GPS Guinea pig serum
GUP Glasgow University Protozoology
GUT at Glasgow University Trypanozoon antigen type
HBSS Hanlc’s balanced salt solution
TIDE High density lipoprotein
FISR Human serum resistant
HSS Human sermn sensitive
hpr Haptoglobin related protein
ISG Invariant surface glycoprotein
i.p. Intraperitoneal
ILT at ILRAD Trypanozoon antigen type
IPTG Isopropylthio-P"D-galactoside
kb Kilobase
kDa Kilo dalton
kDNA Kinetoplast DNA
LB Luria-Bertani medium
LDL Low density lipoprotein
LMP Low melting point agarose
pCi Microcurie
MEM Minimum essential medium
NaCl Sodium chloride
Na^HPO^ Di-sodium hydrogen phosphate
NaOH Sodium hydroxide
NHS Normal human serum
PARP Procyclic acidic repetitive protein
XV
Abbreviations
PBS Phosphate-buffered saline
PCR Polymerase chain reaction
PSG Phosphate-buffered saline-glucose
RACE Rapid amplification of cDNA ends
RADES Random amplified differentially expressed sequences
RAPD Random amplified polymorphic DNA
RNA Ribonucleic acid
RFLP Restriction fragment length poymorphism
RNA Ribonucleic acid
SDS Sodium dodecyl sulphate
SE Standard error
STIB Swiss Tropical Institute, Basel
TAE Tris-acetate EDTA buffer
TBE Tris-borate EDTA buffer
TBS Tris buffered saline
TLF Trypanosome lytic factor
TREU Trypanosomiasis Research, Edinburgh University
UTR Untranslated region
VAT Variable antigen type
VLDL Very low density lipoprotein
VSG Variable surface glycoprotein
WHO World Health Organisation
X-gal 5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside
Acknowledgements
There are many people I would like to thanlc.
Thanks Mike Turner and Andy Tait for much support, encouragement and direction 
all the way tlnough, even when things seemed too much. Thanlcs for three intensive 
but fun years and thanlcs for giving me the opportunity to do a Ph.D. in the first 
place!
Thanks Mike Barrett for your unfailing optimism! Thanks for teaching me how to do 
differential display and for all your help, advice and time that you were never too 
busy to give.
Thanks Michelle Hope and Annette MacLeod for introducing me to the world of 
molecular biology. Thanks for sharing your experience and for all the time you have 
spent on me. Without you, I would probably still be working on that Southern...
Thanks everybody in the North Lab. and in WUMP. Thanks Dan Masiga for your 
company and Dorothy Armstrong for maidng the ordering procedures less painful.
Thanlcs also to Etieime Pays for control RNA samples and to access to information in 
advance of publication and to Jayne Raper for the gift of purified TLF.
Thanks Andrew MacDonald for help with the scanning and for being there for me.
Thanks Mum and Dad for all your support and help and for taking such good care of 
my gorgeous cat Felix while Eve been away!
I was financially supported by the Wellcome Trust, under the Prize Studentship 
Scheme for three years and, during the writing up period, by Sodra Sveriges 
Sjukskoterske forening (SSSH).
XVII
Chapter 1 General Introduction
Chapter 1 
General Introduction
1.1 GENERAL FEATURES OF AFRICAN TRYPANOSOMES
1.1.1 Life cycle
The Trypanosoma brucei group are protozoan parasites belonging to the subphylum 
Mastigophora, order Kinetoplastida and subgenus Trypanozoon. These trypanosomes 
are actively motile haemoflagellates that can parasitise the blood of a variety of 
mammals. They do not invade or live within cells but inhabit connective tissue 
spaces within organs and the reticular tissue spaces of the spleen and lymph nodes. 
They are especially abundant in the lymph vessels and, in later stages of infection, the 
intercellular spaces in the brain. Trypanosomes of the T.brucei group are all 
morphologically identical but have traditionally been divided into three subspecies 
depending on their infectivity to humans; T.b.brucei is not infective to humans while 
T.b.rhodesiense and T.b.gambiense are. The latter two are also distinguished on the 
clinical symptoms they can give rise to (Minter, 1991). T.brucei is transmitted by an 
infected bite of the insect tsetse fly vector of the genus Glossina and this requirement 
restricts the disease to sub-Saharan Africa. African trypanosomiasis and its cattle 
equivalent, nagana, are significant diseases in much of Africa and cause considerable 
suffering and economic loss (Schmidt & Roberts, 1989).
T.brucei has a rather complex life cycle which involves morphological changes to 
its surface membrane and alterations in energy metabolism. During the bite of an 
infected tsetse fly, metacyclic stage trypomastigotes are injected into the dermal layer 
of the hosts' skin and an inflammatory reaction usually follows. The metacyclic forms 
transform into slender trypomastigotes and multiply extracellularly in the 
bloodstream and other body fluids. During the initial phase of rising parasitaemia 
these are the predominant forms but as the parasitaemia peaks and declines short, 
stumpy non-dividing forms come to be predominant. This morphological variation in
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the bloodstream cells is called pleomorphism. If stumpy forms are ingested by a 
feeding tsetse fly, it is possible that the fly becomes infected but in most cases the 
trypanosomes are readily killed off by the tsetse flies' immune system and various 
digestive enzymes. If slender forms are ingested they will die or, sometimes, change 
into stumpy forms in the anterior midgut of the fly. Stumpy trypomastigotes that 
survive this hostile environment transform into procyclic forms in the fly midgut. 
From here trypanosomes penetrate the peritrophic membrane to colonise the 
ectoperitrophic space and migrate forward to the proventriculus where the peritrophic 
membrane is soft and allows the parasites to re-enter the lumen of the gut. They pass 
the oesophagus and move further up the labium before they finally reach the salivary 
glands where they transform into epimastigotes. Epimasigote forms are not free- 
swimming but are attached to the salivary gland endothelial cells by means of their 
flagellum. Epimastigotes are again a dividing stage which will mature into non­
dividing infective metacyclic trypomastigotes, (Vickerman, 1985). It may take 18-34 
days from the ingestion of stumpy trypomastigotes to the production of infective 
metacyclics when approximately lO'* infective metacyclics are discharged during the 
feed of an infective fly (Service, 1986).
Apart from major changes in the gross morphology during the life cycle there are 
also alterations of the ultrastructure in the mitochondrion, activation of oxidize 
systems and the cytochrome electron transport chain as bloodstream trypanosomes 
transform into procyclics. Bloodstream trypomastigotes are covered by a densely 
packed coat consisting of single molecular species, the variable surface antigen. The 
surface coat protects against non-specific immune mechanisms and antibodies 
directed towards the cell and can also undergo antigenic variation. During the 
transformation of bloodstream forms to procyclic forms the surface coat is lost and 
the synthesis of variable surface glycoproteins (VSGs,) that constitute this coat, is 
discontinued (Barry, 1997). The loss of variable antigens occur faster in the posterior 
portion of the fly midgut than in the crop and anterior part. It is therefore concluded 
that the posterior midgut is the main site for transformation of bloodstream 
trypanosomes to procyclics and this transformation takes approximately 48 hours 
(Turner er.fl/., 1988).
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Tsetse flies are restricted to tropical Africa from between latitude 15° north and 20° 
south but extending to about 30° south along the eastern coastal area. Both male and 
female tsetse flies bite humans, a variety of domestic and wild animals, reptiles and 
birds. Most tsetse fly species show some host preference but none feed exclusively 
on one type of host. The flies take blood meals every 2-3 days but the interval may 
be longer in cooler, humid climates. The Glossina species can be divided into 3 
groups; the Fusca group (forest flies), the Morsitans group (savannah flies) and the 
Palpalis group (riverine and forest flies). None of the fusca group are vectors of 
sleeping sickness. The Morsitans group contain the important vectors G. morsitans 
and G.pallidipes and the Palpalis group include G.palpalis and G.fuscipes which are 
important human sleeping siclmess vectors (Service, 1986). Salivary gland infection 
rates are low, less than 1%, even in areas of endemic sleeping sickness (Nekpeni 
et.al, 1991).
1.1.2 African Trypanosomiasis - spread and disease
Human sleeping sickness is endemic in a large area of Sub-Saharan Africa. It occurs 
in 36 African countries south of Sahara where at least 50 million people ai'e at risk of 
infection (Kuzoe, 1993). Around 25 000 cases have been reported each year but since 
only 5-10% of the population is under surveillance it has been estimated that more 
than 300 000 people are carrying the disease (Smith et.al, 1998). The spread follows 
the geographical distribution of the tsetse fly. African trypanosomes of the T.brucei 
species have traditionally been regai'ded as consisting of thi'ee sub-species: 
T.b.brucei T.b.rhodesiense and T.b.gambiense. They have different host preferences 
and cause different disease patterns but are otherwise morphologically and 
antigenically indistinguishable (Hoare, 1970).
T.b.brucei is a paiasite of African antelopes, other ruminants and lizards in tropical 
Africa but it also infects domestic animals such as cattle, horses, camels, pigs and 
sheep. Together with the related species T.congolense and T.vivax, which are the
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primary pathogens of cattle, it causes a disease known as Nagana which involves 
severe anaemia and a significant reduced growth in domestic livestock. The clinical 
course of disease depends on the susceptibility of the host species. Horses, donkeys 
and dogs become acutely ill and usually survive only two weeks to four months. They 
suffer from anaemia, oedema, watery eyes and nose and fever, then become 
uncoordinated and paralysed and finally die. Cattle are usually more resistant to 
disease and can survive for several months after symptoms have been observed. Pigs 
are more refractory and may recover from the infection altogether (Schmidt & 
Roberts, 1989). T.b.brucei is common in most of the open country in Sub-Saharan 
Africa.
In a broad sense, T.b.rhodesiense and T.b.gambiense can be regarded as causing 
acute and chronic human sleeping sickness respectively, with the latter occurring in 
West and Central Africa and the former in East and Southern Africa. There is 
however, much complexity and diversity in these two sub-species which leads to 
variation and overlap in the disease pattern.
At the site of a bite of an infected tsetse fly, a small sore - the chancre, often 
develops. This disappears after 1-2 weeks as the parasites enter the blood and lymph 
and start to reproduce rapidly. The lymph nodes become swollen, especially in the 
neck (Winterbottom's sign), groin and legs. This is accompanied by intermittent 
periods of fever, generalised pain, headache, mood changes and altered 
electroencephalograms (EEG), which all correlate with meningeal inflammation 
(Pentreath, 1995). The ‘gambiense’ form of the disease may go on for years with 
extensive central nervous system involvement while the interval between the start of 
the infection and the encephalitic stage in T.b.rhodesiense is much shorter, usually a 
few months, and may lead to death before central nervous system symptoms develop. 
The heart is particularly susceptible to the general increase in perivascular cellularity, 
haemorrhage and oedema and heart failure are often the cause of death in the 
‘rhodesiense’ form (Manson-Bahr & Beil, 1991). CNS involvement progresses to 
mental deterioration which leads to reversal of sleep patterns and subsequently 
permanent sleep, coma and death. The neurological changes correlate with the 
progression from meningitis to encephalitis (Bentivoglio et.al, 1994). Apart from the
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causes mentioned, death may also oceur as a consequence of malnutrition or 
pneumonia or accidents caused by disturbed co-ordination and balance (Schmidt & 
Roberts, 1986).
Sleeping sickness was relatively well controlled during the early 1950's but political 
and civil unrest as well as poverty have forced many African countries to prioritise 
other issues so that trypanosomiasis is still a major problem and epidemic outbreaks 
are frequently being reported (WHO, 1990; Pepin, 1997; Smith et.al, 1998). 
Recrudescence of old foci and a spread into new areas have recently been reported in 
Southern Sudan, Angola, Uganda, Congo-Zaire and in the Republic of Central Africa 
(Smith eLal., 1998). Other areas with increased incidence include Cameroon, Chad 
and the Kigoma region in Tanzania (Kuzoe, 1993). An increase in human sleeping 
siekness has also been seen in the Ivory Coast since 1976 and is now an important 
health problem (Duoa & Yapo, 1993). A eontributing factor responsible for the 
outbreaks are large population movements and the subsequent increased contact 
between tsetse flies and newly settled people. Another big problem is sleeping 
sickness foci that extend across country borders where co-operation is hindered by 
poor relations between the eountries (Pepin, 1997).
Since the presence of tsetse flies is a requirement for the spread of trypanosomiasis 
and nagana much effort has been put into tsetse fly control. Practised control methods 
include removal of brush, to prevent flies deposit their larvae, and clearing of land to 
remove resting places for the flies, bait catching and spraying insecticides by aircraft 
(Barrett, 1997). Unfortunately, this effort has not significantly reduced the incidence 
of disease in cattle or humans and vast areas of rich grassland can not be used for 
agricultural purposes or for keeping grazing cattle (Perry, 1988). Since many 
available treatments are toxic, parasite detection is an important part of clinical 
assessment and treatment.
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1.1.3 Diagnosis of African sleeping sickness
Diagnosis of African trypanosomiasis is by detection of trypanosomes in the blood, 
lymph node aspirate or the CSF. The simplest and cheapest diagnostic technique is 
the examination of stained, thick blood films. The value of this teclmique was 
demonstrated by True et.al (1994), who recommended it as a simple, effective 
diagnostic method. The quantitative huffy coat (QBC) is a development of the 
haematocrit eentrifligation teclmique where aeridine orange is used to stain the 
trypanosomes and this is now available as a commercial product (Bailey & Smith, 
1992). The QBC® has the advantage that a lower concentration of trypanosomes can 
be detected. The most sensitive assay is the miniature anion-exchange centrifugation 
technique (Lumsden et.al 1981), but imfortunately this is not an easy method to use 
in the field. Serological assays can be used to demonstrate the presence of antibodies 
against Tb.gambiense as the total IgM levels will be elevated during infection. The 
card agglutination test for human trypanosomiasis (CATT) is another commercial kit 
for detecting T.b.gambiense which has been used for initial screening smveys (True, 
et.al, 1994). A development of the CATT is the card indirect agglutination 
trypanosomiasis test {TrypTQcX CIATT®) which can be used to detect both 
T.b.gambiense and T.b.rhodesiense and is rapid and sensitive for both patent and 
non-patent infections (Nantulya, 1997). Finally, the kit for in vitro identification 
(KIVI) can also be used for parasitological diagnosis of trypanosomiasis (Aerts, 
1992). It is a very sensitive method, albeit time consuming, which has shown to 
detect infection missed by other direct teclmiques.
1.1.4 Treatment of African sleeping sickness
Treatment of late stage sleeping siclmess is still mainly based on melarsoprol, a 
trivalent arsenical which was introduced in 1949 as Mel B Arsobal and, until 1990, 
was the only drug available for treatment of late stages of the disease. Melarsoprol 
was thought to be an inhibitor of pyruvate kinase (Flynn & Bowman, 1969) but
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trypanothione was later proposed as the iiitraeellular target (Faiiiamb et.al, 1989). 
These findings are now considered to be wrong and the target for melarsoprol 
remains unknown. Resistance to melarsoprol can be highly variable but has mainly 
remained at a low level probably because patients with melarsoprol resistant 
trypanosomes rarely have parasites in the bloodstream and so transmission is 
unlikely. Unfortunately, melarsoprol can also give rise to severe side effects, a 
danger which is often well known to inhabitants of endemic villages and can 
discourage people from participating in case detecting surveys (Pepin & Milord, 
1994).
Another drug available is pentamidine, a diamidine which is effective against early 
stages of T.b.gambiense. It is a reversible inhibitor of S-adenosyl-L-methionine 
decarboxylase leading to reduction in the synthesis of polyamines but it may also 
have other modes of action (Sands et.al, 1985). Treatment with pentamidine 
generally only gives rise to minor side effects, mainly affecting the digestive system, 
and a noticeable tenderness at the injection site. Resistance to pentamidine is less 
frequent than to melarsoprol and levels vary in different areas but has been 
comparatively stable for the last 30 years (Pepin & Milord, 1994). Pentamidine does 
not penetrate the blood-brain barrier and is therefore not effective against late stage 
sleeping siclmess (Manson-Baln & Bell, 1991).
A third drug, suramin, is effective against both Tb.gambiense and T.b.rhodesiense 
but is mainly used against T.b.rhodesiense. Its mode of action is poorly understood 
since it inhibits several enzymes of which many probably have nothing to do with the 
trypanocidal effect. Suramin has to be given intravenously because of its 
inflannnatory effects on tissue. For early stage ‘gambiense’ infection, it is best given 
together with pentamidine since the two drugs will form a complex which seems to 
be less toxic and more effective than either drug given alone (Pepin & Milord, 1994). 
However, in early stage rhodesiense trypanosomiasis it is thought that suramin is 
more effective than pentamidine. It is not an appropriate treatment for late stage 
sleeping sickness because of its poor penetration of the CNS (Manson-Balrr & Bell, 
1991).
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For late stage T.b.gambiense infection there is a good and less toxic alternative to 
melarsoprol in eflornithine (a-difluoromethylornithine, DFMO) but unfortunately it 
is much more expensive than melarsoprol and ineffeetive against a number of 
T.b.rhodesiense strains. DFMO is an inhibitor of polyamine biosynthesis and has 
rather few side effects when administered intravenously (Doua & Yapo, 1993). A 
drawback, apart from the cost, is that it requires a very large amount administrated 
intravenously every six hours for fourteen days. All manufacture of DFMO has now 
been discontinued (C.M.R. Turner, pers.com.), due to its cost and the limited market.
In summary, there is no trypanocidal drug available that ean claim to fulfil the 
criteria of being effective, non-toxic, cheap, well-absorbed orally and with good 
penetration of the CNS.
1.2 STOCKS AND SUB-SPECIES OF T.BRUCEI
T.b.brucei, T.b.rhodesiense and T.b.gambiense are all morphological identical and 
cannot be distinguished by microscopical observations. The original definition of 
these three subspecies was presented by Hoare (1970), taking into aecount their 
geographical distribution, their host specificity, their ability to infect humans and the 
pattern of disease they cause. Human infectivity was tested by the Blood Incubation 
Infectivity Test (BUT), whieh measures resistance to human serum by exposing 
trypanosome isolates to human serum followed by infection of rodents to detect 
surviving parasites (Riekman & Robson, 1970a). By these criteria, T.b.brucei is 
defined as infecting animals but not humans and is present in all of the tsetse fly 
areas in Africa, T.b.gambiense is human-infective, localised to West and Central 
Afriea and gives rise to chronic trypanosomiasis while T.b.rhodesiense is also human 
infective but is present in East Africa and causes acute sleeping sickness (table 1.1) 
Several studies have been published that are not consistent with these original criteria 
and there are still many practical problems when it comes to distinguishing the
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subspecies. The question therefore arises as to whether it is aceeptable to divide 
T. brucei into these tliree subspeeies.
Trypanosom e M ammalian host Disease Distribution
T. b. brucei wild and domestic 
animals
nagana Tropical Africa
Tb.rhodesiense humans, wild and 
domestic animals
acute human 
trypanosomiasis
East tropical Africa
T.b.gambiense humans and domestic 
animals
chronic human 
trypanosomiasis
W est and Central 
tropical Africa
Table 1.1. Distinguishing features o f the T.brucei group o f trypanosomes (after Hoare, 1970).
1-2.1 Methods for identifying Trypanosome stocks
There are various molecular and biochemical approaches that can be used to 
distinguish and characterise trypanosome species and subspecies. A method widely 
used for parasitic and non-paiasitic protozoa is enzyme electrophoresis where 
differences in the electrophoretic mobility of isoenzymes are used to detect a specific 
banding pattern for stocks and also to determine allele frequencies in populations of 
stocks (Tait et.al, 1980; Gibson et.al, 1980). Several isoenzymes can be compared 
in separate populations of trypanosomes and the relatedness of stocks assessed. A 
trypanosome stock is defined as a population derived by serial passage in vitro and/or 
in vivo from a primary isolation and there is no implication of homogeneity or 
characterisation. Stocks which turn out to have identical patterns are termed 
zymodemes and stocks with a similar pattern are said to belong to the same strain 
group (WHO, 1978). The greater the number of isoenzymes used, the more reliable 
the assessment of relationships will be. Hide et.al (1994) showed however, that 
stocks with identical Isoenzyme patterns may differ when analysed using repetitive 
DNA probes. This means that using isoenzyme profiles to suggest that two isolates 
are genetically identical can be misleading.
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There are various DNA analysis methods available which have been used to 
investigate the variation of DNA sequences and identify trypanosome stocks. These 
include restriction fragment length polymorphism (RFLP) analysis of kDNA 
maxicircles (Gibson et.al.,\9S5a.) and RFLP analysis of repetitive DNA sequences 
(Hide et.al., 1990). The latter can be undertaken by Southern blotting of DNA 
cleaved by a restriction endonuclease and using a repetitive DNA probe, which will 
detect variation in DNA sequence, to generate a ladder of bands which act as a DNA 
fingerprint. Conserved single copy gene sequences or satellite sequences can also be 
used to detect variation in restriction sites by hybridisation (Hide et.al, 1997). Many 
other types of genes can also be targeted and Sogin et.al (1986) used rapid 
sequencing techniques of small subunit ribosomal-RNA genes to analyse the 
evolutionary diversity within species of Trypanosoma. It is also possible, but 
laborious, to use direct DNA sequencing of appropriate genes.
Recently, the use of PCR with specific primers or with random primers referred to 
as RAPDs (Randomly Amplified Polymorphie DNA fragments) have proven very 
useful for distinguishing groups of isolates (Mathieu-Daude et.al, 1995). PCR 
amplifieation of repetitive DNA sequences, which are specific for trypanosome 
species or subspecies, proved to be a valuable tool in field surveys when 
investigating the identity of infections in tsetse flies (Masiga et.al, 1996). The 
prevalence of various mature trypanosome infections could be evaluated when 
satellite DNA was used as a target for primers specific for the T.brucei group 
allowing this group to be distinguished from T.vivax and T.godfreyl
1.2.2 Animal reservoirs of sleeping sickness
It was long assumed that bushbueks and other wild animals were the main 
reservoirs of sleeping sickness, mainly because the first human infective 
trypanosome, isolated from a non-human source, came from a bushbuck in East 
Africa (Heisch et.al, 1958). More recent studies suggest that at least a third of all 
T.brucei infected domestic animals carry trypanosomes that are also infective to
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hmnaiis and includes both T.b.rhodesiense and T.b.gambiense (Hide et.al, 1996;
Hide et.al, 1994). Of three trypanosome stocks isolated from domestic animals in |
Congo and Zaire and investigated for enzyme variation, one showed the typical 
pattern for T.b.gambiense (Tait et.al, 1984) and it has been confirmed that 
T.b.gambiense can be found in domestic animals such as pigs, dogs and sheep 
(Paindavoine et.al, 1986).
A number of studies have examined the prevalence of T.b.rhodesiense in both game 
and domestic animals using the BUT test as a criteria for identification. For example 
when 95 game animals in the Serengeti Area in Tanzania were examined for the |
presence of trypanosomes, 22% was found to be infected with T.brucei subgroup.
10% of these were resistant to human serum according to a BUT test (see next 
section) and therefore regarded as T.b.rhodesiense, 32.5% of them gave equivocal 
results and the remaining 57.5% were completely sensitive i.e. T.b.brucei according 
to the criteria of Floare (1970) (Geigy et.al, 1973). Another study by Bertram (1973), 
also in the Serengeti National Park, estimated that about 7.5% of the mammals were 
infected with T. brucei but only a small proportion of strains proved to be infective to 
humans by the BUT test and this was regardless of the host species they were found I
in. Hide et.al. (1990) collected a large number of T.brucei isolates from hmnans, 
cattle, pigs and tsetse flies in south-east Uganda and showed that a number of stocks 
isolated from cattle were human infective T.b.rhodesiense isolates and that cattle 
were reservoirs for T.b.rhodesiense. Hide et.al. (1996) calculated that it is five times 
more likely that an infected tsetse fly has obtained an infection from cattle than from 
an infected hmnan.
In summary, these analyses show that domestic animals act as reservoir hosts for 
T.b.gambiense and that both domestic and wild animals are reservoir hosts for 
T.b.rhodesiense. However, in the case of T.b.gambiense it is uncertain what role the f
animal reservoir plays as a source of human infection.
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1.2.3 Distinguishing T.b.gambiense from T.b.rhodesiense and T.b.brucei
One of the first attempts to measure genetic differences between T.b.gambiense, 
T.b.rhodesiense and T.b.brucei was carried out by the use of restriction enzyme 
analysis of kinetoplast DNA (Borst et.al, 1981). The results showed strain specificity 
but without a common pattern for the T.b.rhodesiense or T.b.gambiense kDNA. The 
three subspecies were apparently so closely related that they could not be 
distinguished by restriction enzyme analysis alone. Indeed, the differences found 
between trypanosome stocks from different areas in Africa are similar to that found 
in a single subspecies of mice from different areas of North America (Avise et.al, 
1994). If isoenzyme electrophoresis is used instead of restriction site analysis 
however, T.b.gambiense can be differentiated from the other variants as shown by 
Tait et.al (1984), who used electrophoretic enzyme variation to compare the degree 
of divergence between the three T.brucei species. The stocks used had previously 
been isolated and identified on the basis of their geographical and host origin as well 
as their sensitivity to human serum. From 20 screened enzymes, one, peptidase C, 
could differentiate all the T.b.gambiense stocks from the other stocks and together 
with another 5 enzymes could be used to differentiate all stocks. It was also clear that 
T.b.gambiense was more different from T.b.brucei and T.b.rhodesiense than these 
two are from each other. The basis for this argument was the measurement of genetic 
identity and genetic distance.
The combined use of restriction enzyme digestion and molecular hybridisation in 
order to determine relationships between T.brucei stocks was also used by 
Paindavoine et.al, (1986). The overall conclusions were similar to those obtained 
from isoenzyme analysis, i.e. all T.b.gambiense isolates have a conserved and 
specific DNA band pattern in common which was different from T.b.brucei and 
T.b.rhodesiense isolates. More recently Hide et.al (1994; 1998) compared T.brucei 
stocks from various locations by RFLP analysis and showed that T.b.gambiense 
could again be specifically identified as a distinct group.
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1.2.5 Distinguishing T.b.rhodesiense from T.b.brucei
T.b.rhodesiense was first identified and described by Stephens & Fantham, (1910), 
but its identity as a distinct species has since been questioned initially, by Riclcnian & 
Kolala, (1980). They carried out sequential BUT tests on successive clones produced
13
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1.2.4 T.b.gambiense type II
The main criteria to distinguish T.b.gambiense in the T.brucei group is its 
infectivity to humans and its origin in West Africa. It is not clear however, if 
T.b.gambiense is a true subspecies of T.brucei or if there is another subset of human 
infective T.brucei in West Afriea as suggested by Gibson (1986). She examined the 
isoenzyme profiles from several separate studies involving T.b.gambiense (Godfrey 
et.al, 1976; Tait et.al, 1984; Gibson et.al., 1980; Mehlitz et.al, 1982; Zillmami 
et.al, 1984) and found that T.b.gambiense could be divided into two groups, one 
group with limited isoenzyme variability which included the majority of isolates and 
one, less defined, group with greater isoenzyme variation. The latter group, which 
was termed Group 2, also showed variable results in blood incubation infectivity 
tests (Mehlitz et.al, 1982; Zillmami et.al, 1984) whereas the Group 1 stocks were 
highly resistant to human serum. When first identified as a species, the original 
T.b.gambiense was characterised by its low virulence to rodents but the defined 
Group 2 caused a more rapid onset and severe infection in experimental rodents 
(Mehlitz et.al, 1982). As yet, the Group 2 T.b.gambiense has only been found in 
Ivory Coast and Burkina Faso (Gibson, 1986) but RFLP analysis by Hide et.al
(1994) also identified two groups of T.b.gambiense, one of whieh showed a close 
relationship to West African T.b.brucei. A further study by Godfrey et.al (1987) 
found that some isolates collected from patients in gambian sleeping sickness areas 
in Ivory Coast and Burkina Faso grew quickly in laboratory animals and that the 
isoenzyme pattern of these isolates differed from a defined T.b.gambiense enzymic 
pattern. These studies suggest that a sub-set of T.b.gambiense isolates have the 
characteristics of T.b.rhodesiense.
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in vivo from 3 different T.b.brucei isolates, serially syringe-passaged in rats at 10- 
days intervals. After being initially BUT negative, all three stocks eventually gave 
rise to human serum resistant clones typical of T.b.rhodesiense. There were also 
changes in VAT expression. In a follow up study using enzyme electrophoresis no 
enzyme variants or alleles specific for T.b.rhodesiense could be found and it was 
shown that T.b.rhodesiense is a more homogeneous group than T.b.brucei (Rickman 
et.al., 1984).
T.b.rhodesiense typically occurs in East Africa as a disease of low prevalence but 
with epidemics occurring periodically. The reasons for these epidemics are not fully 
understood and various factors have been considered including the occurrence of new 
strains, animal reservoirs, movement of human populations and the development of 
more virulent strains in the same region. Studies by isoenzyme electrophoresis of 
T.b.rhodesiense stocks from Botswana and Zambia have shown that they are clearly 
different from strains causing disease in the northern Uganda/Kenya region and there 
are also differenees in disease patterns (Godfrey et.al, 1990; Stevens et.al, 1992). 
Many hundred stoeks of T.brucei from several countries in Africa were characterised 
by isoenzyme electrophoresis and the data obtained indicated that specific strains 
have a rather limited geographical distribution and little genetic exchange takes place 
between stoeks from different areas (Godfrey et.al, 1990). T.brucei zymodemes were 
only similar within a restricted area and many differences were found within its 
geographical distribution suggesting that the parasites may be adapted to different 
specific environments. Hide et.al. (1994), showed that T.b.rhodesiense populations 
collected in Tororo district of Uganda formed a distinct group but that this group was 
very different from another distinct group of T.b.rhodesiense collected in Zambia. 
From these observations it was subsequently suggested that T.b.rhodesiense strains 
from Zambia and Kenya/Uganda have different and independent origins. (Hide et.al, 
1991; 1994). In order to understand the geographical spread, Komba et.al. (1997), 
compared Tanzanian T.b.rhodesiense isolates with stocks from Uganda, Kenya and 
Zambia and showed that there was a considerable homogeneity within the Tanzanian 
stocks which supports the suggestion that there are different genotypes of 
T.b.rhodesiense in each endemic region of East Africa.
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An epidemic of human sleeping siclmess occurred in the Tororo district of south­
east Uganda in the late 1980's. After an epidemic in the 1920’s, no cases of human 
sleeping sickness were detected until 1984 but many hundred were reported each 
year until 1990. Large numbers of T.brucei isolates were collected from infected 
humans, pigs, cattle and tsetse flies during these years (Maudlin et.al, 1990) and 
analysed for variation in isoenzyme patterns and for RFLPs (Hide et.al, 1990, 1991,
1994, 1996). Repetitive DNA sequences, derived from libosomal RNA genes, were 
used as probes and the resulting restriction enzyme patterns were used to construct a 
dendrogram to define the similarity between stocks (Hide et.al, 1991). The isolates 
were also analysed for their resistance or sensitivity to human serum. Trypanosomes 
collected from humans, tsetse flies and various animals from both West and East 
Africa were included in this dendrogram. In summary, it was shown that all isolates 
collected were very different from a group of T.b.gambiense isolated in West Africa 
but that the human non-infective trypanosomes, assumed to be T.b.brucei, were a 
diverse set of stocks whieh were distributed among several different similarity 
groups. Human infective and human non-infective trypanosomes were 
distinguishable from each other so that human serum resistant stocks all fell into one 
group and formed a defined separate sub-population compared with other stocks 
isolated from animals in Kenya and Uganda. The human serum resistant and himian 
serum sensitive stocks were regarded as T.b.rhodesiense and T.b.brucei respectively.
There was however, one exception with a stock from a human in West Africa which 
was indistinguishable from East African T.b.brucei. The human serum resistant Æ
stocks had a repetitive DNA fingerprint that was similar to that from other human 
serum resistant stocks from human sleeping sickness foci in Kenya and Uganda. Hide 
et.al (1994) are the only group that claims to be able to distinguish T.b.rhodesiense 
isolates from T.b.brucei isolates and it has yet to be investigated whether such 
differences exist in other areas apart from south-east Uganda. Mihok et.al (1990) 
analysed a series of isolates of T.b.rhodesiense collected from the Lambwe valley,
Kenya, over a long time period and, based on isoenzyme markers, concluded that the 
human infective parasites were different from human non-infective trypanosomes.
They suggested that the markers used were linked to genes with direct importance to
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human infectivity. This was, however, only a speculation since the isoenzyme 
markers identified differed from those found in human isolates in Uganda by Gibson 
& Gashumba, (1983).
In conclusion, T.b.rhodesiense may be more related to T.b.brucei stocks in the same 
areas than to other T.b.rhodesiense stocks in different areas and T.b.rhodesiense is 
likely to be a subset of T.b.brucei rather than a genetically distinct type. This would 
explain the difficulties in finding specific isoenzyme markers that can distinguish 
between T.b.brucei and T.b.rhodesiense.
1.2.6 The origin of human infective trypanosomes
It can be postulated that human serum resistant trypanosomes arose from non­
human infective strains, possibly through selective pressure. This can certainly occur 
in laboratory strains when human serum sensitive strains are made human infective 
by exposing them to human serum as demonstrated by Rifkin et.al. (1994) and Seed 
et.al. (1993). In the field this may be initiated by contact of trypanosomes with 
human serum in tsetse flies feeding on humans and non-human infective 
trypanosomes may then evolve to human serum resistant variants. However, the low 
prevalence of trypanosomes in humans and the epidemic nature of the disease makes 
it difficult to see how sufficient selective pressure could occur for human infective 
trypanosomes to develop. Another possibility is that genetic exchange between 
T.b.brucei, T.b.rhodesiense and T.b.gambiense could lead to the inheritance of 
human serum resistance into populations with minimal contact with humans. The 
implications of genetic exchange will be discussed in detail in section 1.5.
1.3 ANTIGENIC VARIATION IN T.BRUCEI
The mammal infective stages of African trypanosomes are completely enwrapped in 
a monolayer of a single species of glycoprotein, the variant surface glycoprotein
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\(VSG). The VSG protects tlf^ parasite from components of non-specific immune 
responses but is itself immunfigenic and stimulates a strong antibody-mediated
immune response. To avoid killing by this specific immunity, trypanosomes
periodically switch from expression of one VSG to that of another. Each VSG
determines a different variable antigWi type (VAT) and this switching process is thus
termed antigenic variation (Cross,/lV75i When bloodstream stumpy forms are
\  //ingested by the tsetse fly their surfacVcoat is rapidly lost in the midgut of the fly. 
This is correlated with the loss of infectivity and occurs within 48 hours (Barry & 
Vickerman, 1978). The surface coat is again acquired at the metaeyelic stage, as a 
pre-adaptation for survival in the mammalian host (Vickerman, 1985).
VSGs have molecular weights of 53-63 kD and each VSG consists of an N-terminal 
domain of 350-400 residues and a C-terminal domain of 50-100 residues. The C- 
terminus is anchored to the cell surface tlrrough the covalent attachment to a 
glycosylphosphatidylinositol (GPI) anchor in the cell membrane (Ferguson et.al,
1988). The N-terminal domain comprises two antiparallel a-helices with several 
smaller elements, together forming an elongated structure (Blum et.al, 1993). More 
than 20 VSG genes have been sequenced to date and they share very little sequence 
homology and no common biochemical activity has been found. The only common 
requirement known is their ability to form a protective surface coat. The N-terminal 
domains share the lowest sequence homology and antigenic variation occurs through 
sequence variation throughout the whole of the N-terminal domain while the C- 
terminal domain is the more conserved region. There are, however, conserved 
regions both in the N- and C-terminal domains and these have been grouped into 3 
classes; A, B and C for the N-terminus and, by sequence homology, into 4 classes, 1, 
II, III and IV for the C-terminus (Carrington et.al, 1991). When the variable domains 
of two VSGs were compared by X-ray crystallography it was shown that the tertiary 
structures were highly similar even though the overall sequence similarity was very 
low (Blum et.al, 1993). It is remarkable for a family of proteins, with a similar 
function, to have such low homology with each other and yet form a very similar 
structure. The switch from one VSG to another is a gradual process so that during 
switching the trypanosome will initially expresses a mixed surface coat. If different
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VSGs had different tertiary structures they would not fit in properly thus 
compromising the integrity of the surface coat. In summary, antigenic variation is 
most likely caused by variation in sequences and not by variation in structures.
1.3.1 Expression of VSG genes
Each VSG is transcribed from a separate VSG gene and there are several hundred 
VSG genes in the genome but only one VSG is expressed per cell. Expression is 
controlled at the transcriptional level and VSG genes can only be expressed from one 
of the approximately 20 VSG expression sites (ES). Only one of the ESs is active at 
any given time (Borst & Rudenko, 1994). The most common mechanism for 
switching between VSGs is for a non-expressed VSG gene to be copied into an 
expression site and replace the previously expressed VSG gene. There aie also VSG 
genes whieh normally reside in expression sites and can be activated where they are 
by stopping transcription from one ES and simultaneously starting transcription from 
another. Alternatively, VSG genes can be transposed between ESs. The activation of 
one site and inactivation of another appear to be independent, spontaneous processes I;
but the mechanisms of activation/inactivation remain unlmown (Borst et.al, 1997).
In an ES, a VSG gene is associated with, at least, eight other genes referred to as 
expression site associated genes (ESAGs) that are co-transcribed as a single 
polycistronic transcription unit (Pays et.al, 1989; Cully et.al, 1985).
VSGs are not expressed at random but in a semi-predictable order in an infection.
The order of VSG gene expression in T.brucei appears to correlate to the ease with 
which VSGs are switched on so that telomeric genes in expression sites that are more 
easily activated tend to appear first in an infection. Other telomeric genes are then 
expressed because they show good homology with the active expression site and 
these are followed by expression of non-telomeric genes with good homology at both 
3' and 5' ends and finally genes with poor homology in flanking sequence with the 
expression site will be expressed (Borst, 1991).
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Metacyclic trypanosomes also have a VSG coat which protects them from lysis by 
host serum factors. VSG genes are activated and expressed differently in the 
metacyclic and bloodstream stages. The expression of VATs by metacyclic 
trypanosomes shows much more predictability than VATs by bloodstream 
trypanosomes. There are no more than 27 metacyclic VATs (M-VATs) in 
T.b.rhodesiense and there is no switching between different VSGs in metaeyelic 
forms. Instead of antigenie variation, there is a mixture of VATs present in the 
metacyclic population before they enter a mammal (Barry et.al, 1983). This occurs 
by simultaneous and random activation of individual telomeres containing the M- 
VSG repertoire and the VSG genes in each M-expression site are conserved so that 
the M-VSG repertoire is predictable (Tetley et.al, 1987). M-VSG genes all occupy 
the telomeres of the largest chromosomes (Barry et.al, 1990). The advantage of 
having a mixture of VSGs is thought to derive from the improved probability of 
establishing infection in semi-immune hosts.
Procyclie trypanosomes do not express VSG genes. Instead they produce an 
abundant invariant surface protein called the procyclie acidic repetitive protein 
(PARP) or procyelin (Roditi & Pearson, 1990).
1.3.2 VSG switching during trypanosome infection
A trypanosome infection can be induced by a single trypanosome after which a 
parasitaemia takes the form of waves peaking at irregular intervals. The profile of the 
parasitaemia can take a variety of shapes including small sharp peaks arising from a 
background of more or less permanent parasitaemia or regular or irregular peaks of 
parasitaemia. These differences in parasitaemia patterns are reproducible and only 
partly determined by the host's immune response (Barry & Turner, 1991). For 
antigenic variation to be successful in evading the immune system, the different 
VATs must appear consecutively and this takes place in a semipredictable way, in a 
hierarchical but ill-defined sequence of expression. The switching rate is 
approximately 100 switches per generation (Turner & Barry, 1989). That is, at least 
one in every 100 trypanosomes switches its VAT expression every generation. Some
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VATs have a high tendency to appear early in infection whereas others are more 
common later in infections even though this relationship is not totally fixed. VATs 
appearing early in infection continue to be produced throughout infection but these 
trypanosomes are killed off by the immune response. Factors involved in determining A
the pattern of parasitaemia involve the growth rate and trypanosome population size A:
in a particular host species, the overall number of different antigenic variants and the 
hosts’ immune response. However, no adequate model of how the hierarchy of 
switching occurs has been proposed.
/
%
Switching is not induced by antibody since switching in VSG expression also 
occurs in immuno-compromised animals and in in vitro cultures (Doyle et.al., 1980).
The presence of other bloodstream populations in lymphatics or extravascular sites A
does not influence the rate of switching and it is thought that selective pressure from
the hosts' immune response is important for the generation and maintenance of the
high rate of switching (Turner & Barry, 1989). ?
1.3.3 Surface receptors of T.brucei
The entire external surface of T.brucei is covered by VSG molecules with the 
exception of the flagellar pocket. The flagellar pocket is an invagination in the 
surface at the site of flagellar attachment and forms 1-3 % of the total cell surface. 
The layer of VSG molecules is much less dense in the flagellar pocket and receptors 
for the uptake of host macromolecules such as transferrin and low density 
lipoproteins (LDL) are located in the pocket. The presence of surface receptors for 
these large molecules has been demonstrated by showing that uptake of transferrin 
and LDL occurs much faster than fluid phase endocytosis and that uptake is saturable 
(Coppens et.al, 1987). LDL and transferrin are required by the bloodstream stages of 
T.brucei for their growth (Coppens et.al, 1988; Schell et.al, 1991). All the available 
iron in the blood of mammals is bound by transferrin and the concentration of free 
iron is reduced to a level which cannot support growth of micro-organisms so the
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specific uptake of transferrin is a method for trypanosomes to overcome this 
limitation in iron availability (Coppens et.al, 1987).
The structure of LDL and transfemn molecules may vary between mammals but 
they are invariant within a specific host and the receptor binding site must therefore 
also be relatively invariant. The receptors for these molecules may extend out beyond 
the VSG coat but it has been suggested that in order not to be recognised by the 
immune system they may be capable of some variation (Borst, 1991). ES AG 6 and 7 
together form a transferrin binding protein complex so that the transferrin receptor of 
T.brucei is encoded by ES AG 6 and 7. This means that the parasite could modify the 
receptor by switching to another ES as different members of the ESAG 6/7 gene 
family vary in gene sequence. Bitter et.al (1998), have shown that the small 
differences between transferrin receptors can be very important and allow T. brucei to 
adjust to the large sequence diversity in transferrin from different hosts.
The most abundant surface protein, after the VSGs, are the invariant surface 
glycoproteins (ISGs). The functions of the ISGs are not yet laiown and the sequences 
of the genes for ISG-65 and ISG-75 do not show homology to any known proteins 
(Ziegelbauer et.al, 1992). They are distributed over the whole surface of the cell and 
the flagellum but they are not readily accessible to antibodies in live cells because 
they are ‘shorter’ than the VSGs so that binding is prevented (Overath et.al, 1994). 
Invariant surface proteins are expressed at a level 100-10 000 fold less than VSGs 
(Overath et.al, 1994). Several other non-VSG proteins are also thought to have the 
same kind of dimensions as a VSG N-terminal domain and examples of these non- 
VSG surface molecules with the same tertiai'y struetme, apart from the ISGs, are the 
polypeptides produced by ESAG 6 and 7 and the procyelin associated gene 1 (PAGl) 
product (Carrington & Bootlii’oyd, 1996).
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1.4 HUMAN INFECTIVITY
1.4.1 Sensitivity of African trypanosomes to human serum
Identification of the T.brucei subspecies pathogenic to humans was originally 
dependent on human volmiteers. The first demonstration that animals can be 
reservoirs of T.b.rhodesiense was made by the use of human volunteers (Heisch 
et.al, 1958) and human volunteers were also used to show that Tb.gambiense and 
T.b.rhodesiense ean retain their infectivity even after long periods of cyclical 
transmission by tsetse flies (Willett & Fairbairn, 1955). These unethical infectivity 
assays have now been replaced with new methods and several trypanosome species 
have been tested for their sensitivity/resistance to normal human serum using both in 
vitro and in vivo assays. Isolates of the cattle trypanosome T.b.brucei, the horse 
species Tequinum and T.equiperdum (Verducci et.al, 1989) and isolates of the 
camel parasite T.evansi are all lysed by the presence of human serum while the 
human infective subspecies T.b.gambiense and T.b.rhodesiense are resistant and can 
withstand lysis by normal human serum (Seed et.al, 1990; Paindavoine et.al, 1986; 
Van Meirvenne et.al, 1976). Most isolates, but not all, of the cattle trypanosome, 
T.congolense, are also lysed when incubated with human serum (Hajduk et.al, 
1994).
Wlien discussing the susceptibility or resistance to trypanosome infections it is 
important to separate the effect of the host's immune response, both specific and non­
specific, and the non-immune, innate resistance that results in host selectivity. In 
addition to human serum, serum from other primates can have a killing effect upon 
T.b.brucei and a sui'vey by Seed et.al (1990) showed that baboon serum had the 
highest trypanocidal activity followed by serum from human, mandrill and gorilla. 
Many other host species show some degree of tolerance to trypanosome infection. 
Parasitaemia can be controlled in the animal by specific and non-specific antibodies 
and by cell mediated responses although naturally evolved, non-immune serum 
factors may also play an important role (Mulia & Rickman, 1988; Muranjan et.al, 
1997).
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The stability of the human serum resistant (HSR) or human serum sensitive (HSS) 
phenotypes appears to vary between isolates. Most isolates of T.b.gambiense appear 
to be stable for the HSR phenotype as demonstrated by the fact that isolates 
maintained in laboratory animals for long periods are still capable of infecting 
humans. The HSR phenotype of many T.b.rhodesiense isolates can, on the other 
hand, be lost if passaged in laboratory rodents for prolonged periods (Yorke et.al, 
1930; Rifkin et.al, 1994; Rickman et.al, 1982). Some T.b.brucei isolates have been 
made resistant to human serum by repeatedly injecting infected animals with human 
or baboon serum in sub-curative doses but others appear to have a stable HSS 
phenotype (Rickman & Kolala, 1980). It is however, unclear whether the HSS 
isolates whieh have been made serum resistant can infect humans. Old data implies 
that human volunteers did not develop a parasitaemia after infection with such strains 
(Yorke, et.al, 1930). In these isolates, which can be changed from resistance to 
sensitivity, or from sensitivity to resistance, extensive passaging in mice or rats is 
required perhaps implying that this is not a single step process. Ortiz et.al (1994) 
reported that it took at least one year to convert T.b.gambiense to a sensitive state 
(24-36 mouse passages). It always took longer for clones to acquire resistance than it 
took for clones to revert to sensitivity. Studies on T.b.rhodesiense and T.b.brucei 
report a similar time scale and number of passages for change in sensitivity/resistance 
(Hawking, 1976; Rifkin et.al 1994). At least one T.b.rhodesiense has however, been 
passed through sheep and other animals for 23 years without contact with human 
serum but was still human infective at the end of the experiment (Ashcroft, 1959).
A number of studies have indicated a change in HSS or HSR phenotype is 
associated with a change in VAT expression (Hawking, 1977; Rickman & Kolala, 
1980; Rickman et.al, 1981; Gibson, 1989; Van Meirvenne et.al, 1976) but no in- 
depth studies were eompleted until Rifkin (1994) analysed 3 pairs of HSS and HSR 
T.b.rhodesiense. No correlation between changes in resistance and VAT expression 
was observed. In a parallel study, using T.b.gambiense, a change in VAT was always 
observed when there was a ehange in human serum susceptibility (Ortiz et.al, 1994).
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Each time a HSR elone was selected from a HSS clone, by gradually increasing the 
amount of normal human serimi (NHS) injected into an infected mouse, they seemed 
to change their VAT. The same VAT was therefore never observed in both resistant 
and sensitive clones. It may well be that there is great variation in stability between 
different stocks for reasons that will be discussed below.
Fresh human serum can have a trypanocidal effect upon both proeyelic T.b.brucei, 
which otherwise are resistant to human serum, and upon bloodstream 
T.b.rhodesiense (Rifkin, 1978). This is probably due to non-specific activation of the 
complement system. When the serum is heat-treated at 56° C for 30 minutes to 
inactivate complement, this sensitivity disappears. Non-heat inactivated fi*esh sera 
from rat, guinea pig, mouse and rabbit, on the other hand, have been reported to have 
no effect upon trypanosomes and are therefore often used as control sera in 
sensitivity/resistance assays (Rifldn, 1978). Early studies showed that a trypanosome 
lytic factor was present in human serimi which was non-immune and very unlikely to 
involve the host's complement pathway. The basis for this conclusion was mainly 
that heat-inactivation of both the classical and alternate pathways of complement has 
little or no effect on the trypanocidal activity (Rifldn, 1978). Furthermore, human 
serum did not cause the T. brucei group trypanosomes to agglutinate and no decrease 
in trypanosome killing could be noted when the IgG fraction of an anti-IgM serum 
was used to absorb out human IgM (Riflcin, 1978).
Apart from certain stocks being resistant or sensitive to human serum there are also 
differences in susceptibility between the various developmental stages in the life 
cycle. All of the bloodstream stages of T.b.brucei are susceptible to human serum 
even though the dividing slender forms are more sensitive than the non-dividing 
stumpy forms, probably due to the slender forms having a higher rate of endocytosis 
(McLintock et.al, 1993). Procyclie stages are all sensitive to complement mediated 
lysis but they are resistant to killing by heat-inactivated human serum. This is 
probably because procyclics take up macromolecules by a mechanism different from 
that of the bloodstream and metacyclic forms and some studies have shown that 
procyclics do not endocytose macromolecules at all and therefore will avoid any
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cytotoxic factors in the NHS (Vickerman, 1985). If bloodstream T.b.brucei are 
incubated under conditions that promote the differentiation into proeyclics they will f
develop resistance to NHS (Moore et.al 1995). Long slender forms, that cannot 
differentiate into procyclics, did not develop any resistance when they were kept 
under the same conditions. Differentiating stumpy forms further showed a decrease 
in protein synthesis and it was suggested that a protein required for binding and 
endocytosis of a cytotoxic factor is lost during the differentiation from bloodstream 
forms into procyclics (Moore et.al, 1995).
1.4.2 Methods for measuring HSS/HSR
Originally, the only way to test a particular strain of trypanosomes for its infectivity 
to humans was to inject it into lumian volunteers (Heisch et.al, 1958; Willett & 
Fairbairn, 1955). For obvious ethical reasons, there was a need for a reliable method 
for measrning HSS/HSR to replace these volunteer studies. To this end, Rickman & 
Robson (1970) developed an assay, involving the use of rodents instead of humans, 
known as the blood incubation infectivity test (BUT). In this assay trypanosomes 
were isolated and incubated in the presence of human blood for 5 hours at 37°C and 
then irqected into mice or rats. Next, the animals are screened for parasitaemia and, if 
an infection developed, the initial trypanosomes are scored as resistant to human 
serum (HSR) and if not, they are referred to as human serum sensitive (HSS). The 
BUT proved to be a valid and reliable test where all T.b.rhodesiense (isolated from 
humans) gave positive results and strains which had shown to be human non- 
infective, and presumed to be T.b.brucei, gave a negative BUT result (Rickman & 
Robson, 1970). There were however, a few strains which gave ambiguous results in 
that the parasitaemia took much longer to develop and retests were negative. The 
tests were repeated a large number of times with the same results.
In vitro methods have been developed based on the BUT, which consist of 
microscopically counting the percentage lysis caused after a certain time of 
incubation in human serum (Rifkin, 1978) or, as developed by Tomlinson el. at.
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(1995), the use of a probe, acetoxymethyl (AM) ester of calcein, for measuring the 
viability of cells. AM-caleein is an uncharged, colourless and non-fluorescent ester 
which enters the trypanosomes and, in viable cells, is cleared by intracellular 
esterases resulting in the generation of the fluorescent free acid inside the cells. These 
in vitro methods allow comparison between stocks and/or clones but cannot 
determine whether a particular stock is capable of causing a parasitaemia in humans 
or other mammals. Brun et.al (1981) described an in vitro culture system for 
bloodstream T.brucei in which T.b.gambiense and T.b.rhodesiense stoeks could 
survive and grow in the presence of human serum while T.b.brucei was killed. This 
in vitro test consisted of a feeder layer of fibroblast-like cells from Microtus 
montanus embryos, culture medium and normal hmnan serum (NHS). The cultures 
were maintained for 10 days after which HSS stocks were neutralised by NHS while 
HSR stocks showed continuous growth in the presence of human serum (Jemii & 
Brun, 1982). This method was however, not widely used since it has been proven 
difficult to reproduce in other laboratories.
It has been argued that it would be more appropriate to test resistance to human 
serum in metacyclic forms instead of in bloodstream forms since these are the stage 
which first encounter human serum when injected by a tsetse fly. Brun & Jenni 
(1987), carried out initial tests of metaeyelic forms and the resulting bloodstream 
forms of representative stocks of T.b.brucei T.b.gambiense and T.b.rhodesiense 
using the above method. It is open to question however, whether this test genuinely 
measures the HSS/HSR of metacyelics since within 1 day in culture, all of the 
metaeyelic forms have transformed into bloodstream forms. However, it would be 
possible to analyse metacyelics by the BUT but this has not been undertaken.
In conclusion, while there are reliable and reproducible methods for measuring the 
resistance or sensitivity of trypanosomes to lysis by human serum, it is unclear 
whether these fully reflect the ability of the trypanosomes to infect humans. A 
number of representative assays have been developed that vary in the degree of 
simplicity of screening but, given that human experiments cannot be midertaken, it is 
difficult to fully evaluate how well they reflect true human infectivity.
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1.4.3 Intermediate resistanee to human serum
A particular feature of HSS/R assays that has tended to be overlooked in recent 
years is that intermediate levels of resistance can be detected in some stocks or lines 
of trypanosomes. These intermediate levels of resistance have been attributed to the 
presence of unknown factors in the test animal, inaccuracy in the test method, 
artefacts or have simple been ignored (Tai-gett & Wilson, 1973; Geigy et.al, 1975; 
Mehlitz & Feddersen, 1987; Rifkin, 1984; Jennings & Urquhart, 1985). It is entirely 
possible however, that trypanosomes with intermediate levels of resistance represent 
a valid and specific phenotype. Rickman & Robson, (1980), found intermediate 
levels of resistance while developing the BUT when two T.brucei stocks repeatedly 
showed infectivity for some, but not all, rats. Metacyclic forms can also exhibit 
intermediate resistance. Wlien Brim & Jemii (1987), analysed stocks of T.b.brucei, 
T.b.rhodesiense and T.b.gambiense they found inconsistent results from resistance 
assays within a group of T.b.rhodesiense stoeks. If these isolates were passaged in 
rodents the resistance disappeared completely whereas if they were cultivated in the 
presence of human serum they all became resistant.
A key feature in discussing findings of intermediate resistance is whether the stocks 
used for analysis are clones as uncloned stocks could be a mixture of distinct human 
serum sensitive and human serum resistant trypanosomes. An artificial model of such 
a mixed strain was tested by Hawking (1976) who mixed a very small nmnber of 
cells from a highly resistant population with one million cells from a sensitive stock 
and could show that when no human sermii was present infection was dependent on 
the size of the inocula but in the presence of human serum infection was instead 
dependent on the small number of resistant cells. Hawking explained his finding of 
sub-resistant strains as being due to the presence of a mixed population, and the level 
of resistance depended on the number of resistant individuals in it. All the 
trypanosomes used in the study were uncloned strains.
27
Chapter 1 General Introduction
The existence of trypanosomes with intermediate levels of resistance may be 
explained by there being one or two genes responsible for resistance and the 
intermediate, or sub resistant, strain contains a mixture of cells without the resistanee 
gene/genes but also a few with the resistance gene/genes (Hawking, 1976). Other 
possible explanations may involve gene amplification, the presence of several 
mechanisms for resistance or resistance being a particularly labile trait prone to 
mutations so that they ai'e generated repeatedly from a sensitive stock. A spontaneous 
switching from sensitive to resistant would probably also cause strains to appear of 
an intermediate resistance but since converting a sensitive strain to a resistant strain 
or vice versa, seems to take at least 25-30 mouse passages (Rifkin et.al, 1994; Ortiz 
et.al, 1984; Riclanan et.al, 1982; Riclanan & Kolala, 1980) a complete switching 
may appear unlikely. Alternatively, the whole population of cells may express an 
intermediate level of resistance between fully resistant and sensitive.
1.4.4 The trypanolytic effect of human serum on HSS trypanosomes
Trypanosomes which are sensitive to human serum will go tlnough a series of 
morphological changes prior to lysis when incubated with human serum. The 
cytotoxic factors in the serum cause acute, irreversible damage to the plasma 
membrane and the cell will eventually die. The morphological changes are consistent 
with a colloid osmotic mechanism (Rifkin, 1984). First there is a lag phase when no 
visible damage can be seen on the trypanosomes. This lag phase usually lasts 20-40 
minutes regardless of the serum concentration used. The morphological changes of 
cells incubated with NHS cannot be reversed even if they are exposed to serum for 
only 10 minutes, washed and placed in non-cytotoxic medium. After 2 hours these 
cells showed the same changes as cells which had been incubated with human serum 
for 2 hours (Rifkin, 1984). A decrease in protein synthesis starts after an 
approximately 30 minutes lag phase. After the lag phase the cells appear distorted 
and swollen with a prominent flagellum but they are still motile. Complete lysis 
occur within 2 hours when only a cell ghost with a prominent nucleus can be seen. 
When the ultrastructure of the cells was examined 20 minutes after the start of
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incubation, a decrease in cytoplasmic staining with uranyl acetate and lead citrate 
was observed (Rifldn, 1984; Hawking et.al. 1973). The cytoplasm becomes pale and 
vacuolated and finally appears to disintegrate. The structure of the mitochondrion, 
ribosomes and nucleus did not change however, and morphological changes in the 
cell membrane could only be observed late in the lytic process. Rifldn, (1984) 
demonstrated that lysis by human serum led to an osmotic imbalance and a rapid 
efflux of K+. The K+ efflux and the lysis could be prevented by the presence of low 
levels of sucrose or dextran during in vitro incubation and the cells remained of 
slender morphology with normal motility under these conditions. Rifldn gives two 
explanations for this apparent protection. Firstly, sucrose may be a competitive 
inliibitor of the trypanocidal factor, or, secondly, sucrose might simple block the cell 
swelling and lysis caused by osmotic imbalance without interfering with the 
trypanocidal factor at all (Rifldn, 1984).
1.4.5 Potential factors involved in human serum mediated lysis
HDL as a lytic factor (TLFl)
Rifkin (1978) was the first to isolate a potential candidate for the trypanocidal factor 
in human serum by showing that trypanolytic activity coincides with human high 
density lipoprotein (HDL). Human HDL was purified by density gradient 
centrifugation or size-exclusion cliromatography and in both cases a fraction of each 
had the ability to kill trypanosomes. When the lytic ability of the fraction was 
compared with that of intact human serum it was discovered however, that the peak 
of trypanosome lytic activity overlapped, but did not actually coincide, with the 
eluted HDL. It was therefore suggested that the lytie factor is a minor part of the 
purified HDL or even a specific HDL serum subclass.
Human lipoproteins consist of neutral lipids with a shell of phospholipids and 
apolipoproteins. Their function is to transport insoluble cholesterol, cholesterol esters 
and triglycerides to peripheral tissues and to the liver. This will ensure adequate 
amounts of cholesterol for membrane assembly, steroid hormone synthesis and bile
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acid production. There are four major classes of lipoproteins, very low-density 
lipoprotein (VLDL), low-density lipoprotein (LDL), high-density lipoprotein (HDL) 
and chylomicrons and each is chai'acterised by the addition of specific lipids and 
apolipoproteins (Illingwoi’th, 1993).
Hajduk et.al (1989) supported the idea that the lytic factor is a specific HDL serum 
subclass. Human serum was fi-actionated by gel filtration chromatography and the 
lytic factor was found only in a very minor subclass of HDL which is now named the 
trypanosome lytic factor 1 (TLFl). The majority of serum HDL was subsequently 
shown to be non-toxic to trypanosomes. TLFl consists of very lai’ge HDL particles 
with an estimated size of 500 kDa (average size of human HDL is 250 kDa) and is 
unique in that it contains two apolipoprotein complexes, apoLI and apoLIII which are 
not found in any of the other four human lipoproteins mentioned. It does however 
contain apoAI and apoAII which can be found also in the non-lytic human HDL 
fraction and may indicate its close relationship with HDL. ApoAI, apoLlII and apoLl 
are, according to Tytler et.al. (1995), all needed for trypanosome lysis by 
reconstituted TLFl particles but individually they cannot cause lysis. ApoLIII in 
particular appears to be essential for the formation of a cytotoxic pai'ticle and either 
apoAI or apoLI must also be present. ApoAII, on the other hand, is not required for 
lysis to take place. Human serum lipids were needed for a correct assembly of the 
TLFl particle but may not be involved in lysis directly. A second set of data that 
support the idea that TLFl is a trypanosome lytic factor is that antibodies produced 
against apoLI and apoLIII can inliibit lysis by purified TLFl (Seed et.al. 1990). This 
is however not true for antibodies against apoAI and apoAII which have no effect on 
the lytic ability. This has been explained by competition for antibody binding 
between TLFl and non-lytic HDL since the concentration of non-lytic HDL in serum 
is several hundred fold higher than the concentration of TLFl (Seed & Sechelski,
1989).
Apolipoprotein as the sole toxic factor
In contrast to these data suggesting that several components of HDL are required for 
lysis, other studies have suggested that apoA-I is the sole trypanosome lytic factor in
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TLFl (Owen et.al., 1992; Gillet & Owen, 1992). Purified apoAI from human, 
baboon, sheep and cattle HDL was incubated with T.b.bmcei and it was shown that 
human and baboon apoAI lysed trypanosomes both when it was free in solution and 
when associated with lipids (Gillet & Owen 1992). Sheep and cattle apoAI did not 
have any significant effect on T.b.bmcei. Owen et.al. (1992) went on to test the 
trypanolytic effect of sera from transgenic mice expressing human apoAI levels 
similar to those found normal human sera. The authors report the paradox that sera 
from these mice had a raised ability to lyse trypanosomes in vitro, compared with 
control mice, but when trypanosomes were exposed to the same sera in vivo, the 
infected mice showed no resistance to the infection at all and developed patent 
parasitaemias at the same rate as normal mice. Furthermore, sera from patients with 
apoAI deficiency had no measurable activity against T.b.bmcei (Owen et.al, 1996). 
The view that human apoAI alone can cause lysis of T.b.brucei is not shared by a 
number of other investigators (Rifkin, 1991; Tomlinson, et.al 1995). RilLin (1991) 
tested extracted apoAI from human, rabbit and rat HDL on T.b.brucei but found no 
lytic activity either with purified free apoAI or with apoAI reconstituted with HDL 
lipids. Serum from transgenic mice expressing the human apoAI gene did not have 
any elevated trypanocidal effect in this study and the same is true for a study by 
Tomlinson et.al (1995). None of the authors offer any explanation for these 
contradictory results and the only differences in the assays consists of the use of 
different strains of T.b.bmcei and that Gillet & Owen (1992) used twofold higher 
concentrations of purified apolipoprotein which might increase its lytic ability.
Can se rum from HDL deficient people cause lysis?
There are other data concerning the trypanolytic factors in human serum that have 
caused much controversy and one issue is whether serum from patients suffering 
from Tangier disease has the ability to lyse HSS trypanosomes. Tangier disease is a 
rare autosomal recessive disorder which causes a severe lack of HDL, not exceeding 
5% of the normal concentration, and, if the trypanocidal factor is confined to the 
HDL fraction serum from these individuals, it would be predicted to lack the ability 
to lyse trypanosomes. Rifkin (1978) noted that serum from persons with diagnosed 
Tangier disease did indeed lack trypanocidal activity. But when a new fluorescence
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based, viability assay was used to measure parasite death caused by serum from 
patients with Tangier disease (Tomlinson et.al, 1995) the results did not support 
Rifkins (1978) finding. The percentage lysis of parasites was as high with serum 
from individuals with Tangiers disease as with normal human serimi. These findings 
are in conflict with the idea that the lytic factor is always associated with HDL and 
has encourage the investigation into alternative lytic factors. Human HDL is itself a 
very heterogeneous particle and by examining various fractions of HDL, Lorenz 
et.al (1994) found trypanolytic activity in several particles with different properties.
Another lytic factor? (TLF2)
Barth (1989) using a novel procedure, first isolated a cytotoxic particle from pooled 
normal human serum with a molecular’ weight >1000 kDa. The protein was 
composed of foin polypeptides, none of which appear to be known apolipoproteins, 
according to size estimates, suggesting that the protein may not be part of HDL. This 
would support the idea that TLFl is not the only fraction with trypanosome lytic 
activity. The isolated fraction had the same lytic effect on T.b.brucei as human serum 
used in a control assay. Owen et.al (1996) identified the particle as the p-heavy 
chain of IgM and two light chains of Ig but this work was not pursued further since 
Rifldn (1978) convincingly had shown that IgM is not important in trypanolysis. 
Hajdulc et.al (1994) were not convinced that the >1000 kDa protein is not a HDL 
particle and argued that the size of one of the proteins in the trypanocidal fraction 
was consistent with being apoAI because its initial size estimation had been wi’ong. 
The novel trypanolytic particle also loses its lytic activity when treated with anti-a- 
lipoprotein serum (Owen et.al, 1996).
Other investigators have also found the presence of a trypanolytic >1000 kDa 
fraction distinct from HDL. Tomlinson et.al (1995) size fractionated proteins from 
both NHS and Tangier patients serum and found two distinct peaks of lytic activity 
against T.b.brucei. One of the peaks correlated with the described >1000 kDa particle 
but contained no apoAI while the other peak resembled the HDL and very likely 
include the TLFl fraction described by Hajduk et.al. (1989) and Tytler et.al, (1995). 
The >1000 IcDa fraction, which can be routinely separated by gel filtration and which
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is thought not to be a lipoprotein has been named TLF2 by Raper et.al (1996). 
Partially purified TLF2 binds specifically to T.b.brucei in a saturable manner 
(Tomlinson & Raper, 1996). This may suggest the presence of a specific TLF2 
receptor. It must therefore be considered likely that human serum mediated lysis of 
T. b. brucei is not an exclusive property of human serum HDL and that at least one 
other factor may be involved.
1.4.6 Possible mechanisms for the action of TLF
The search for the toxin within the TLF still continues. Smith et.al (1995) 
identified the specific toxin as human haptoglobin related protein (hpr). Haptoglobin 
normally exists as an abundant serum protein which can bind haemoglobin after 
which it is removed from the blood by the liver. The hpr is similar to haptoglobin in 
that it can bind haemoglobin and it is also a component of the very high density 
subclass of HDL. When the NH^-terminal sequences of apoLI and apoLIII were 
determined they were found to be identical to that of both haptoglobin and hpr. 
Further evidence for the importance of hpr in trypanosome lysis was that antibodies 
against human hpr could inhibit TLFl mediated lysis (Smith et.al, 1995). The 
proposed mechanism of lysis by hpr is as follows: the haptoglobin related protein in 
TLFl binds haemoglobin and is endocytosed and incorporated into lysosomes. At 
this low pH, the /zpr-haemoglobin complex has peroxidase activity which is 
damaging to trypanosomes as they lack catalase. The hpr cleaves peroxide present in 
the cell leading to the formation of hydroxyl radicals, disruption of lysosomal 
membranes, oxidative damage and ultimately cell death. Catalase was able to inhibit 
TLFl mediated lysis thus supporting the model. Pmified TLFl shows a higher 
degree of lytic activity than the same amount of TLFl diluted in human serum and it 
was further shown that the loss of inhibitor activity was associated with the loss of 
haptoglobin. Subsequently, haptoglobin was suggested as a natural inhibitor of TLFl 
trypanocidal activity (Smith et.al, 1995). Haptoglobin has on the other hand, been 
reported to have no effect on the lytic activity of TLF2 (Raper et.al, 1996). An 
interesting observation is that many individuals living in areas of sleeping sickness
33
Chapter 1 General Introduction
have genetically lower blood-haptoglobin levels than the average population (Pintera, 
1971) but the trypanolytic effect of TLFl may still be active. In addition, these 
people may have increased levels of hpr (S.Hajduk, personal communication, 1998).
Betchart et.al (1989) were the first to suggest that trypanolysis involved binding of 
trypanolytic HDL to cell surface receptors followed by the uptake and transport of 
the particle to acidic intracellular compartments. Lorenz et.al (1994) later provided 
evidence that acidic intraceilulai’ compartments are indeed involved in HDL- 
mediated trypanolysis. Weak bases that raise the intracellular pH and inliibit 
degradation of endocytosed macromolecules also inhibit trypanolysis. This is equally 
true for TLFl- and TLF2-mediated lysis which would imply that they both may need 
to enter an intracellular acidic vesicle to be cytotoxic. The same group also showed
that T.b.rhodesiense can bind and accmmilate the same amounts of radiolabelled 
HDL as the HSS T.b.brucei and therefore resistance can not be explained simply by a 
lack of ability to bind or internalise trypanolytic HDL particles (Lorenz et.al, 1995). 
It may therefore be more likely that differences between HSS and HSR stocks are 
due to differences in intracellular processing of the endocytosed HDL-paiticle. This 
idea has heen further developed by Hagar & Hajduk (1997) who demonstrated that 
both HSS and HSR T.b.rhodesiense were capable of receptor mediated endocytosis 
of macromolecules like TLFl but HSR T.b.rhodesiense did not accumulate TLF at 
the same rate as HSS T.b.rhodesiense. HSR T.b.rhodesiense bound TLF in the 
flagella pocket but did not accumulate TLF intracellulai'ly while HSS T.b.brucei both 
bound and accumulated TLF in endocytic vesicles thought to be lysosomes. Further 
support for this observation comes from the observation that TLFl mediated lysis is 
temperature sensitive and is completely inliibited at 17°C and below (Hajduk et.al, 
1989; Rifldn, 1978). Binding, but not endocytosis, does however occur, as cells
incubated with TLFl for a short time at 17°C and then washed, will still lyse if the 
cells are moved to 37°C. Electron and fluorescence microscopy of trypanosomes 
incubated with gold-labelled TLF shows that TLF binds specifically in the flagella 
pocket and to the fiagellum at 4°C, 17°C and 37°C but is only free or within large
vesicles when the cells are at 37°C. These cytoplasmic vesicles disrupted before the 
onset of cell lysis (Hagar et.al, 1994).
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If a component of normal human serum is responsible for trypanosome lysis and is 
taken up by cells by a specific and saturable mechanism it would be predicted that 
the activity of this factor would decrease as parasite density increased. An early study 
by Rifldn (1983) could not confirm this prediction since, according to her data, 
binding appeared to be independent of trypanosome cell concentration. Several more 
recent studies do however, suggest that binding of TLFl to trypanosomes is saturable 
and that TLFl requires receptor mediated endocytosis (Hager et.al, 1994; Lorenz 
et.al, 1995; Ortiz & Seed, 1995). The study by Ortiz and Seed (1995) also implied 
that HSS clones removed more trypanolytic factors than HSR clones.
1.4.7 Individual differences in trypanolytic effect
It is interesting to note that sera from different individuals vaiy greatly in their level 
of lytic activity. It seems however as if it is only whole NHS from different 
individuals that differs in its ability to kill trypanosomes (Rifkin, 1978), while 
isolated TLFl from different individuals had similar levels of killing activity (Hajduk 
et.al 1989). Purified TLFl normally has a more than 3-fold higher killing activity 
compared with the whole HDL fraction. Wlren other fractions of HDL were mixed 
with TLFl however, the killing activity reached the same levels as in human serum 
which would suggest that there is an antagonistic factor to TLF 1 in human serum. It 
may be the presence of this inliibitory factor that accounts for individual variation in 
trypanosome killing activity. Smith & Hajduk (1995), conducted experiments 
indicating that haptoglobin is present in the inliibitory fraction of TLFl in HDL and 
that haptoglobin on its own inliibits TLFl in the same way as the whole lipoprotein- 
deficient fraction of human serum. It might be the ratio between haptoglobin and the 
haptoglobin-related protein in serum that determines an individuals capacity to kill 
trypanosomes. The only report arguing against this theory is that of Lorenz et.al 
(1994) who found that the size and density of the trypanolytic factor differed 
considerable between individual serum donors. Individual variation in killing by 
TLF2 has not yet been investigated.
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1.4.8 Trypanocidal factors in non-hnman mammals
When trying to identify the lytic factor in NHS it is potentially useful to make 
compai'isons with trypanocidal factors found in animals which have co-evolved with 
African trypanosomes and which can tolerate infections with few or no signs of 
disease. Certain wild African animals can resist or control T.brucei parasitaemia 
partly due to the production of IgM, IgGl and IgG2 directed against specific 
trypanosomal antigens (Rurangirwa, 1986). There may also he other imiate, 
trypanocidal factors active against some strains which aid wild animals in tsetse 
infested areas in protection against trypanosomiasis (Mulla & Rickman, 1988).
Muranjan et.al. (1997) studied serum collected from cape buffalo which are laiown 
to be able to restrict infection to a low level parasitaemia by mechanisms not 
involving production of protective antibodies (Reduth et.al, 1994). Cape buffalo 
serum has the capacity to kill T.b.brucei, T.b.rhodesiense and T.h.gambiense in vitro. 
A number of findings indicated that the trypanocidal factor was a protein with a 
molecular mass of 150 kDa and this has been identified as xanthine oxidase. 
Xanthine oxidase is an enzyme that converts purines such as hypoxanthine and 
xanthine to uric acid. Bloodstream trypanosomes rely on the catabolism of glucose to 
pyruvate for their energy supply. Hydrogen peroxide, which is generated during 
catabolism of oxypurine by the catabolic enzyme xanthine oxidase, directly inhibits 
trypanosome glycolysis. Resistance to trypanosome infection is therefore induced by 
the ability to accumulate large amounts of hydrogen peroxide in the serum which 
will lead to the lysis of trypanosomes.
The evidence that xanthine oxidase mediates lysis of trypanosomes was provided by 
immunodepletion experiments using an antibody to xanthine oxidase. The depleted 
sera had no lytic activity showing the importance of xanthine oxidase. The origin and 
secretory pathway of serum xanthine oxidase is not known but the enzyme is found 
in the cytosol in a variety of cells. Cow and mouse sera do not accumulate hydrogen
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peroxide during catabolism of xanthine by xanthine oxidase and cows and mice are 
also susceptible to the trypanosome species mentioned above.
Few studies have been conducted on human serum killing of Trypanosoma species 
other than the T.brucei group. Verducci et.al. (1989) concluded that natural 
antibodies of the IgM class, not HDL, are responsible for lysis of T.equiperdum. 
Only human serum and not sermn from laboratory animals, sheep, horses or cattle 
could agglutinate T.equiperdum and eventually caused lysis. This group were also 
unable to detect significant trypanocidal activity of pmified human HDL either in 
vitro or in vivo.
1.4.9 The serum resistant associated gene
Since no biochemical differences could be found between resistant and sensitive 
strains of T.b.rhodesiense (Rifldn et.al, 1994), attention has focused on finding 
genes responsible for changes in human sermn sensitivity. Genes differentially 
expressed in the resistant and sensitive phenotypes from a common cloned line of 
T.b.rhodesiense (EATRO 3) were therefore studied by looking for differentially 
expressed mRNAs by subtractive hybridisation (De Greef et.al, 1989). A transcript 
of 1.5 kb was found to be unique for all serum resistant sub-clones while it was 
absent in serum sensitive forms of the same stocks and VATs. This led the authors to 
suggest that a resistance-specific transcript was associated with sermn resistance in 
T.b.rhodesiense and that switching from sensitive to resistant forms involved 
expression of a specific gene. Since expression of resistance or sensitivity could 
occur in subclones expressing the same VAT, switching between phenotypes was 
independent of VSG switching (De Greef et.al, 1989). The resistance-specific cDNA 
(niRNA) was later sequenced and named the serum resistance-associated (SRA) gene 
(DeGreef & Hamers, 1994). The SRA gene encodes a protein similar in sequence to 
VSGs (De Greef et.al, 1992) with the best fit in the carboxy-terminal part of the 
molecule. It was concluded that the resistant-specific mRNA codes for a protein with 
some homology with VSG (De Greef & Hamers, 1994) but with a smaller overall
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size. The lack of an N-terminal leader sequence of the protein would, however, mean 
that it is not inserted into the membrane. Several related genes, or possible 
pseudogenes which are not actively transcribed, may also be present in the genome 
since Southern blot analysis showed a number of bands rather than the few predicted 
from the restriction map of the cloned gene. The SRA gene has also been identified 
in freshly collected T. b. rhodesiense isolates from infected patients with symptoms of 
East African trypanosomiasis, originating from various locations in Zambia (De 
Greef et.al, 1992). T.b.brucei parasites, which are human sermn sensitive, lacked the 
resistance specific transcript and so did T.evansi and T.equiperdum, Expression of 
the SRA gene could not be detected in the human sermn resistant T.h.gambiense as 
might be predicted if a single mechanism is present in all stocks and subspecies 
(DeGreef et.al, 1992). The resistance specific cDNA also failed to hybridise with 
RNA from other T.b.rhodesiense strains (ETatl.9 and ETatl.3) (Rifldn et.al, 1994). 
Recent data does however, suggest that the SRA gene can confer serum resistance 
since transfection of SRA into the ribosomal locus of T.b.brucei resulted in resistance 
to human serum (Van Xong et.al, 1998). The same authors also provided data 
suggesting that the SRA is an ES AG of the ETatl.lO expression site. The SRA gene 
appears to be developmentally regulated; procyclic forms do not express the SRA 
specific sequences despite being resistant to lysis by human serum.
1.5 GENETIC ORGANISATION AND GENETIC EXCHANGE
1.5.1 Ploidy and karyotype
Chi'omosomes in trypanosomes do not condense during ceil division and therefore it 
has not been possible to make direct cytological observations of ploidy and 
karyotype. Instead, ploidy has been determined indirectly from electrophoretic 
patterns of isoenzymes, from Southern blotting of restriction digests with single copy 
gene probes and from the measurement of total DNA content relative to its kinetic 
complexity. Results from these studies in general conclude that the major part of the 
genome in bloodstream trypanosomes is diploid (Tait, 1980; Gibson et.al, 1980;
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Gibson et.al, 1985; Borst et.al, 1982). One important exception to this diploidy has 
been described for the VSG genes where only one allele per genome for each VSG 
gene is present and therefore they can be regarded as haploid, (Borst & Cross, 1982). 
An explanation for VSG genes being haploid might be their ability to change 
position within the genome together with the large number of different VSG genes 
present which makes them appear as different alleles (Tait & Turner, 1990). Mini and 
intermediate size clu'omosomes may also be exceptions to the general state of 
diploidy (Wells et.al, 1987).
The ploidy of other life cycle stages has also been examined by comparison to the 
DNA contents within bloodstream form cells. Zampetti-Bosseler et.al (1986) 
suggested that metacyclic stages are haploid after measuring the DNA content by 
microfluorometry and comparing it with other stages of the life cycle. This 
conclusion is probably wrong since Shapiro et.al (1984), Kooy et.al (1989) and 
Sternberg et.al (1988) showed that bloodstream, metacyclics and procyclics all had 
identical DNA contents. Shapiro et.al (1984) failed to find any haploid forms in 
bloodstream stmnpy and slender forms or in metacyclics or procyclics when 
measuring DNA content by flow cytometry. Tait et.al (1989) showed that the 
genetic consequences of haploldy, homozygosity of all heterozygous markers in 
metacyclic clones, were not observed. Therefore the metacyclics must be diploid and 
not a product of meiosis.
Trypanosome clrromosomes can be visualised directly by pulsed-field gel 
electrophoresis (PFGE) and the chromosomes fall into three different classes which 
together form 80% of the genome with the reminder of the DNA in the kinetoplast. 
Mini-chromosomes are between 50 and 150 kb in size, intermediate chromosomes 
are between 200-1000 kb and large cluomosomes are >1 Mb long. There are 
approximately 11 defined large chromosomes per genome and these have been 
shown to contain housekeeping genes and many VSG genes (Van der Ploeg et.al, 
1989; Melville et.al 1998). The mini-chromosomes and intermediate-chromosomes 
vary in number between species and isolates but there are approximately 100 and 1-7 
per genome respectively. The larger chiomosomes are diploid but clrromosomes
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homologues show considerable variation in size. Such size variation can lead to non- 
homologous as well as homologous cluomosomes being of the same size which can 
cause difficulty in interpreting PFGE results. The reason for this size difference is not 
laiown as yet but change in size is associated with meiosis (Tait et.al, 1993) and, 
unlike many other pathogenic parasites, chromosome sizes remain constant at mitosis 
(Tait et.al, 1996).
1.5.2 Genetic exchange in laboratory crosses
The first demonstration of genetic exchange between two different clones of 
trypanosomes in a laboratory cross was described by Jemii e la l  (1986). Mixed 
infections were produced in the laboratory by allowing tsetse flies to feed through a 
membrane on bloodstream trypanosomes from two different clones mixed in equal 
proportions. Flies producing metacyclic stages were subsequently fed on mice and 
the resulting bloodstream forms were passaged tluough another set of mice. Clones 
derived from this mixed infection, parental clones and clones derived from a separate 
cyclical transmission of each clone were all screened by isoenzyme electrophoresis 
for five enzymes for which the parental clones differed. It was found that the enzyme 
phenotypes of the single transmitted parental clones stayed the same after 
transmission tluough tsetse flies while some progeny of the mixed infection differed 
from either of the parental clones and were heterozygous at loci for which parental 
clones were homozygous and different. The genotype of parental and hybrid 
trypanosomes was also investigated by detection of RFLPs and with Southern 
hybridisation of DNA probes for VSG genes. It was observed that the parental clones 
were homozygous but different while the hybrid clones were heterozygous. The 
hybrid clones from this cross had identical phenotypes, genotypes and molecular 
karyotypes. These experiments cleaiiy demonstrated that recombinant phenotypes 
and genotypes could be produced when two trypanosome clones were transmitted 
simultaneously through tsetse flies and thus that genetic exchange and hybrid 
formation had taken place.
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Since this first cross, which provided evidence for the occurrence of genetic 
exchange in T.brucei, several subsequent crosses have been conducted in order to 
understand the mechanisms of genetic exchange (Sternberg et.al, 1989; Turner et.al, 
1990; Gibson, 1989). The progeny from the crosses have been analysed with the two 
marker systems mentioned above, electrophoretic variants of specific isoenzymes 
and RFLPs of single and multicopy gene probes. Results of such experiments have 
shown that genetic exchange is a non-obligatory but frequent event. Approximately 
40% of flies with mature infections produce hybrid trypanosomes but this figure can 
be highly variable. Results, in summary, show that the co-transmitted trypanosomes 
fall into one of three categories: one that is identical to one of the parent clones, one 
that has a novel combination of parental markers from both parents and one that is 
the result of self-fertilisation (Tait et.al, 1996). The genotype of the progeny depends 
on whether the marker is homozygous or heterozygous in one or both parents. Hybrid 
formation was demonstrated by the inlieritance of markers for which the parents are 
homozygous but different, by inlieritance of markers for which parents are 
heterozygous or by inheritance of multiple markers for which at least one parent is 
heterozygous. Self fertilisation products were demonstrated when one class of 
progeny were similar to one of the parental clones except for being homozygous for 
one or more loci for which the parent is heterozygous. The finding that all possible 
combinations of alleles at several loci occurred is consistent with allelic segregation, 
independent assortment and recombination as would be predicted if the progeny were 
the offspring of a diploid Mendelian system (Sternberg e ta l, 1989; Gibson, 1989; 
Turner et.al, 1990). The fact that some parental clones are cyclically transmitted 
without change would imply that mating is a non-obligatory event.
The nuclear DNA content of the first three hybrids was demonstrated to be greater 
than the nuclear DNA content of the parents (Paindavoine et.al, 1986; Wells et.al, 
1987). The mean value of the DNA content was about 1.6 times the parental value. 
This could he interpreted in different ways, including the hybrids being tetraploid 
and loosing DNA during growth or hybrids being a result of the fusion of haploid 
gametes followed by amplification of part of the genome or, possibly, that the 
chromatin structure in the hybrids was different from that in the parents which would
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result ill the increased uptake of dye during cytofluorimetry. It could also be that 
these hybrids are aneuploid and have lost or gained one or more chromosomes (Tait 
& Turner, 1990). A review by Tait et.al (1993) of the DNA content measiued in 24 
hybrid progeny by several investigators reveals that 21 of the hybrids have DNA 
contents equal to or between the parental values but the remaining three hybrids 
showed increased DNA levels. Hybrids with an increased DNA content have been 
found in other crosses as well (Gibson & Garside, 1991; Gibson et.al, 1992). It is 
generally accepted that triploid trypanosome clones occur and such progeny are 
frequent in some crosses but not in others.
1.5.3 Chromosome and kinetoplast inheritance
The use of PFGE has led to the ability to separate and define pairs of homologous 
chromosomes and determine the inlieritance of these chromosomes in progeny from 
genetic crosses. Wells et.al, (1987) investigated the inheritance of mini­
chromosomes in hybrid progeny and fomid that most, but not all, of these 
chromosomes were inlierited from both parents which contributed to an increase in 
DNA content. It should however, be noted that the progeny class analysed were sub- 
tetraploid and thus may be atypical products of genetic exchange. Mini-clu'omosome 
inheritance in diploid F, progeny of a genetic cross have not heen analysed.
Because of the small size of intermediate size chromosomes their pattern of 
inlieritance would not be expected to have a major effect on DNA content. 
Inlieritance of intermediate size cluomosomes is difficult to analyse because they 
contain no housekeeping genes and no unique polymorphic markers which would 
enable detailed analysis. When analysing a hybrid clone by pulse field gel analysis, 
Sternberg et.al (1988) showed that intermediate size chromosomes also segregate 
since the hybrid displayed a new combination of these chromosomes. The smaller 
size chromosomes do not segregate as diploid homologues and are perhaps best 
considered as aneuploid cluomosomes which are inlierited randomly. The larger
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chi'omosomes are diploid and in general segregate in a Mendelian fashion in genetic 
crosses as discussed in detail in section 1.5.2.
Much less is laiown about the inheritance of kinetoplast DNA and maxi circles 
were first thought to be inlierited uniparentally, with no apparent preference for either 
parent (Gibson, 1989; Gibson & Garside, 1991; Sternberg et.al, 1989). Turner et.al. 
(1995) showed however, that maxicircles can be inlierited biparentally as well. 
Minicircles are inherited from both of the parents. This was demonstrated when 
hybrid progeny were found to have minicircle networks which appeared to be a mix 
from the two parents (Gibson & Garside, 1990; Gibson et.al, 1997). It has been 
suggested therefore that during the formation of hybrid progeny, the kinetoplasts 
from both parents fuse with subsequent stochastic segregation of both the maxi- and 
mini-circles.
1.5.4 Frequency and stage of mating
The lifecycle stage of T.brucei at which mating takes place has not yet been 
identified. It occurs between the time the fly ingests hloodstream cells and 
production of metacyclic forms in the fly's salivary glands. Procyclic, proventricular, 
epiniastigote or metacyclic stages are all possible stages at which mating could take 
place. However, proventricular and metacyclic forms are thought not to divide 
(Vickerman, 1985) and it would be unusual for a non-mitotic cell to undergo meiosis. 
Schweizer & Jenni (1991) have published the only finding of a procyclic population 
with hybrid characteristics suggesting that hybridisation takes place in the posterior 
part of the fly midgut. Unfortunately, no clones from these hybrid procyclics could 
be derived and therefore no firm evidence for mating at this stage exists. In contrast, 
Gibson & Whittington (1993) conducted genetic crosses using parents into which 
selectable markers had been introduced and detected double resistant (i.e. hybrid 
progeny) cells amongst the metacyclic population but not amongst procyclics. These 
data infer that it is highly likely that genetic exchange occurs in the salivary glands 
rather than in the fly gut.
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The frequency of mating in laboratory crosses has been analysed in two different 
ways; by looking at the proportion of metacyclic producing flies that produce hybrids 
and by looking at the proportion of clones at a single time point from a single fly that 
are hybrid. Sternberg et.al. (1989) used the first approach and determined the 
proportion of mixed infected flies that produced hybrid trypanosomes. Flies with 
early infections produced mainly parental stocks without mating but approximately 
25 days after initial infection, recombinant progeny started to be transmitted. 
Hybrids, together with parental clones were produced and mating was shown occur at 
a high frequency. These observations were in agreement with an earlier study by 
Schweizer et.al. (1988) who used the second approach and investigated hloodstream 
form populations produced from a mix of two T.brucei clones after fly transmission. 
Of 23 tsetse flies examined, 9 trypanosome populations contained hybrid progeny
which led to the conclusion that hybrid formation is a regular and frequent event.
Even though it was shown that mating occui’s at a high frequency, Sternberg et.al.
(1989) also demonstrated that it is not an obligatory event in the life-cycle of 
T.brucei. One or both of the parental stocks could pass through the fly without any 
genetic exchange taking place. The same observation was made by Gibson (1989) 
who used pulsed-field gel electrophoresis to study non-parental karyotypes from a 
cross between T.b.rhodesiense and T.b.brucei stocks. Again, the hybrid clones 
produced shared many characteristics with both parents and their genotypes f
confirmed that segregation and re-assortment of parental alleles had taken place.
To investigate the extent to which there might be genetic barriers to mating a study 
was conducted of progeny produced from mixed infections by crossing tluee stocks 
of T.brucei, (STIB 247L, STIB 386AA and TREU 927/4) in all possible pairwise 
combinations (Turner et.al, 1990). The resulting analysis showed that F, hybrid 
progeny could be produced by all three combinations of stocks. The simplest 
explanations of these data are that mating is controlled by a mating type locus for 
which at least one stock is heterozygous or that there are no barriers to mating.
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The above findings would predict that self fertilisation can occur as a result of 
genetic exchange and recombinant products of self fertilisation, "selfers", have now 
been identified (Tait et.al, 1996; Gibson, 1997). Interestingly, self-fertilisation 
products have only heen observed when cross-fertilisation also occurs, perhaps 
implying that the presence of two dissimilar stocks within a fly is required to trigger 
the mating process.
1.5.5 Genetic exchange in natural populations
The first indication that genetic exchange takes place between different 
trypanosome stocks came after a study of isoenzyme electrophoretic variation 
between stocks isolated from a single population (Tait, 1980). A high degree of 
polymorphism was found when 17 stocks of T.b.brucei, collected in Lugala, Uganda, 
were screened for electrophoretic variation in 19 enzymes. The observed genotype 
frequencies agreed with those predicted by the Hardy-Weinberg equilibriimi and 
could not readily be explained by models based only on mutations thus providing 
strong evidence for trypanosomes being diploid, undergoing random mating and 
recombination between different loci occurring. However, while the presence of 
genetic exchange in laboratory populations of trypanosomes has been confirmed 
experimentally, the importance of genetic exchange in natural populations in the field 
is still uncertain. Knowing more about the nature and frequency of genetic exchange 
in natural populations of trypanosomes would aid the understanding of factors 
involved in inlieritance and geographical distribution of medically important traits 
such as human infectivity and drug resistance (Tait, 1980; Tait, 1983; Gibson, 1980). 
Initial analyses of genetic exchange in the field yielded results which were consistent 
with a random mating pattern (Tait, 1980). Genotype frequencies from only 17 
isolates were determined, and when Cibulskis (1988) subjected these data to more 
detailed statistical methods he found the sample size was too small to exclude the 
possibility of chance heing the reason for the agreement with Hardy-Weinberg 
equilibrimii. The number of expected recombinant genotypes was higher than the 
observed number and linlcage between loci could not explain the absence of some
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combinations. Tibayrenc & Ayala (1991) proposed that T.brucei has a clonal 
population structure and that this is well confirmed in most cases apart from some 
wild samples from East Africa. Several statistical methods were used to detect 
divergence from Hardy-Weinberg equilibrium frequencies and linkage 
disequilibrium with the null hypothesis being panmixia and random mating. It was 
found that there was an absence of recombinant genotypes with an over­
representation of identical genotypes. Linkage disequilibrium was also found and 
these observations, when taken together, argue against a pamnictic population 
structure where mating between individuals occurs at random. Instead, there is a non 
random association between alleles or genotypes at different loci. The study was 
however, mainly based on results from trypanosomes isolated from himians and 
cattle and the authors add that a higher genotype diversity was found in isolates from 
wild animals and tsetse flies and therefore recombination or clonal diversity may be 
higher in trypanosomes from these sources.
Cibulskis (1992) explained the apparent clonality by taking into account the h
prediction that certain strains may show host species preferences which would cause S
differential selection pressure for different strains and result in deviation from Hardy- 
Weinberg equilibrium when all stocks were pooled as a single population. This view 
was shared by Mihok et.al (1990) who also described considerable diversity within 
an isolated focus and suggested this was caused by introduction of new zymodemes 
which stimulated genetic recombination. Cibulskis (1992) examined trypanosome 
samples collected over a 14 years period from man, cattle, game animals and tsetse 
flies in Lambwe Valley, Kenya, and found a significant difference in strain 
frequencies over even short geographical distances. The association between strains 
and the species of host mammal was also strong and this led the author to suggest 
that transmission of T. brucei was to some extent localised and that certain strains are 
adapted to different host species. The degree of genetic exchange does not seem to 
interfere with host association over this 14 years time scale which may be explained 
by selection pressure for particular transmission cycles. An important conclusion 
from this study was that whilst the data did not support pamnictic random mating, 
neither could it be explained by a model of clonality.
46
Chapter 1 General Introduction
Deviations from Hardy-Weinberg expectations, which would suggest some 
restrictions in mating, have heen found in studies on other trypanosome populations 
(Hide et.al, 1994, Stevens and Welburn, 1993). Hide et.al (1994) found clear 
evidence for genetic exchange within the T.b.brucei population but much less in 
T.b.rhodesiense isolates, both collected in a confined location in south-east Uganda. 
Despite the occurrence of genetic exchange in both populations none of them 
fulfilled the criteria for random mating and certain stocks seem to occur more 
frequently than others. An epidemic population structiue would however, involve 
random mating but with predominance of particular genotypes due to epidemic 
expansion. Stevens and Welburn (1993) examined isolates in this same area by 
isoenzyme analysis and also concluded that mating was not random. The hypothesis 
of all trypanosomes being clonal was tested using a collection of already published 
data which was subjected to analysis in order to detect association between genes at 
different loci (Maynard-Smith et.al, 1993). This analyse could not fully support the 
clonality theory but instead suggested an “epidemic” population structure with 
frequent sex and recombination within the population as a whole but that this genetic 
exchange was masked by occasional epidemic clones arising. Stevens & Tibayrenc 
(1995) studied T.brucei species isolated from the midguts of wild tsetse flies and 
found that mixed populations of trypanosomes are common. From an investigation of 
linkage disequilibrium within populations the authors concluded that the 
trypanosomes are not undergoing random mating and that epidemic clonality is not 
enough to explain the many genetic valiants present in individual flies. The 
hypothesis by Cibulskis (1992) that certain T.brucei genotypes in certain 
transmission cycles are selected for may also explain why T.brucei in some 
circumstances may be regarded as clonal in the short term even though other 
population studies suggests that sex is occurring and leads to genetic exchange and 
diversity in the longer term.
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1.5.6 Proposed mechanisms of genetic exchange
The cytological details of genetic exchange and the precise time and place of mating 
are still unclear but there appears to be an agreement that most data conform to a 
Mendelian model for the hybrid progeny being F, products in a diploid system. A 
rearrangement of clu'omosomes occurs with the segregation and independent 
assortment of alleles at different loci. It should be noted however that, from any 
single cross, the numbers of F, hybrid progeny analysed have been insufficient to 
determine statistically robust segregation ratios.
A classical Mendelian system, with meiosis producing haploid gametes which 
subsequently fuse, was suggested by Sternberg et.al, (1988), Sternberg et.al, (1989) 
and Turner et.al, (1990). This would involve diploid parental stocks undergoing 
meiosis to produce haploid nuclei which fuse to produce diploid progeny. The data 
are also consistent with an alternative Mendelian model where fusion precedes 
meiosis. Either model would predict Mendelian inlieritance of loci on the large 
cliromosomes but would not explain inlieritance patterns of mini-cliromosonies or the 
elevated nuclear DNA content of some hybrids. The occurrence of triploidy may 
instead be explained by a failme in meiosis which leads to frision of diploid and 
haploid nuclei, or three or more haploid nuclei may be present in one cell with 
subsequent fusion of multiple nuclei (Gibson, 1995).
A fusion model where parental stocks fuse to yield “sub-tetraploid” trypanosomes 
was proposed by Paindavoine et.al (1986). Their suggestion came after a report on 
increased DNA contents in hybrid clones produced in the laboratory by Jenni et.al 
(1986) and later analysed by Wells et.al, (1987). The tluee hybrids analysed were 
found to have 50-60% higher DNA content than that of parental clones and DNA 
content was reported to be stable during serial passage tlirough mice. The increase 
was accompanied by an almost doubling of minichromosomal DNA but this was not 
enough to explain the difference in total DNA content. Paindavoine et.al (1986) then 
suggested that hybrids are subtetraploid and have resulted from fusion of diploid 
nuclei and they calculated the mean amount of hybrid DNA to be 175% of either
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parent. The fusion was suggested to be followed by random loss of chromosome 
content in several stages to re-establish diploidy.
As larger number of hybrids from a variety of genetic crosses have been analysed 
over recent years, it has become clear that Fi hybrid progeny are usually diploid and 
the “sub-tetraploid” model was based on an inadequate data set. It seems most likely 
that the process is essentially Mendelian with meiosis before or after fusion but to 
date there is no evidence to distinguish between these models.
1.6 AIMS OF STUDY
Some strains of T.brucei infect humans and cause African sleeping sickness whilst 
others are lysed by (a) lytic factor(s) in the human serum and can only survive in 
cattle or game animals. These strains are otherwise morphologically 
indistinguishable. Early studies have concluded that the lytic factor in human serum 
is separate from an immune response and does not involve the complement pathway. 
The underlying mechanisms for human serum sensitivity/resistance are not yet fully 
understood and more than one factor in human serum may be involved. The overall 
aim of this thesis was to investigate the inheritance and molecular basis for human 
serum resistance/sensitivity. This was made possible because of the availability of 
recombinant progeny from a cross between a human serum resistant and a human 
serum sensitive trypanosome strain. A molecular approach based on differential 
display RT-PCR was also used to complement the more biochemical approaches 
adopted by others. The objectives of this thesis was to;
• develop a reliable human serum sensitivity bloodstream form assay
• identify the number of loci and alleles determining sensitivity/resistance
• determine whether inheritance is dominant or recessive
• determine whether the gene putatively associated with human serum resistance (the
SRA gene) is present and expressed in genetically competent stocks used as 
parents in inheritance studies.
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• identify candidate genes potentially involved in human serum sensitivity/resistance
A better understanding of these areas may lead to new ways of blocking human 
infectivity in trypanosomes causing human sleeping siclmess.
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Chapter 2 
Materials and Methods
2.1 TRYPANOSOME STOCKS
Several different trypanosome stocks have been used in both the genetic and the 
molecular analysis undertaken in this study. Swiss Tropical Institute Basel (STIB) 
247 was originally isolated from a hartebeest {Alcelaphus buselaphus) at Kongoni in 
the Serengeti Park in Tanzania during a sleeping sickness survey in November 1971 
(Geigy & Kauffmann, 1973). At the time of the study, large numbers of animals in 
the park were investigated for the presence of trypanosomes and strains of T.brucei 
were isolated in rats before being preserved in liquid nitrogen. STIB 247 was also 
immediately tested with the BÛT and found to be lysed by human serum. STIB 386 
was obtained from a human in Koudougou in the Ivory Coast in 1978 (Feigner et.al, 
1981). It was shown to be highly resistant to human serum and referred to as a type II 
T.b.gambiense. Trypanosomiasis Research Organisation (TREU) 927 comes from 
Kiboko in Kenya, where it was isolated from a tsetse fly in 1970 (Gobloed et.al, 
1973). All three stocks have been cloned and they are all pleomorphic and 
transmissible through tsetse flies. STIB 247 and STIB 386 are within 10 mouse 
passages of original isolate whereas TREU 927 is approximately 14 mouse passages 
from the original isolate. Virulence and parasitaemia characteristics are given in 
Turner et.al (1995). The two subcloned lines, ETatl.2 and ETatl.lO are derived 
from East African Trypanosomiasis Organisation (EATRO) 3 which was originally 
isolated from a tsetse fly in Busoga district in Uganda, 1959.
The method for generating Fi hybrid progeny from crosses has been described as 
have some of the Fi progeny used in the current study (Sternberg et.al, 1989; Turner 
et.al, 1990). In addition, F] clones were obtained by optical cloning of bloodstream 
trypanosome stabilates. The stabilates had been made from trypanosome infected 
mouse blood where the infection had been initiated by the bite of a mixed infected 
tsetse fly. The optical cloning was carried out by Prof. Andy Tait. Recombinant
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progeny from self-fertilisation events were also used in the study and the generation 
of these clones was described in Tait et. al. (1996).
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2.2 TRYPANOSOME GROWTH AND ISOLATION
Bloodstream trypanosomes were grown in mice which had been infected with 
cryopreserved clones by intraperitoneal (i.p.) inoculation or by transferring infected 
blood from one mouse to another. Routinely, outbred adult female mice were used, 
either Hsd/01a:MFl or CFLP, both from Harlan Olac Ltd. Adult female Wistar rats 
(Harlan Olac Ltd) were used when larger numbers of trypanosomes were required 
and these were infected by i.p. inoculation of whole blood obtained from 
ti-ypanosome-infected mice. The mice and rats were monitored by tail bleeding 
(Herbert & Lumsden, 1976) and trypanosomes harvested by cardiac puncture during 
the exponential phase growth, usually at a parasitaemia corresponding to 
approximately 1x10^ trypanosomes/ml of blood. Bloodstream trypanosomes were |
Xthen separated from blood cells by one of tlrree methods; differential centrifugation :I
(Ghiotto et.al. 1979), centrifugation on a Percoll density gradient (modified from 
Grab & Bwayo^ 1982) or by ion exchange chromatography on a DEAE-cellulose 
column (DE-52, Wliatman) by the method of Lanliam & Godfrey (1970).
Purification by differential centrifugation 
Purification of bloodstream trypanosomes from whole blood involved adding an 
equal volume of Ix Phosphate buffered saline (PBS) pH 7.4 and centrifugation at 
200xg for 7 minutes at room temperature. The upper straw coloured layer, containing |
the trypanosomes, was then transferred to a new tube and the trypanosomes pelleted I;
by centrifugation for 5 minutes at 2500xg at 4°C. After removal of the supernatant,
the trypanosomes were resuspended in MEM + Earles salt w/o L-glutamine (Gihco- 7:sBRL) and the concentration measured using an improved Neubauer haemacytometer. T
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Percoll purification o f bloodstream trypanosomes
Isolation using DEAE-cellulose columns 
Isolation of bloodstream trypanosomes by ion exchange clnomatography on DEAE- 
cellulose columns was essentially carried out as previously described (Lanham & 
Godfrey, 1970). The method depends on differences in cell-suiTace charge so that the 
more negatively charged blood cells and platelets are absorbed onto the DEAE- 
cellulose while the less negatively charged trypanosomes are allowed to pass 
through. Blood from infected mice or rats was mixed with an equal volume Ix 
Phosphate buffered saline containing 1% glucose (PSG) pH 8.00 and centrifuged at 
200xg for 7 minutes in order to remove most of the blood cells. The upper layer, 
containing the trypanosomes, was transferred into a new tube to be added to the 
column. DE-52 cellulose (Whatman) was stored in a suspension in PBS pH 8.0 and 
1% azide and then washed with at least 5-6 volumes of IxPSG pH 8.0 before use to 
remove the azide and to ensure a pH of 8.0. The PSG solution containing the 
trypanosomes was then gently added to the top of the column and the flow-tluough 
collected. Samples were placed on microscope slides and examined for trypanosomes 
at regular intervals. Wlien all of the trypanosomes had been eollected they were
diluted in IxPBS pH 7.4, centrifuged for 5 minutes at lOOOg and then resuspended in 
IxPBS pH 7.4 to return them to iso-o 
improved Neuhauer haemocytometer.
smotic neutral pH conditions and counted in an
4.
Percoll with a density of 1.130/ml (Pharmacia) was mixed with 2% (w/v) glucose i:and 8.55% (w/v) sucrose and the pH adjusted to 7.4 with solid HEPES. The percoll T
mixtuie was mixed with whole blood immediately after it was removed from the 
infected animal. 5 ml Percoll/sucrose/glucose and 2 ml PBS was used for every 1 ml 
of blood. The suspension was then centrifuged for 20 minutes at 30 OOOxg at 4°C and K
the trypanosomes collected from the upper phase. The cells were then transferred to a 
fresh tuhe and pelleted by centrifugation at lOOOg for 5 minutes, resuspended and 
counted with an improved Neubauer haemocytometer.
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Parasitaemia determination 
Parasitaemias in mice and rats were monitored at least every other day by the rapid 
matching method of Herbert & Lumsden (1976).
Cryopreservation of hloodstream trypanosomes 
Bloodstream trypanosomes were preserved as stabilates in plastic straws in liquid 
nitrogen. Infected mouse blood was obtained by cardiac puncture and immediately 
mixed with 7.5% DMSO in CBSS (Fairlamb et.al., 1992) containing heparin at a 
concentration of lOOU/ml. Using a Nalgene™ Cryo P C  Freezing container the 
stabilates were allowed to freeze at P C  per minute until they reached -70°C when 
they were transferred for storage in liquid nitrogen and assigned a unique identifier 
GUP number.
Optical cloning of bloodstream trypanosomes 
Cloning of single trypanosomes was essentially carried out as described by 
McLintock et.al. (1990). A drop of infected blood was diluted in 100-200 |li1 guinea 
pig serum and, using a fine pin, a small drop of the suspension was added to wells of 
a humidified Terasaki tissue culture plate at 10°C. The wells where then examined 
for the presence of single trypanosomes using an inverted microscope. 10 |ll1 of 
guinea pig serum was added to wells containing single trypanosomes and this was 
mixed with CBSS before being injected i.p. into a mouse. The mice where then 
monitored for at least 10 days for a parasitaemia and trypanosomes harvested by one 
of the methods described above.
2.3 IN VITRO HUMAN SERUM SENSITIVITY ASSAY
A range of conditions were examined in order to optimise the assay and details of 
these are given in 3.2.1. In brief, a reliable assay which gave consistent results could 
not be developed even under optimal conditions. Following the investigation of the 
effect of the various factors involved, the most reliable assay was a lysis test 
monitored by microscopy. Bloodstream trypanosomes were purified from mouse or
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rat blood by the methods described in section 2.2 and the concentration estimated 
using a haemocytonieter. The cells were then diluted in MEM + Earles salt culture 
medium (Gibco-BRE) and 25% (v/v) serum to a concentration of 1x10? cells/ml and 
incubated at 37°C for 4 hours. At the end of the incubation time at least 200 cells 
were counted and the percentage normal, ‘tadpole’ shaped and lysed cells recorded.
Serum
Serum for the development of the hmnan serum sensitivity assays was obtained 
from five human volunteers. Wliole blood was drawn by venous punctui'e and 
transferred from the syringe to a glass bottle where it was left to coagulate at room 
temperature for 2 horns. The clot was loosened from the glass surface and stored at 4 
°C overnight. Serum could then be sepai'ated from remaining blood cells by 
centrifugation for 15 minutes at 3000g before being heat inactivated by incubation at 
56°C for 30 minutes. The serum was then stored in single aliquots at -70°C until 
needed. For the standar d in vitro HSS-assay only serum from one of the volunteers 
(Mike Turner), was used and this was always obtained after overnight fasting.
Blood from the volunteers was tested for the presence of circulating trypanosomal 
antigens by the card agglutination trypanosomiasis test (CATT) and all samples were 
found to be negative.
Guinea-pig serum (SeroTech) was used as a positive control serum for each assay 
performed.
2.4 IN  VIVO HUMAN SERUM SENSITIVITY ASSAY
After the initial optimisation of the assay described in section 3.2 it was essentially 
carried out in the following way: mice were infected with cryopreserved bloodstream 
trypanosomes of the stock or line to be tested and bled by cardiac puncture once the 
parasitaemia reached approximately 1x 10  ^trypano some s/ml and the clear majority of 
observed trypanosomes were slender forms. These were then purified from blood
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cells by one of the methods described under 2.2, resuspended in MEM+Earles salt 
and counted using a haemocytonieter. The cells were diluted with MEM+Earles salt 
and 25% serum to a final concentration of 1x10’ cells/ml and incubated at 37°C for 4 
hours. 100 cells were subsequently isolated by appropriate dilution in IxPBS pH 7.4
'■Ïand added to CBSS containing heparin at a concentration of lOOU/ml before being 
injected i.p into mice. For standard in vivo human serum sensitivity assays, three +
outbred mice, Hsd/01a:MFl (Harlan Olac Ltd) or CFLP (Harlan Olac Ltd), were 
used for each assay, two for trypanosomes incubated with human serum and one for 
control cells incubated with guinea-pig serum. The mice were immunosuppressed
...
using a dose of 150 mg/kg cyclophosphamide by i.p. injection 24 hours prior to 7
trypano some inoculation. The presence or absence of parasitaemia in the miee was S
I]then screened by tail bleeding at least every second day for a minimum of 14 days. |
2.5 CONDUCTING TRYPANOSOME CROSSES
>•
Crosses between cloned trypano some populations, STIB 386 x STIB 247, STIB 386 
X TREU 927 and STIB 247 x TREU 927, had all been produced prior to the study 
and products from crosses were available in the laboratory. The method for 
conducting the crosses has been published by Jenni et.al (1986). Briefly, the two 
cloned trypanosome populations were fed as an equal mixture in whole infected 
blood to groups of tsetse flies. The flies were monitored for the presence of 
metacyclic stage trypanosomes by encouraging them to probe on warmed glass slides 
which then were examined under a phase contrast microscope. Infected flies were 
allowed to feed on mice and the resulting bloodstream trypanosomes were cloned |
and screened for the presence of non-parental phenotypes and genotypes. 
Alternatively, or in addition, the salivary glands of the fly were removed and 
metacyclic forms obtained, cloned and screened for their genotypes.
i
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2.6 IDENTIFYING HYBRID PROGENY
Recombinant FI trypanosome populations were identified using a range of |
polymorphic markers. The majority of the hybrids had been identified prior to this 
current study using electrophoretic variation detected by starch gel electrophoresis 
and/or isoelectric focusing and using probes detecting RFLPs (Jenni et.al, 1986;
Sternberg et.al, 1988; Sternberg et.al, 1989; Turner et.al, 1990). A proportion of 
the hybrids were also identified after PCR amplification of the polymorphic 
minisatellite markers ms42 (Barrett et.al., 1997), Tb292 and CRAM or the 
microsatellite marker JS-2 (Amiette MacLeod, pers.comm) and were carried out by 
Amiette MacLeod, University of Glasgow. Most of the previously identified hybrids 
were also rescreened with this new PCR-based method.
2.7 DNA ISOLATION
Total genomic DNA was prepared from purified bloodstream trypanosomes using a 
conventional method (Sambrook et.al., 1989). Pelleted trypanosomes were 
resuspended in extraction buffer (50 mM Tris, 5 inM EDTA, 100 mM NaCl), 10% 
SDS and proteinase K and incubated at 37°C for 2 hours to lyse the cells. The 
organic solvents phenol and chloroform were then used to deproteinize the solution, 
first using phenol alone in a 1:1 v/v ratio and then a 1:1 mixture of phenol and 
chloroform, mixing and centrifuging at 10 OOOg between each step and collecting the 
aqueous supernatant. The DNA samples were finally concentrated by adding 1/10 
volume 3M sodium acetate and 2.5 volumes 100% ethanol to the DNA solution, 
incubation at -70°C for a minimum of 30 minutes and then centrifligation to pellet 
the nucleic acid precipitate. The DNA was washed with 70% ethanol before being 
left to dry and resuspended in an appropriate volume of sterile ddH^O or TE buffer 
(10 mM Tris-HCl, pH 7.5, 1 mM EDTA). The concentration of the DNA was 
measured by ultraviolet absorbancy spectrophotometry (GeneQuant II, Pharmacia 
Biotech). Absorbance was measured at 260 nm at which wavelength an absorbance 
of 1.0 corresponds to 50pg of double stranded DNA per ml. The DNA was usually
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.digested with a restriction endonuclease before the concentration was measured to 
ensure that DNA was in solution.
Rapid DNA purification from whole blood.
A rapid blood DNA miniprep method was used for DNA extraction when preparing 
control DNA from mouse and rat. This involved centrifuging the whole blood for 1 
minute, discarding the supernatant, washing the cells with IxSSC and then 
resuspending them in IxSSC and 10% SDS. The protein was removed by shaking the 
suspension with phenol-chloroform in a 1:1 v/v mix. The mixtme was centrifuged 
and the aqueous layer retained. 2.5 volumes of 100% ethanol was then added to 
precipitate DNA, the solution centrifuged to pellet the DNA which then was 
dissolved in ddH20 . AfEer another ethanol precipitation and wash, the pellet of DNA 
was resuspended in ddH20 or TE buffer and kept at -20°C until needed.
H 2O .
2.8 RNA PREPARATION
Total RNA was isolated from bloodstream trypanosomes using the ready-to-use 
reagent TRIzol (Gibco-BRE) which is a monophasic solution of phenol and 
guanidine isothiocyanate. Basically, the method was carried out as recommended by 7
the manufacturers. Bloodstream trypanosomes were isolated from infected mouse or |
rat blood on DEAE cellulose columns, with no visible contamination of blood cells 
or platelets, and pelleted by centrifugation. The pellet was then lysed in TRIzol 
reagent, approximately 1 ml reagent per 1x10% cells, and incubated for 5 minutes at
room temperature. 0.2 ml of chloroform per 1 ml of TRIzol was added followed by €7'centrifugation at 10 000 g for 5 minutes to separate the solution into an aqueous 
phase and an organic phase. The RNA remains exclusively in the aqueous phase and I
was recovered by precipitation with isopropanol at room temperature followed by 
centrifugation at 10 OOOg for another 5 minutes. The RNA pellet was then washed 
with several volumes of 75% ethanol, air-dried briefly and dissolved in RNase free 7
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Preparation of RNase free equipment and RNase free H2O 
The introduction of RNases during RNA isolation and all work involving RNA was 
prevented in several ways. Sterile disposable plasticware was used whenever possible 
and all nondisposible glassware and plasticware were soaked in 0.5M NaOH for 10 
minutes, rinsed in ddH20  and autoclaved. RNase free pipette tips were prepared by 
filling tipboxes with HgO, adding DEPC to 0.01% (v/v), leaving at 37°C overnight 
and then draining and autoclaving. RNase free HgO was prepared by adding 2 drops 
of diethylpyrocarbonate (DEPC) (0.01% v/v) per litre and leaving the bottles at 37°C 
overnight before autoclaving. All solutions used for RNA work were either treated in 
this way or were prepared using DEPC-treated water. Electrophoresis tanks used for 
electrophoresis of RNA, were first cleaned with detergent, dried with ethanol and 
then filled with a solution of 3% H2O2. After 10 minutes at room temperature the 
electrophoresis tank was rinsed with water that had been treated with DEPC. 
Alternatively, plastic, stainless steel and glassware were treated with the ribonuclease 
decontaminant, RNase AWAY (Molecular Bio-Products) according to the g
manufacturers recommendations.
,;s;
DNase treatment of total RNA 
RNA isolated by TRIzol reagent is supposedly free of contaminating DNA, but it 1
was sometimes necessary to treat the RNA samples with DNase to remove remaining 
DNA that was clearly present. This was particularly important prior to RT-PCR 
reactions and during the preparation of starting material for mRNA differential 
display RT-PCR. lp,g of RNA was mixed with Ijil lOxDNase I reaction buffer (500 
mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mg/ml BSA, Gibco-BRE) and 1 |ll1 DNase I 
(Amp grade, 1 U/|il) or 1 pi RQl RNase free DNase (lU/pl, Promega) and DEPC 
treated water to a final volume of lOpl. The tubes were then incubated for 15 minutes 
at room temperature before DNase was inactivated by the addition of 1 pi 25 mM 
EDTA solution and heat inactivated for 10 minutes at 65°C. Alternatively, the RNA 
was extracted with an equal volume of phenohchloroform, followed by an equal 
volume of chloroform and then precipitated with ethanol to recover the RNA. Only 
phenol saturated in NET-buffer (100 mM NaCl, 10 mM Tris, pH 8.0, 1 mM EDTA, 
pH 8.0) was used.
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2.9 FIRST STRAND cDNA SYNTHESIS
ÿ
' iTwo different, but similar, protocols were used for the synthesis of first strand 
cDNA from total RNA. Initially, Moloney Murine Leukemia Virus Reverse 
Transcriptase (M-MLY RT, Promega) was used. Total RNA was stored in ethanol |
and 3M sodium acetate at -70°C and was pelleted by centrifugation before use. 5 pi |
of a glycogen solution (10 mg/ml) was added per tube of RNA solution as a carrier 
for RNA. 0.5 pg of oligo(dT)]g primer (Promega) was added for each pg of RNA 
sample in a total volume of 15 pi DEPC-treated water. The solution was then heated 
to 70°C for 5 minutes to melt secondary structures within the template and 
immediately cooled on ice. To the solution was then added: 5 pi M-MLY RT 5x ’
reaction buffer (250 mM Tris-HCl, pH 8.3, 375 mM KCl, 15 mM MgCl2, 50 mM 
DTT, Promega), 1.25pi each of dATP, dCTP, dGTP and dTTP, all at 10 mM, 25 1
units Recombinant RNasin®Ribonuclease Inhibitor (Promega), 200 units M-MLY 
RT and nuclease free water to a final volume of 25 pi. The reaction was finally 
incubated at 42°C for 60 minutes and either used immediately for second strand |
synthesis by RT-PCR, or stored for a limited time at -20°C.
An alternative method involved the use of components of the Gibco-BRL 
Superscript preamplification system for first strand cDNA synthesis. 1-5 pg total 
RNA was mixed with 0.5 pg oligo(dT);g primer (Promega) in a total volume of 12pl, 
incubated at 70°C for 10 minutes and chilled on ice. To this reaction 2 pi lOxPCR 
mix, 2 pi 25 mM MgCl2, 1 pi 10 mM dNTP mix and 2 pi 0.1 M DTT were added 
and the reaction incubated at 42°C for 5 minutes before 200 units of Superscript II 
RT was added and incubation continued for a further 50 minutes. The reaction was 
terminated by heating at 70°C for 15 minutes and then chilled on ice. Finally 1 pi 
RNase H (2 units/pl) (Gibco-BRL) was added to each tube and incubated for 20 
minutes at 37°C in order to digest the RNA template from the cDNA:RNA hybrid 
molecule before second strand synthesis. The cDNA was then either amplified 
directly in PCR reactions or stored at -20°C until needed.
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2.10 GEL ELECTROPHORESIS
61
Agarose gels for electrophoresis of DNA or RNA were prepared as described in 
Sambrook et.al (1989). Powdered agarose (Sigma, Promega or Gibco-BRL) was 
mixed with electrophoresis buffer (either IxTAE or 0.5xTBE) and ethidium bromide 
to a final concentration of 0.5 pg/ml. An agarose concentration of 0.8-2.0 % (w/v)
was used, the concentration depending on the size of DNA fragments to be separated.
When appropriate, low-melting-temperature agarose (Agarose Prep from Pharmacia ? |
or NuSieve®GTG® agarose from Flowgen) was used instead of standai'd agarose. The 
slurry was then heated in a microwave oven mitil the agarose was completely 
dissolved after which the solution was cooled to 60°C and the warm agarose poured 
into a plastic electrophoresis tray and an appropriate sample well comb inserted.
After the gel was completely set, the comb was removed and the gel mounted in an 
electrophoresis tank. The gel was covered with electrophoresis buffer with added 
ethidimn bromide (0.5 pg/ml) and the DNA or RNA samples, mixed with a gel- 
loading buffer (0.25% w/v bromophenol blue, 30% glycerol in HgO), loaded into the 
wells. The first well was usually loaded with a marker DNA of a Icnown size, either a 
1 kb DNA ladder with 13 bands (Advanced Biotechnologies) or a Lambda/Hind HI 
molecular weight marker (Appligene). A voltage of l-5V/cm was applied and the 
DNA was allowed to migrate towards the anode until the bromophenol blue had 
migrated the appropriate distance through the gel. The gels were then examined by
ultraviolet light and photographed with a Polaroid camera or a Gel Imager.
2.11 RECOVERY OF DNA FROM AGAROSE GELS
'I
7
Frequently there was a need to recover DNA from agarose gels and several different |
protocols were used for this purpose. The QIAEX II gel extraction kit (Qiagen) is 
based on dissolving agarose in the presence of a buffer and silica particles that will 
absorb the DNA. Non-nucleic acid impurities are then washed away and the DNA 
can be eluted from the silica particles with water. After elution the silica particles are
I
■f
■:«
1
Chapter 2 Materials and methods
pelleted by centrifugation and the DNA recovered in the supernatant. The complete 
protocol is described in the QIAEX® II handbook. Another method used for recovery 
of DNA from agarose gels was the Wizard™PCR preps DNA purification system for 
rapid pmification of DNA fragments (Promega). With this method, agarose 
containing the desired DNA fragment is melted in the presence of resin, to which it 
becomes bound, loaded onto a minicolumn and washed with isopropanol before the 
DNA is eluted from the column with water. The full protocol is described in 
Promega's Teclmical bulletin for the purification system. Fast recovery of DNA using 
spin columns was also used. GenElute™ Agarose spin columns (Supelco, tlnmigh 
Sigma) were washed with TE buffer before the gel slice containing DNA was placed 
in the spin column and centrifuged for 10 minutes at 12 000 x g. The DNA was 
eluted in its original buffer and concentrated by ethanol precipitation in the presence 
of 3M sodium acetate before use. Another spin-column based method used was the 
QIAquick gel extraction kit (QIAGEN). Gel slices containing DNA were dissolved 
in the buffer provided, which generates the appropriate conditions for binding of 
DNA fragments, and loaded onto the silica membrane in the column. Impmities were 
washed away and the purified DNA could be eluted with elution buffer (10 mM Tris- 
Cl, pH 8.5). A complete protocol can be found in the QIAquick Spin Handbook 
(QIAGEN).
Genomic DNA was purified from possible contaminating enzymes, salts, proteins 
and other inhibiting factors using the Wizard™ DNA clean up system (Promega). The 
DNA sample was mixed and bound to a resin and then loaded onto a minicolmmi and 
washed with isopropanol. The resin was dried and the DNA eluted with prewaimed 
water or TE buffer. For a complete protocol see Promega's Technical Bulletin for 
Wizard™ DNA clean up system.
2.12 RESTRICTION ENZYME DIGESTS
Restriction enzyme digests, with various restriction endonucleases, were performed 
prior to Southern blots, prior to estimating genomic DNA concentrations and in order
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to cut out inserts from plasmid DNA. Restriction endonucleases were used together 
with their optimal enzyme assay temperature and buffers and details are given in 
table 2.1, A standard protocol was used in which 1 pg DNA was digested with Ipl 
enzyme in the presence of an appropriate restriction endonuclease buffer. The 
mixture was incubated, usually overnight, at a temperature optimal for the particular 
enzyme. Another 1 pi of enzyme was added the next morning and the digestion 
allowed to proceed for another 1-2 hours after which the products could be run on an 
agarose gel. Occasionally, the digest was carried out in a large volume in order to 
dilute possible contaminants and inlribitors and this was then followed by a phenol- 
chloroform extraction and ethanol precipitation. Wlren high molecular weight DNA 
was digested, 1 Ox restriction enzyme buffer was added to the DNA solution and left 
at 4°C, with gentle agitation from time to time, for several hours before the 
restriction endonuclease was added. The solution was stirred for several minutes 
before warming it to the optimal digestion temperature. The digestion was incubated 
for at least 2 hours before a second aliquot of enzyme was added and the solution 
stirred again and incubated for an additional 2 hours.
Restriction enzyme Buffer Optimal assay 
temp.
Bam H  I 50mM Tris-HCl, pH 8.0, lOmM M gC f, 
lOOmM NaCl
37°C
Eco47 III 50mM  Tris-HCl, pH 8.0, lOmM M gC f, 
lOOmM NaCl
37°C
EcoR I 50mM Tris-HCl, pH 8.0, lOmM M gC f, 
lOOmM NaCl
37°C
H ind 111 50mM  Tris-HCl, pH 8.0, lOmM M gC f, 
50mM NaCl
37°C
Kpn I 20mM  Tris-HCl, pH 7.4, 5mM M gC f, 50mM 
KCl
37°C
P s t I 50mM Tris-HCl, pH 8.0, lOmM M gC f, 
50mM NaCl
37°C
Rsa I 50niM Tris-HCl, pH 8.0, lOmM M gC f 37°C
Sina I 20mM  Tris-HCl, pH 7.4, 5mM M gC f, 50mM 
KCl
25"C
Tag I 50mM Tris-HCl, pH 8.0, lOmM M gC f, 
50mM NaCl
65°C
Table 2.1. Restriction endonucleases, buffers components and optimal assay temperatures. The
table lists restriction enzymes used in the study together with the recommended buffer components at 
Ix  concentration. The optimal temperatures for assays with respective enzymes are also given.
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2.13 SOUTHERN BLOTTING AND HYBRIDISATION
Genomic DNA was digested with restriction endonuclease(s) and separated by 
agarose gel electrophoresis in IxTAE containing ethidium bromide to a final 
concentration of 0.2 pg/ml at a voltage of 4-6V/cm. The DNA in the agarose gel was 
fragmented in 250 mM HCl for 10 minutes at room temperature with gentle 
agitation, denatured in 1.5 M NaCl, 0.5 M NaOH for 30 minutes, washed in ddH20 
and neutralised in 1.5M NaCl, 0.5 M Tris-HCl, pH 7.5 for another 30 minutes. The 
gel was then transferred to a solid support capillary transfer system, using a piece of 
Whatman 3MM paper as the source of capillary action and overlaid with a nylon 
membrane, either Hybond™ -N+, positively charged nylon membrane (Amersham, : l
UK) or MSI nylon transfer membrane (Micron Separation Inc.). The membrane was 
overlaid with 3 MM paper which had been wetted with 20xSSC and a stack of paper I
towels were placed on top followed by a glass plate and a 1 kg weight. lOx or 
20xSSC (IxSSC is 150 mM NaCl, 15 mM sodium citrate, pH 7.0) or SSPE (2Ox 
SSPE is 3.6 M NaCl, 0.2 M sodium phosphate, 0.02 M EDTA, pH 7.7) was used as 7
transfer buffer and the transfer completed in 12-16 hours. After blotting, the 
apparatus was dismantled, the positions of the gel slots marked on the filter and the 
filter washed in 2x or 6xSSC or SSPE. The blots were fixed either by UV- 
crosslinking, using the optimal setting of 1200 units in a UY-crosslinlcing oven, or by 
alkali fixation. The method for alkali fixation involves placing the membrane with |
the DNA side up on a pad of absorbent paper soaked in 0.4 M NaOH for 20 minutes.
The membrane was then rinsed briefly in 6xSSC or SSPE. Filters that were not used 
immediately in hybridisation experiments were wrapped in SaranWrap and stored at 7
4°C until needed.
Hybridisation
Hybridisation to Southern blots was either carried out with radiolabelled probes or 4
with probes labelled with fluorescein. For fluorescein labelled probes, the filter was 
prehybridised in a hybridisation buffer recommended by the Gene Images labelling
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and detection system (Amersham; 5xSSC, 0.1% (w/v) SDS, 5% dextran sulphate and 
20-fold dilution of a liquid blocking buffer supplied with the system). Pre- 
hybridisation was then carried out for at least 30 minutes at 60°C before the 
fluorescein labelled probe was added. The DNA probes were labelled with 
fluorescein-11-dUTP random primer labelling kit according to the manufacturers 
recommendations (Amersham). 50 ng of probe was routinely used which was 
estimated to give a final probe concentration of approximately 8 ng/ql. After addition 
of the probe, denatured at 100°C for 5 minutes, hybridisation was carried out 
overnight at 60°C and the filter washed at the same temperature, initially in IxSSC, 
0.1% SDS (w/v) for 15 minutes and then in 0.5xSSC, 0.1% SDS for another 15 
minutes. Detection was achieved via an antibody conjugate labelled with alkaline 
phosphatase (Gene Images CDP-Star detection module, Amersham). After 
application of a detection reagent, the antibody catalyses a chemoilluminscent 
reaction with dioxetane substrate and the signal could then be captured on Medical 
X-ray film (Fuji).
For hybridisation of radiolabelled probes to DNA immobilised on nylon
membranes, one of two alternative prehybridisation solutions were used; either
Denhardts solution (6xSSC, 5xDenliardf s reagent, 0.5% SDS, lOOpg/ml denatured,
fragmented herring sperm DNA) or Church & Gilbert buffer (0.5 M Na^HPO^, pH
7.2, 1 mM EDTA, 7% SDS). The filter was prewetted in 6xSSC prior to 
. . .hybridisation and prehybridised for at least 45 minutes at 60°C. The probes were
labelled with a^^P-dCTP, 3000 Ci/mmole (NEN’"'^  Life Science Products) either
using the Prime-Ifl"^ II Random Primer Labelling kit (Stratagene) or the redipximQ
DNA labelling system (Amersham). For the Prime-Ifl'^ system, 25-50 ng of probe
were labelled for each reaction following the instmctions for the kit. The system
relies on the ability of random hexanucleotides to anneal to several sites along the
DNA template. The newly synthesised DNA was labelled by substituting a
radiolabelled nucleotide for a non-radioactive one during the reaction with the use of
the Klenow fragment of DNA polymerase I. In some experiments the probe was
purified with NucTrap® Probe Purification Columns (Stratagene) using the Push 
.Column Beta Shield Device (Stratagene) in order to remove unincorporated 
nucleotides from the probe. The rerizprime DNA labelling system contains a buffered
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solution of dATP, dGTP and dTTP, exonuclease free Klenow enzyme and random 
primers, all in a stabilised form in ready to use tubes. The working principle is the 
same as for Prime-It™ system but the amount of probe needed is less, usually 2-25 ng 
per reaction. The labelling was carried out as recommended in the Rediprime 
protocol. After labelling, the probe was denatured and added to the hybridisation 
buffer and filter and left to hybridise at 60°C overnight. The blots were washed, first 
in 5xSSC, 0.1% SDS for 15 minutes at 60°C and then in 2xSSC, 0.1% SDS for 15 
minutes at 60°C. Additional washes at higher stringency were carried out as 
necessary. The filter was removed, wrapped in SaranWrap and exposed to X-ray film 
at -70°C for an appropriate length of time. Probes were prepared in various forms 
depending on requirements and were purified PCR products, PCR products in LMPA 
or whole midiprep or purified midiprep inserts from recombinant plasmids.
Removal o f  radiolabelled and fluorescein labelled probes from nylon membranes 
Nylon membranes that had been kept wet at all stages during hybridisation, washing 
and exposure of X-ray film could be stripped, checked and reprobed. The filters were 
either immersed for at least 30 minutes in 0.4M NaOH at 42°C or added to a boiling 
solution of 0.1 or 0.5% SDS and allowed to cool to room temperature on a bench-top 
shaker. If the filters were still hot, the procedure was repeated.
2.14 NORTHERN BLOTTING AND HYBRIDISATION f'
Northern blotting was carried out essentially as described in Sambrook et.al (1989). I
A 1.2% agarose gel was prepared by dissolving 1.2 g agarose in 10 ml lOxMOPS 
buffer (0.2 M MOPS, 80 mM sodimn acetate, 10 mM EDTA) pH 8.0, 73 ml RNase 
free H2O and 17 ml formaldehyde (38%). Total RNA was prepared and stored as 
described in section 2.8. Normally 5 pg RNA was resuspended in loading buffer 
(50% formamide (w/v), 6.7% formaldehyde (w/v) and IxMOPS buffer in RNase free 
H2O) and denatured at 70°C for 10 minutes. The samples were immediately chilled 
on ice and mixed with loading dye (40% (w/v) glycerol in water, 0.25% 
bromophenol blue) and loaded onto a prerun gel. An RNA marker, 0.28-6.58 kb,
(Promega), was loaded in the first lane for size estimation of the RNA. A small
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amount of ethidium bromide (1 pi of a 1 mg/ml solution) was usually added to the 
samples before electrophoresis to allow detection of undegraded RNA when viewed 
under ultraviolet illumination at the end of the run. IxMOPS buffer was used as 
ruiming buffer and the gel photographed with a ruler aligned with the marker to be 
able to calculate the size of the RNA species detected by hybridisation. The gel was 
washed in lOxSSC and then blotted directly onto a nylon filter using the same 
transfer teclmique, equipment and fixation protocols as for Southern blotting 
described in section 2.13.
Slot blotting o f  RNA
To increase the amoimt of RNA/cm^ of filter, a slot blotting teclmique was used 
when low-abundance mRNA was to be detected. The method for this was essentially 
as described in Sambrook et.al. (1989). A piece of nylon membrane, either Hybond™ 
-N+, positively charged nylon membrane (Amersham, UK) or MSI nylon transfer 
membrane (Micron Separation Inc.), was soaked in 20xSSC for at least 1 hour at 
room temperature. The slot manifold was cleaned with 0.1 M NaOH or with RNase 
AWAY (Molecular Bio-products) before use. Two sheets of Wliatman 3MM paper, 
prewetted in 20xSSC, were placed on top of the vacuum unit and the nylon 
membrane on the bottom of the sample wells and the two parts clamped together. 
The slots were then washed twice with lOxSSC prior to adding the RNA samples. 
Samples of 5-10 pg RNA were prepared in a final solution of 50% formamide, 7% 
formaldehyde, IxSSC and denatured at 68°C for 15 minutes before snap cooling on 
ice. The samples were mixed with 20xSSC and gently sucked through the filter, 
using a vacuum pump, which was then washed with lOxSSC. The filter was allowed 
to dry before the RNA was UV-crosslinlced to the filter at 1200 units in a UV- 
crosslinking oven (Amersham).
Dot blotting RNA
Dot blotting was undertaken using the same nylon membranes as described above. 
5-10 pg total RNA, resuspended in DEPC treated HgO, was incubated at 65°C for 5 
minutes in thiee volmnes of a solution of 500 pi formamide, 162 pi formaldehyde 
(37%) and 100 pi lOx MOPS buffer. The samples were chilled on ice, 1 volume of
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cold 20xSSC added and the RNA then spotted onto the filter in 2 pi aliquots, 
allowing it to dry between applications. The filter was dried and fixed as described 
above. All solutions used were rendered RNase free by DEPC treatment.
Hybridisation
Northern hybridisations were carried out in the same way as described for Southern 
blots in section 2.13, except that a higher hybridisation temperature of 65°C was used 
in most experiments.
2.15 PCR AMPLIFICATION OF THE SRA GENE
The Polymerase Chain Reaction (PCR) was used to test for the presence or absence 
of the SRA gene in various stocks of trypanosomes. A range of synthetic 
oligonucleotide primers were designed which are all described in section 5.2.1 The 
optimal annealing temperature for each primer combination was determined by 
running reactions on a Robocycler PCR machine to cover the temperature range 50- 
70°C. For these control reactions ETatl.2 was used as DNA template before other 
stocks were included. Typically, 20 ng of template and IpM of each of primer with 
Taq DNA polymerase, 5 units/pl (Advanced Biotechnologies) and 11.1 x PCR buffer 
to give a final concentration in the reaction of 45 mM Tris Hcl, pH 8.8, 11 mM 
ammonium sulphate, 4.5 mM MgCD, 6.7 mM 2-mercaptoethanol, 4.4 pM EDTA, pH 
8.0, and dATP, dCTP, dGTP and dTTP all at 1 mM, in a total volume of 10 pi. fi
Optimal cycling conditions were usually found when performing the reactions at 29 
cycles of 94°C for 50 seconds (denaturing), 55-65°C for 50 seconds (annealing) and 
12°C for 2 minutes (extension). Nested PCR reactions were frequently needed in 
order to obtain strong signals. In these cases a final primer concentration of 0.2 pM 
was used instead of 10 pM and the number of cycles reduced to 24 during the first 
reaction. The second reaction was essentially as described above using a Ipl carry 
over as the DNA template. Occasionally, the reactions were carried out using the 1 Ox 
reaction buffer IV with separate MgCIg, supplied by Advanced Biotechnologies.
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2.16 RT-PCR AMPLIFICATION OF THE SRA GENE
Reverse transcription PCR (RT-PCR) is a sensitive method for detection of mRNA 
sequences from cDNA and was used for identification of expression of the SRA 
gene. The cDNA was isolated from the valions trypanosome stocks as described in 
section 2.9 and typically 1 pi of the reverse transcription reaction used for each RT- 
PCR reaction of 25 pi. The synthetic oligonucleotides that were used are all 
described in section 5.2.7 and the positions of the primers used for amplification 
within the SRA gene locus are shown in figure 5.1. The heat-treated reverse- 
transcriptase reaction product was usually used immediately for PCR amplification 
and only occasionally stored at -20°C before use. The number of PCR cycles 
required was 30 or less and the thermal cycle profile that worked well foi- 
amplification of the SRA gene in the control stock ETatl.2, was: denaturing for 1.5 
minutes at 95°C, annealing primers for 1 minute at 55°C and extending the primers 
for 1 minute at 72°C. The same buffer was used for both reverse transcription and 
PCR; either Advanced Bioteclmologies formula with separate MgCl^ (buffer IV) or 
Promega lOx PCR buffer, depending on which Taq DNA polymerase was used. A 
control reaction with primers for the single copy triosephosphate isomerase (TIM) 
gene was always carried out simultaneously with each RT-PCR reaction. TIM is an 
enzyme found exclusively within the glycosome in T.brucei (Swinkeis et.al, 1986).
2.17 DNA SEQUENCING
The primary structure of PCR products and cloned cDNA from differential display 
RT-PCR were determined on an automated Applied Bio systems 373 DNA sequencer 
by using the Dye Terminator Cycle Sequencing Ready Reaction (Applied 
Biosystems). Cycle sequencing reactions were prepared as recommended for the Dye 
Terminator Cycle Sequencing Ready Reaction Kit (The Perkin-Elmer Corporation) 
followed by ethanol precipitation. The automated sequencing was cairied out by the 
Molecular Biology Support Unit, University of Glasgow.
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2.18 ANALYSIS OF SEQUENCE DATA
Sequencing results were supplied in electronic form and usually downloaded 
directly into the Unix version of the Wisconsin GCG program. After editing of the 
sequence to remove vector sequence or removal of unsuccessful sequence stretches 
and the comparison of reverse and forward sequences, the sequence was submitted to 
a database search. FASTA and BLASTN were both used to perform nucleotide vs. 
nucleotide sequence comparisons and BLASTX was used to compare the translated 
product of an unknown sequence against translated nucleic acid and protein 
databases. Databases used include the GeiiBank (National Centre for Biotechnology 
Information, Bethesda, USA) the EMBL database (European Bioinformatics 
Institute, Cambridge, UK), the protein sequence databank SWISS-PROT (Centre 
Medical Universitaire, Geneva, Switzerland) and the African Trypanosome DNA 
database at the Parasite Genome Blast Server (http://www.ebi.ac.uk/parasites/parasite 
_blast_server.html). Other modifications and analyses were performed using the 
GCG program.
2.19 INDIRECT IMMUNOFLUORESCENCE
An indirect iimnunofluorescence antibody technique for bloodstream trypanosomes 
was used when determining the variable antigen type (VAT) of pai'ticular 
trypanosome lines. Thin blood smears were prepared with infected mouse blood 
displaying a parasitaemia above antilog 7.5 cells/ml. The smears were airdried and 
fixed in 70% ethanol for 1 hour at 4°C and could then be used either immediately or
diluted first antibody was applied and again incubated in a humid chamber for 30 
minutes at room temperature. All VAT-specific antibodies were provided by Mike 
Turner and usually needed to be diluted 1:100 or 1:50 in PBS before use. After
stored at -20°C in the presence of silica gel. After returning to room temperature the 
slides were rehydrated in a himiid chamber for 10 minutes before an appropriately
70
Chapter 2 Materials and methods
incubation the slides were tapped on the bench to remove most antibody solution and 
then washed twice in PBS/0.01% Tween for 5 minutes each. Excess PBS was 
removed by tapping the slides on the bench but care was taken to ensure the slide did 
not dry out. The appropriately diluted conjugated secondary antibody, anti-rat FITC 
(Sigma) or anti-rabbit FITC (SAPU), was then applied to the slides and incubated in 
a humid chamber for 15-30 minutes. Wlren 10 minutes remained of the incubation 
time, 4,6-diamidino-2-phenylindole (DAPI) (0.01 mg/ml) was applied as a 
counterstain for DNA. The slides were washed briefly in PBS/0.01 % Tween 20 
before mounting with Citifluor antifadant (Citifluor Ltd) or in non-autofluorescent 
glycerol. The trypanosomes were then examined by immunofluorescence microscopy 
aird the prevalence of the major VAT, in percentage, determined by comiting 200 
cells.
2.20 ANTIBODY MEDIATED COMPLEMENT LYSIS
An antibody mediated complement lysis assay for bloodstream trypanosomes was 
used when selecting for populations expressing particular VATs. To perform the 
assay, trypanosomes were separated from blood, resuspended in PSG, pH 8.05 at 
4x10^ cells/ml and incubated with VAT-specific antisera in double dilution’s. The 
antisera, produced against a specific VAT, were diluted in guinea pig serum starting 
with 1/10 dilution and mixed with equal volume of trypanosome suspension in a 
disposable microtitre plate. The plate was then incubated at room temperature for 
between 30 minutes and 3 hours after which the surviving trypanosomes were cloned 
optically and injected i.p. into mice.
2.21 DIFFERENTIAL DISPLAY RT-PCR
Differential display RT-PCR was the major tool used to identify genes differentially 
expressed in a human serum resistant population compared with a human serum 
sensitive population. The method, invented by Liang and Pardee (1992), was carried
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out using the RNAimage^'^ system produced by GenHunter. The method involves the 
reverse transcription of mRNAs with oligo-dT primers anchored to the begimiing of 
the poly(A)tail and a PCR reaction in the presence of a second lOmer which is 
random in sequence. The PCR products were visualised on a denaturing 
polyacrylamide gel and any bands of interest, i.e. differentially displayed between the 
two populations, reamplified, ligated into a vector and cloned. The resulting cloned 
inserts were then screened by Northern blotting and analysed.
Preparation o f starting material 
The method of differential display depends on the isolation of intact RNA 
obtaining, free from cluomosomal DNA contamination and the method used is 
described in section 2.8. The selection of trypanosome lines of the same genotype but
expressing differences in human serum resistance phenotype is described in 6.2.1. I
Reverse transcription o f mRNA 
One-base anchored oligo-dT primers were used for reverse transcription in order to 
avoid under-representation of certain mRNA populations. Therefore, three reverse 
transcription reactions were set up for each of the two RNA samples, each containing 
one of the different primers H-T,i-G, H-T],-A or H-T,i-C, RT-buffer and dNTP s. A 
complete protocol can be found in the RNAimage’’^  system information booklet. The 
reverse transcription reaction was carried out in a thermocycler at 65°C for 5 
minutes, 37°C for 60 minutes, 75°C for 5 minutes with the addition of MMLV 
reverse transcriptase after 10 minutes at 37°C. The reactions were then either used 
immediately for PCR or stored at -20° for later use.
Polymerase chain reaction 
24 different 5’-primers, which are short and arbitrary in sequence, were used in 
combination with the anchored primers to amplify a set of cDNA fragments from the 
3’ end of the mRNA. These random primers were all supplied with the ILNAimage™ 
system and are 10 nucleotides long but sequence information is withheld. The PCR #
reaction was carried out in the presence of a-^^P dATP (2000 Ci/mmole) (DuPont- 
NewEngland Nuclear) so that the resulting PCR products could be visualised by 7
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autoradiography. The PCR reactions were otherwise set up as recommended by 
GenHunter in the information booklet about RNAimage™. PCR reactions were 
carried out at 94°C for 30 seconds, 40°C for 2 minutes and 72°C for 30 seconds 
repeated for 40 cycles and followed by an extra extension time of 72°C for 5 
minutes. After the reaction was complete, samples were usually used for the next step 
in the system but were occasionally stored at -20°C for later use.
Band separation
A  6% denatuiing polyacrylamide gel, commonly used for DNA sequencing, was 
used for resolution of amplified cDNAs. The gel was prepared either by a standard 
polyacrylamide gel protocol (Sambrook et.al, 1989) or the Sequagef^XR (National 
Diagnostics) was used and prepared according to the manufacturers instructions. 
After addition of 0.8 ml of 10% (w/v) ammonium persulfate for every 100 ml of gel 
casting solution, the solution was poured into the cleaned and siliconized gel casting 
cassette. The gel was polymerized for at least 2 hours or overnight. The cassette was 
then assembled into the electrophoresis apparatus and using IxTBE as running 
buffer, the gel was prerun for 30 minutes and the wells carefully flushed before 
loading the samples. 3.5 pi of each sample was mixed with 2 pi loading dye (95% 
formamide, 10 mM EDTA, pH 8.0, 0.09% xylene cyanole FF, 0.09% bromophenol 
blue) and incubated at 80°C for 2 minutes before loading onto the gel. Each sample 
was prepared in duplicate and two samples from the human serum resistant 
trypanosome population and two samples from the human serum sensitive 
population, produced by the same primer combination, were loaded next to each 
other. Electrophoresis was then carried out at 60 W constant power until the xylene 
dye had reached the bottom of the gel. The gel apparatus was dissembled and the gel 
transferred to a piece of Wliatmann 3 MM paper. The gel was covered with plastic 
wrap and dried under vacuum on a gel dryer at 80°C for 2 hours and marked with 
fluorescence stickers (Stratagene) for later orientation and autoradiography.
Reamplification o f  cDNA probes o f  interest
Retrieval of differentially expressed bands from polyacrylamide gels was achieved 
by a boiling and ethanol precipitation method (Liang et.al, 1993). After developing
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the film, the autoradiogram was oriented with the gel and bands of interest marked 
with a needle at each of the four corners so that the same band could be cut out with a 
clean razor blade fiom the dried gel. The gel slice, along with the 3MM paper, was 
soaked in 100 pi ddH20 for 10 minutes and boiled for 15 minutes. The supernatant 
was transferred to a new tube and 1/10 volume 3 M sodium acetate and 2.5 volumes 
100% ethanol was added together with 5 pi glycogen(10 mg/ml). The DNA was 
precipitated at -70°C for at least 30 minutes followed by centrifugation to pellet the 
DNA; the pellet was washed once with ice-cold 85% ethanol. After dissolving the 
DNA in ddHgO a portion of it was used for reamplification using the same primer set 
and PCR conditions, except with a higher dNTP concentration (20 pM instead of 4 
pM) and no radioactive nucleotide added. A detailed protocol is included in the 
RNAimage’^''^  booklet. The amplified PCR product was then run on a 1.5% agarose 
gel stained with ethidium bromide and in the few cases where no product could be 
visualised, another 40-cycle PCR amplification was carried out using a 1:100 dilution 
product as template. The reamplified cDNA was extracted from the agarose gel by 
one of the methods described in section 2.11 and the yield determined. In most cases 
the recovered DNA band was subsequently cloned, by the method in section 2.22, 
before serving as a probe to confirm mRNA expression.
Confirmation o f gene expression 
The next crucial step was to confirm gene expression i.e. to identify false positive 
bands and remove them from the study. Initially, after comparing the sizes of the 
reamplified PCR product with the sizes of the original band on the DNA sequencing 
gel, the amplified cDNA was used as a probe in Northern blot experiments, see 
section 2.14. Unfortunately, signals were rarely detected on the Northern blot, 
presumably because of low abundance of the mRNA, and all retrieved bands were 
therefore rescreened with Northern slot hybridisation for increased sensitivity, again 
as described in section 2.14.
Sequencing analysis o f the differentially expressed genes 
After cloning of the differentially expressed cDNA fragments, they were sequenced 
by the automatic sequencing method described in section 2.17. Cloning was
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necessary because multiple DNA species were likely to have been present in the 
recovered DNA band and the differential display primers are too short to be used for 
direct sequencing. The sequence information was then used in searching for the 
identity of the differentially expressed genes in computer databases. In a few cases, a 
longer cDNA sequence was obtained by RT-PCR before meaningful sequence 
analysis could be carried out.
2.22 PRODUCTION OF RECOMBINANT DNA, TRANSFORMATION OF 
E.COLI A m )  CLONING
Ligation of PCR fragments into a vector was performed using the SureClone® 
Ligation kit from Pharmacia Biotech. The protocol uses a Klenow digestion, a 
column purification and a blunt-end ligation into the pUC 18 vector. The PCR 
product is prepared for ligation by the 3’-5’ exonuclease activity of the Klenow 
fragment of DNA polymerase I to remove single base 3’ overhangs on the fragments. 
Depending on the concentration of the gel purified PCR product and length of the 
fragment, approximately 300 ng was used in the blunt end kinase reaction in the 
presence of the Klenow fragment and polynucleotide kinase, as described in detail in 
the instruction booklet for the SureClone® Ligation kit. The reaction was allowed to 
proceed for 30 minutes at 37°C and the product purified by a phenol/chloroform 
extraction. The upper, aqueous layer was further purified on MicroSpin coluimis of 
Sephacryl® S-200 (Pharmacia Biotech) and a portion of the elute used to ligate into 
the vector. After calculating how much column purified sample was needed in the 
ligation reaction (in order to obtain the right ratio of ends) a ligation reaction with T4 
DNA ligase, DTT solution and the dephoshoryiated pUC 18 vector was set up as 
described in the instruction booklet for the SureClone® Ligation kit. The reaction was 
incubated at 16°C for 1.5-2 hours.
Transformation o f competent E.coli cells
Transformation was performed either by heat-shocking JM 109 competent cells 
(Promega or Stratagene) which had been made competent by a modification of the
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method of Hanahan (1983) or by electroporation of electrocompetent JM 109 cells 
(Stratagene) prepared in the laboratory. For heat-shock transformation of E.coli, 
frozen competent cells were thawed on ice and approximately 50 ng of ligated DNA 
added to 100 pi cells. 1 ng pUC 18 was also added to a separate portion of cells as a 
positive control for the competent cells. The tubes were left on ice for 10 minutes, 
heat-shocked at 42°C for 45 seconds and immediately placed on ice for 2 minutes. 
900 pi cold LB or SOC medium was then added to each transformation and the 
suspension incubated for 60 minutes at 37°C on a shaker. Cells were then plated, 
undiluted or in a 1:10 dilution, onto agar plates containing ampicillin, 100 pg/ml, 
IPTG and X-gal. The pUC 18 vector expresses p-galactosidase and displays a- 
complementation in E.coli so that recombinants can be identified by screening with 
IPTG and X-gal which results in the colonies being blue or white; colonies that 
contain a non-disrupted (3-galactosidase will appear pale blue while colonies that 
contain a plasmid will not be capable of a-complementation and therefore appear 
white. To each LB-agar plate 40 pi X-gal (20 mg/ml) and 4 pi IPTG (200 mg/ml) 
was added. The plates were only inoculated with the bacteria when all the fluid had 
disappeared and then incubated for 12-16 hours at 37°C. Bacteria for transformation 
by electroporation were grown overnight, diluted in LB and allowed to grow until the 
OD^ oo of the cultui'e reached 0.6. The cells were then washed twice in cold sterile 
water, pelleted by centrifugation and resuspended in cold sterile water with 10% 
glycerol. Cells not used immediately were snap-frozen on dry ice and stored at -70°C 
until needed. Electrotransformation was performed using a GenePulser (Bio-Rad) in 
pre-chilled cuvettes using the suppliers conditions: 25 pF, 200 Q and 2.5 kV. After 
transformation, 1 ml of SOC medium was added immediately and the solution 
incubated at 37°C for 1 hour to allow initiation of expression. Plating of the 
electrotransformed cells was as described above.
2.23 RECOMBINANT CLONE CHARACTERISATION
The presence and size of plasmid DNA inserts were determined directly by PCR 
before mini- or midipreparation of DNA and restriction analysis. Material from a
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colony was transferred into PCR mix (14.9 pi H^O, 2 pi lOx PCR mix, 1 pi 5 mM 
dNTPs, 1 pi each of primers Ml 3 forwai'd and Ml 3 reverse (Cruachem Ltd), both at 
10 pmole/pl and 0.1 pi Taq polymerase) with a toothpick. A stock of the colony was 
established by placing the remaining material on the toothpick directly into culture 
media or streaking out on a new plate. The insert was amplified by PCR; 94°C for 5 
minutes followed by 25 cycles of 94°C, 1 minute, 55°C, 1 minute, 72°, 5 minutes 
and 72°C for 5 minutes. A portion of the amplified insert was analysed on an agarose 
gel stained with ethidium bromide including a control reaction of vector without 
insert for size comparison.
Mini and midipreps of plasmid DNA from each clone were prepared using 
QIAGENs plasmid purification system according to the protocol found in the 
QIAGEN plasmid handbook. The resulting DNA pellet was resuspended in TE 
buffer and the yield determined on a UV spectrophotometer followed by analysis on 
an agarose gel. A restriction enzyme digest was designed to cut out the insert from 
the vector. For pUC 18, double digestion with EcoRI and BamHI was used. After gel 
electrophoresis the insert could be isolated and purified and used as a probe in 
hybridisation experiments.
2.24 5’RACE
With the aim of obtaining full length cDNA, from the 3’end fragment isolated 
during differential display RT-PCR, one approach was to use rapid amplification of 
cDNA ends (RACE) anchored PCR with the aid of the 573’ RACE kit (Boelninger 
Mannlieim). The method was first described by Frohmann et.al. (1988) and is based 
on the principle of first strand cDNA synthesis from total RNA using a nested series 
of gene-specific primers. The first strand cDNA was purified from unincorporated 
nucleotides and primers with the High Puie PCR Product Purification Kit 
(Boelninger Mannheim). Terminal transferase was then used to add a poly(A)-tail to 
the 3’end of the cDNA and this was followed by PCR amplification using a second 
gene-specific primer and an oligo dT-anchored primer. The PCR product obtained
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was further amplified by a second, nested reaction with a third gene-specific primer 
and a pre-designed PCR anchor primer. In theory, this sequence of PCRs would 
result in a product corresponding to the full length gene sequence which can be 
sequenced and analysed. A detailed protocol for the method is published in the 
instruction book for the 573’ RACE kit.
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Chapter 3
Development of an assay for human serum resistance/sensitivity
3.1 INTRODUCTION
A fundamental requirement for the study of serum resistance/sensitivity is that a 
reliable assay for experimentally measuring this trait is available. The test must rely 
on differential killing of resistant and sensitive T. brucei by the trypanolytic factors in 
human serum. This was originally carried out in vivo by the blood incubation 
infectivity test (BUT), developed by Riclanan & Robson (1970), and involved 
injecting trypanosome-infected rats with human serum to investigate if the human 
serum could clear the infection and, later, incubating piuified trypanosomes with 
human blood and then injecting them into rodents. Since there were some concerns 
that the resistance of strains could change with variable antigen expression and with 
passage in vivo (Rickman, 1977; Van Meirvenne et.al, 1976) in vitro tests were 
developed as described in 1.4.2. The initial aim of this study was to establish a 
reliable in vitro bloodstream form human serum resistance assay to be used for all 
further analyses. Basically, this assay was to consist of incubating piaified 
trypanosomes with human serum and then count the percentage of lysed cells 
compared with unaffected cells. A range of variables were examined and optimised 
but despite every effort to design a reliable and stable assay it was clear that cell 
viability could not be estimated from morphological appearance alone. A statistically 
significant difference in mean percentage lysis was observed between stocks that 
correlated with hmnan serum sensitivity but the level of lysis varied too much 
between individual assays for it to be unambiguous. Instead, a more reliable in vivo 
human serum resistance assay, which involved incubating bloodstream trypanosomes 
with human serum, injecting them into mice and screening of the mice for the 
development of parasitaemia, had to be optimised and adopted.
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3.2 RESULTS
3.2.1 Development of an in vitro HSS assay
In a series of preliminary experiments the following potential variables were 
investigated: serum from different individuals, the use of heat-inactivated/non heat- 
inactivated serum, incubation temperature, serum concentrations, trypanosome 
concentration, source of control serum, the morphology of the trypanosomes, 
incubation volume, scoring of live or fixed cells and the use of viability stains and 
dyes. When serum sensitive bloodstream trypanosomes were incubated with human 
serum, a whole range of deformed, swollen and ‘tadpole’ shaped cells started to 
appear after approximately 1 hour of incubation (depending on conditions used), for |
an example see figure 3.8, When measuring the percent lysis in the following 
experiments, these deformed cells are scored as lysed cells and only cells with an 
apparent normal morphology are scored as ‘normal’.
Serum from different individuals 
Serum from different individuals was tested for lytic activity since differences in 
activity between serum from different donors has previously been reported (Lorenz 
et.al, 1994). Serum samples from five different volunteers were taken, three of them ^
after overnight fasting. To evaluate the different sera, the time to maximum lysis and 
the percentage of trypanosomes lysed was determined. Two different stocks of 
trypanosomes were used for this purpose, STIB 247, which is regarded as human 
serum sensitive, and STIB 386, which has been shown to resist killing by human 
serum (Hide et.al, 1994). Purified trypanosomes were incubated with the sera, non­
heat inactivated, at a concentration of 1x10^ cells/ml in MEM+Eai*les salt and 25% 
sermn at 37°C for various length of times. A graph of percent lysis with time is 
shown in figure 3.1. Individuals differed mainly in the time of onset of lysis but 
there was also a small difference in the percentage of lysed trypanosomes after 4 
houi's. The most significant difference in lytic effect was after 1.5 hours when serum 
from two of the donors failed to cause lysis greater than that of the control serum.
The differences between donors was still significant after 3 hours but much less so
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hours. There were larger differences between different sera for STIB 247 than for 
STIB 386. The assay was repeated three times for two of the sera and twice for the 
remaining three sera. Serum from the same individual was constant in its trypanolytic 
effect (data not shown) and during subsequent experiments (section 3.3 onwards) 
only serum from the same person was used.
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Figure 3.1. A comparison o f the lytic effect o f serum  from five different individuals. Serum from 
five different individuals was tested both with STIB 247 bloodstream trypanosomes (upper graph) and 
with STIB 386 (lower graph). Purified trypanosomes were incubated with 25%  non heat-inactivated 
serum at a concentration of 1x10^ cells/ml at 37°C. The assays were performed twice for three of the 
sera and three times for two of the sera, the % lysis calculated and the mean values are shown. Guinea 
pig serum (GPS) was used as a negative control serum.
Heat~inactivated/non heat-inactivated serum 
To reiuove complement components the serum was heat-inactivate prior to use. 
Serum was heated to 56°C for 30 luinutes according to standard procedures. This 
process did not affect the trypanosome lytic properties of the sera because heat- 
inactivated sera was as active as unheated sera as shown in figure 3.2.
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Figure 3.2. Comparisons of the lytic effect of heat-inactivated and non heat-inactivated human  
serum. H eat inactivated and non heat-inactivated sera were compared in an in vitro HSS-assay in 
order to detect possible differences in their lytic capacities. Comparisons were made using cells from 
the three trypanosome stocks STIB 247, STIB 386 and TREU 927 by incubating purified cells with 
25% heat-inactivated or non heat-inactivated serum at a concentration of 1x10^ cells/ml for 2.5 hours 
at 37°C. The assay was performed four times for STIB 247 and twice for STIB 386 and TREU 927 
and the mean % lysis calculated and displayed above for serum collected fi'om different individuals. 
The overall lysis for STIB 247 was 73% using heat inactivated serum and 77% lysis when incubated 
with non-heat inactivated serum.
Incubation temperature 
Because of observations that TLFl mediated lysis is temperature dependent and can 
be inhibited at 17°C (Hajduk et.al, 1989; Rif kin, 1978) it was of interest to test lysis 
at different temperatures. The trypanocidal effect of heat-inactivated serum from the 
same individual was evaluated both at room-temperature (20°C) and at 37°C in the 
presence of 25% serum and with a cell concentration of 1x10^ cells/ml. Only STIB 
247 was used for this experiment which was repeated twice. In each case there was a 
clear, almost ten-fold, increase in lytic activity at 37°C compared with incubation at 
room-temperature, as shown in figure 3.3.
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Figure 3.3. Comparison o f trypanosome lysis at room temperature and at 37°C. STIB 247 cells 
were used for comparing the extent of lysis at two different incubation temperatures; room temperature 
(20°C) and 37°C. The in vitro HSS-assay involved incubating purified trypanosomes at a 
concentration of 1x10^ cells/ml with 25% human serum (HS) for 2.5 hours at either room temperature 
(RT) or at 37°C. The assay was performed twice, the level of lysis determined and the mean values 
calculated and displayed in the above graph. Guinea pig serum (GPS) was used as negative control 
serum.
Serum concentrations 
The percent lysis obtained in an assay may depend on the concentration of serum 
present. Heat-inactivated serum was used to examine the percentage lysis for serum 
concentrations ranging from 10% to 50% (v/v). There was an increased percentage 
lysis with increased serum concentration between 10% and 30% but a limited 
increase in percentage lysis above 30% (figure 3.4). With 20% serum there was a 
sufficient and reliable difference between lysis by human serum and lysis by the 
control serum. The differences between the two negative control sera are discussed 
below.
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Figure 3.4. Different serum concentrations and their effect on percentage trypanosom e lysis.
Serum concentrations between 10% and 50% were used in an in vitro HSS assay and the % lysis 
calculated for each serum concentration. STIB 247 trypanosomes were purified and incubated with 
25%  serum at a concentration o f 1x10’ cells/ml for 2.5 hours after which the % lysis was calculated. 
HS; human serum, RS; rabbit serum; GPS; guinea pig serum, the latter two were used as negative 
control sera.
Trypanosome concentration
Viability of bloodstream trypanosomes in in vitro cultines is affected negatively if 
they reach concentrations that are too high. To investigate the effect of different 
trypanosome concentrations in the HSS assay, trypanosome concentrations were 
varied between 1x10^ cells/ml and 5x10^ cells/ml using 25% heat-inactivated serum 
in the assay. As shown in figure 3.5 there was a general trend apparent with all tlnee 
stocks towards a direct correlation between parasite density and percentage of 
parasites lysed by human serum. This correlation was also observed for 
trypanosomes incubated with controls using either guinea-pig or rabbit serum, 
indicating that MEM+Eaiies salt alone could not support the survival of the cells at 
higher cell concentrations, resulting in non-specific lysis. At a concentration of 1x10’ 
cells/ml there was a significant difference in percentage lysis between cells incubated 
in human serum compared with cells incubated with the guinea pig control serum. 
For STIB 247 the average percentage lysis always exceeded 70% while lysis in the 
guinea pig control serum never reached more than 8%. For STIB 386 the trend 
towards higher lysis with higher cell concentrations was less clear than for STIB 247 
and trypanosomes were generally more resistant to killing by both human serum and
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control sera at higher cell concentrations. Similar results were observed for TREU 
927.
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F igure 3.5. C om parisons o f percentage lysis a t d ifferen t trypanosom e concentra tions. Six
different trypanosome concentrations ( I x 10^, 5x 10\ 1x10’, 2x10’ , 3x10’ and 5x10’ cells/ml) were 
used in an in vitro HSS assay in order to identify differences in the resulting percentage lysis. Purified 
trypanosomes from the three stocks STIB 247, STIB 386 and TREU 927 were used in individual 
assays using guinea pig serum (GPS) and/or rabbit serum (RS) as control serum by incubating the 
cells, in the various final concentrations, with 25% human serum (HS) for 2.5 hours at 37°C.
Control serum
Serum from rodents and rabbits have been reported to lack the trypanocidal factor 
(Hajduk et.al, 1989) and should therefore serve as a good negative control serum 
when testing for the trypanosome killing effect of human serum. Initially, rabbit 
serum was chosen as the control serum for all the in vitro human serum sensitivity 
assays since it was available in the laboratory. Unfortunately, this rabbit serum had 
the ability to cause an unacceptable high level of background lysis, at a trypanosome
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concentration of 1x10’ and a serum concentration of 20-25%, rabbit serimi often 
caused more than 20% lysis, as shown in figures 3.4, 3.5 and 3.6. It was therefore 
desirable to identify an alternative serum with a lower non-specific effect upon the 
trypanosomes. The lytic effect of both fresh and heat-inactivated guinea-pig serum 
was thus compared with lysis by rabbit serum and the results in figure 3.6 show that 
guinea-pig serum caused less lysis than rabbit serum. The percent lysis caused by 
guinea-pig serum was usually under 5% and never reached more than 10%.
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F igu re  3.6. A com parison o f guinea-pig  serum  and  rab b it serum  as po ten tia l negative contro l 
sera . Both guinea pig (GPS) and rabbit sera (RS) were tested and their lytic abilities assessed in an in 
vitro  HSS assay. Trypanosomes from STIB 386, STIB 247 and TREU 927 were puiified and 
incubated with 25% serum for 2.5 hours at a concentration o f 1x10’ cells/ml at 37°C. n= 3, x ± 1SD;
Morphology o f  bloodstream trypanosomes 
As has been noted by others (Rickman & Robson, 1972; Rifldn, 1978) there is a 
great variability in susceptibility to lysis depending on the parasitaemia of the donor 
animal. During a rising parasitaemia the majority of trypanosomes are slender form 
trypomastigotes and these are more sensitive to lysis than the stumpy bloodstream 
forms seen during lag phase parasitaemia and subsequent peaks of parasitaemia as 
shown in table 3.1. Stumpy forms am relative resistant to lysis and to minimise 
variation due to a mixture of morphological types all subsequent experiments were 
carried out with bloodstream trypanosomes during log phase parasitaemia when 
slender forms predominate.
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% lysis
STIB 386 STIB 247
Predom inantly slender forms 
(>85% )
52 86
Predominantly stumpy forms 
(>85% )
27 54
Table 3.1. A comparison o f the percentage lysis caused by human serum of slender and stumpy 
form trypomastigotes. The susceptibility o f two morphologically different stages o f bloodstream 
trypanosom es to human serum was tested by comparing the % lysis for the two forms in an in vitro 
HSS-assay. Slender forms were harvested during log phase growth while stumpy form were purified 
after the initial peak o f parasitaemia. The proportion o f slender and stumpy form trypanosom es in 
each population were determined according to the criteria o f Hoare (1970) from Giemsa stained blood 
smears. The cells were then incubated with 25%  human serum for 2.5 hours at 37°C after which the 
percentage lysis was determined.
Incubation volume
The total incubation volume is another factor which might influence the percentage 
lysis and incubation volumes from 250 pi to 2 ml were compared for variability in 
lysis. Using a standard assay with 1x10’ cells/ml, 25% serum and a 2 hours 
incubation time at 37°C in eppendorf tubes, only a very minor difference could be 
observed, implicating a slight trend towards higher percentage lysis under smaller 
volumes (figure 3.7). Even though the difference is not statistically significant in 
these experiments, it was considered best to perform subsequent assays in a standard 
volume of 0.5 ml.
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Figure 3.7. A comparison o f percentage lysis in different incubation volumes. STIB 247 cells 
were used to Investigate if  the total incubation volume during an in vitro HSS-assay had an effect on 
the % lysis. Cell were purified and incubated in eppendorf tubes at a concentration o f 1x10’ cells/ml 
for 2.5 hours in 25%  human serum at 37°C. The difference between the various incubation volumes 
ranged from 74% lysis in 2 ml to 88% lysis in 0.25 ml.
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Counting live cells/fixed cells 
A potentially important variable is the method by which the lysed cells were 
counted. Using unfixed cells, inaccuracies could arise firstly as a result of the time 
taken to count the cells leading to the time of incubation being variable and secondly, 
because live cells are much more readily observed than those undergoing lysis. The 
latter could lead to underestimates of the percentage lysis. These potential problems 
could be overcome by fixing the cells at specific time points during the incubation. A 
preliminary experiment was therefore conducted to compare the results of counts of 
fixed and unfixed cells. STIB 247 and STIB 386 trypanosomes, at a concentration of 
1x10’ cells/ml, were incubated with 25% serum at 37°C for 1 hour, 2 hours, 3 hours 
and 4 hours after which one sample was fixed in an equal volume of 1% 
formaldehyde in PBS and a second sample left unfixed. The percent lysis of the 
samples were then calculated after differential counting of the trypanosomes using 
phase-contrast microscopy. No differences between fixed and unfixed samples could 
be noticed once the incubation time was longer than 2 hours (table 3.2). It is possible 
that the reason for this is that the majority of cells are lysed within the first 2 hours 
and therefore the exact time point for counting is only of importance during the first 
2 hom’s because after that time the majority of lysis has already taken place.
Stock T rea tm en t Serum
source
Tim e (min)
60 120 180 240
386 Fixed HS 12 27 65 78
" " GPS nd 6 13 14
" Unfixed HS 4 22 68 72
927 Fixed HS 8 38 53 52
GPS 10 10 17 12
Unfixed HS 17 40 55 55
T ab le  3.2. A com parison o f percen tage lysis observed w hen counting unfixed o r  fixed 
trypanosom es. Bloodstream trypanosomes from the two stocks STIB 386 and TREU 927 were tested 
for then  resistance/sensitivity to human serum in a standard in vitro HSS-assay and the percentage 
lysis assessed either by counting the cells directly under a phase-contrast microscopy or after they had 
been fixed in 1% formaldehyde. The assay was repeated twice and the mean % lysis for cells 
incubated in human serum (HS) and cells incubated in control guinea pig serum (GPS) are shown for 
four different incubation times, nd, not determined.
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3.2.2 Viability stains and dyes for an in vitro HSS assay
While there was no difficulty in distinguishing between lysed and normal, healthy 
trypanosomes, there was a whole range of slightly deformed, swollen and “tadpole” 
shaped cells which started to appear after 1 hours incubation of human serum 
sensitive cells in human serum. The extent to which these cells of abnormal 
morphology are viable or non-viable is unclear and cannot be readily determined 
either by iiifectivity tests or by phase-contrast microscopy. Four different staining 
methods were tested as markers for parasite viability: rhodamine 123, acridine 
orange, bis-henzimide and MitoTracker Green FM (Molecular Probes).
Rhodamine 123
Rlrodamine 123 is a fluorescent, cell-permeant relatively non-toxic stain that is 
readily sequestered by active mitochondria without morphological distortion. 
Trypanosomes were stained with rhodamine 123 by diluting a 10 mM 
rhodamine:DMSO stock solution in MEM to a final concentration of 100 pg/ml and 
mixing with the trypanosome suspension at 1/10 of the total volume. Both STIB 386 
and STIB 247 were used but in different experiments. The solution was incubated for 
10-30 minutes at 24-37°C and the cells then centrifuged and resuspended in MEM. 
This method was modified after Ronot et.al (1986). Observation by fluorescence 
microscopy with appropriate filters (Zeiss filter-set 09 which gives maximum 
emission at green wavelengths) showed the mitochondria of trypanosomes stained 
with rhodamine 123 as bright yellow-green. Dead cells did not stain at all while 
“tadpole” shaped cells all stained with bright green mitochondria. The staining was 
however not completely discriminatory and there were always some motile cells that 
did not become stained and often dead (i.e. immotile) cells had a faint green stain 
which was difficult to distinguish from “tadpole” shaped cells.
Acridine Orange
Acridine orange accumulates in acid structures e.g. DNA, RNA and lysosomes and 
is well retained in the mitochondrion. The mitochondrial uptake of acridine orange is 
not dependent on membrane potential and all live cells will fluorescence. High purity
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acridine orange was diluted to a stock concentration of 0.01% (w/v) in sterile saline 
and 1 pi of this stock mixed with 100 pi of a trypanosome suspension. Both STIB
386 and STIB 247 were used in separate experiments. The cells were then
immediately viewed by fluorescence microscopy using Zeiss filter-set 09 which 
gives maximum emission at green wavelengths. Acridine orange appeared slightly 
toxic to bloodstream trypanosomes at this concentration and made them very
sensitive to UV-light so that they died if viewed for too long. Live cells
fluorescenced with a bright green mitochondrion and nucleus while dead cells had a 
yellow mitochondria and nucleus. Tadpole shaped trypanosomes all had yellow 
mitochondria. The green and yellow colorus were however, rather hard to distinguish 
which made differential counting time-consuming and unreliable.
MitoTracker Green FM  
MitoTracker Green FM is a commercial mitochondria-stain, produced by Molecular 
Probes, which was developed to be retained in cells after cell fixation and 
permeabilisation. When the MitoTracker probe enters an actively respiring cell it is 
oxidised and sequestered in the mitochondria where it reacts with accessible thiol 
groups on peptides and proteins to form an aldehyde-fixable coiijugate which is I
fluorescent. The MitoTracker was prepared as recommended by the manufacturer; 
one ampoule, 50 pg, was dissolved in 75 pi pure anhydrous DMSO to give a 1 mM
!stock solution, diluted to a working concentration of 200 nM, mixed with pelleted i
cells, which had been incubated with human serum, and incubated for 15-45 minutes 
at 37°C. The cells were then washed in HBSS, fixed in 1% formaldehyde for 15 
minutes at 37°C and finally washed twice in PBS before being viewed by 
fluorescence microscopy using Zeiss filter-set 09. Live cells gave a bright green 
staining of the kinetoplast but the whole cell surface became stained to some degree.
The staining appeared to be the same after fixation with either formaldehyde or 
paraformaldehyde or no fixation. Procyclic trypanosomes gave the same fluorescence 
pattern and intensity as bloodstream trypanosomes. Dead cells did not stain at all and 
very sluggish, “tadpole” shaped cells stained as live cells. The percentage live cells 
identified when stained with MitoTracker Green was slightly higher than when 
counted without staining; on average 59% instead of 51% for STIB 386 and 32%
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instead of 24% for STIB 247, n = 2. It was very convenient to be able to work with 
fixed cells and smears stained with MitoTracker Green were useful for counting live 
cells but a counterstain for dead cells was also required because in fixed preparations 
it was extremely difficult to detect dead and lysed cells.
Bis-benzimide
Bis-benzimide has been used for staining the nucleus of non-viable 
Cryptosporidium (Brown et.al, 1996) and this dye turned out to work equally well 
for staining the nucleus of dead trypanosomes. 0.01 mg bis-benzimide was mixed 
with 100 pi trypanosomes suspension in MEM immediately before viewing the cells 
by fluorescence microscopy using filter set 00 which gives optimal emission of blue 
light. All immotile and lysed trypanosomes stained with a bright blue nucleus 
whereas none of the normal, live cells or the tadpole shaped cells stained at all.
3.2.3 Lysis under optimal in vitro HSS-assay conditions
Taking the results from each of these preliminary experiments and using the optimal 
conditions for each variable, a set of standard incubation conditions was decided 
upon. The following standard incubation conditions were subsequently used. 
Trypanosomes were harvested during log-phase pai'asitaemia and purified by 
differential centrifugation or by DEAE-cellulose purification. The cells were then 
incubated in 25% heat-inactivated serum (v/v) from a single donor, using guinea-pig 
serum as control serum, at 37°C for 2.5 hours. Cell concentration was kept at 1x10’ 
cells/ml in a total reaction volume of 0.5 ml in sealed 1.0 ml eppendorf and the cells 
were placed on ice immediately after incubation. The percentage lysed cells was then 
counted using phase-contrast microscopy without prior fixation, counting 200 cells at 
400x magnification. Human serum sensitive trypanosomes started to become affected 
after 1 hours incubation, after 2 hoius the majority of eells had become swollen, 
‘tadpole’ shaped or lysed and within 3 horns all of the human serum sensitive cells 
had lysed (figure 3.8).
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Figure 3.8. Phase-contrast photomicrographs of T.brucei (ETatl.2S) incubated at 
37°C in 25% human serum for (A) 0 min, (B) 60 min and (C) 120 min.
Chapter 3 Development o f an assay fo r human serum resistance/sensitivity’
The standard assay was repeated 18 times for STIB 386, 16 times for STIB 247 and 
8 times for TREU 927 and the combined results are shown in figure 3.9.
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Figure 3.9. Percentage lysis after standard in vitro HSS-assay for each of the trypanosom e stocks 
STIB 386, STIB 247 and TREU 927. Purified cells were ineutmted with 25% serum for 2.5 hours at 
37°C_at a final concentration of IxiO ’ cells/ml. For STIB 386 x± SD = 52.2+11.4 (n-18), for STIB 
247 x+SD = 76.4+9.5 (n=16) and for TREU 927 x+SD = 79.2+3.8 (n=8). A comparison between 
STIB 386 and STIB 247 using Mann-W itney U-statistics indicated a significant difference (U=16.5, 
p<0.05) but the considerable variation between individual assays made it too unreliable for further use.
The mean percentage lysis for STIB 386 was 52% but varied between 33% and 80% 
for different assays, equivalent to a SD of 11.44, despite identical conditions. The 
variation in percent lysis was also observed for the other two strains with STIB 247 
showing a mean lysis of 76% with individual assays varying between 61% and 87% 
(SD 9.50) and TREU 927 varying between 74% and 88% with a mean lysis of 79% 
(SD 3.83). In addition, two T.b.gambiense stocks were tested as biological controls 
since T.b.gambiense is known to be highly resistant to human serum. Both these 
T.b.gambiense isolates, ELIANE and BIM, showed only 5% lysis after 2 hours 
incubation in human serum, 11% after 4 hours incubation and after 19 hours 
incubation 68% of the cells had a normal morhpology as observed by phase-contrast 
microscopy. The T.b.gambiense isolates shows a much higher degree of serum 
resistance than the other three trypanosome stocks. Two conclusions can be drawn
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from the in vitro HSS-assay data. Firstly, that STIB 386 was more resistant to killing 
with human serum than the other two stocks and secondly that there was 
considerably variability between individual assays such that, as a potential screening 
assay for F, progeny of genetic crosses, it was too unreliable for the pmposes of this 
analysis.
3.2.4 Development of an in vivo HSS-assay
The variation between replicates of in vitro assays of the same trypanosome strain 
under identical and optimal conditions, as defined in 3.2.3 was too large and 
investigations into developing an in vivo human sermn sensitivity assay were 
therefore initiated with the prediction that this should produce more reliable results. 
The results from the in vitro assays were used to help develop the in vivo assay. 
Starting conditions for the in vivo assay were: the use of purified bloodstream 
trypanosomes, harvested during log-phase parasitaemia, incubation at a final 
concentration of IxlO’ cells/ml in 25% serum from a single donor and incubation at 
37°C. Other parameters had to be reinvestigated since they were not applicable to an 
in vivo assay.
3.2.5 Comparisons of potential variables for an in vivo HSS assay
The in vivo human sermn sensitivity assay was planned to involve incubating 
pmified bloodstream trypanosomes with human serum for a fixed length of time and 
injection of the trypanosomes i.p. into mice which were then monitored for the 
development of parasitaemias. A set of variable parameters were investigated for the 
development of the assay: the number of trypanosomes to be injected, the duration of 
incubation with hmnan serum, the number of days needed for monitoring the mice 
and the choice of control serum.
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Number o f trypanosomes for injection 
It is clear that some cloned lines of T.brucei are stable and sensitive to lysis by 
human serum, such as STIB 247, some are stable and resistant whilst others can 
switch phenotype (see section 1.4.1). The stability of phenotype had not been 
determined for STIB 386 or TREU 927. There is the potential, therefore, for the 
numbers of trypanosomes in an inoculum to influence the assay results and so this 
variable was investigated. The apparently human serum sensitive strain TREU 927 
might, for example, include a small proportion of human serum resistant cells which 
could give rise to a parasitaemia in mice if a large inocula was used.
Results of preliminary experiments (table 3.3) indicated that when a total of either 
100 or 1000 cells were used for inoculation into mice, with an incubation time of 2.5 
hours, patent parasitaemias for STIB 386 but not for STIB 247 were obtained. The 
situation with the (presumably) human serum sensitive TREU 927 was ambiguous in 
that inoculations of 100 trypanosomes in some cases was enough to cause a 
parasitaemia whereas 1000 trypanosomes in all cases gave rise to an infection in the 
mice.
Inocula
size/mouse
Trypanosom e line No. o f mice developing patent infection 
/no. inoculated 
HS GPS
1000 STIB 386 8 / 8 4 / 4
STIB 247 0 / 8 2 / 2
TREU 927 8 / 8 2 / 2
100 STIB 386 8 / 8 4 / 4
STIB 247 0 / 8 2 / 2
TREU 927 3 / 8 2 / 2
Table 3.3. The number o f mice that developed a patent parasitaemia when injected i.p. with 
either 100 or 1000 trypanosomes which had been incubated with human serum. M ice were 
injected i.p. with either 100 or 1000 trypanosomes which had been incubated with 25% human serum 
or with control guinea pig serum for 2.5 hours at 37°C and monitored for parasitaemia for 20 days. 
These are the combined data o f  2-4 replicate experiments.
Incubation time
The length of the time trypanosomes are incubated with hmnan serum before being 
injected into mice will affect the degree of damaged caused to them and their ability
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Table 3.4. The proportion o f mice which developed parasitaemias after injection with 
trypanosom es which had been incubated with human serum. Mice were inoculated with 100 
trypanosom es which had been incubated with 25% human serum or guinea pig serum for 2 to 8 hours. 
The in vivo HSS-assays were repeated 2 to 4 times in 2 to 4 mice for each assay and one control 
mouse, injected with cells incubated in guinea pig serum instead o f human serum, was included in 
each assay.
Immunosuppression o f mice 
One concern was that small numhers of viable trypanosomes inoculated into 
immunocompetent mice might not always generate a detectable parasitaemia if the 
immune response cleared infections before they become patent. This possibility 
would apply in particular to STIB 247 which grows more slowly than the other 
stocks (Turner et.al, 1995). Evidence suggesting this possibility is that incubation of 
STIB 247 in the control guinea pig serum on several occasions failed to produce a 
parasitaemia (data not shown). To avoid any potential interference of the mouse 
immune system with the assay it was therefor considered more reliable to use only
96
Chapter 3 Development o f an assay fo r human serum resistance/sensitivity i
to initiate an infection. To investigate this effect, purified bloodstream trypanosomes 
.were incubated with 25% human serum for various lengths of time at 37°C. 100 cells 
from each sample were then injected i.p. into mice and the mice monitored for the 
development of a parasitaemia for at least 20 days. The human serum resistant line,
STIB 386, was capable of infecting mice in all cases after it had been incubated in 
human serum for 2, 3 or 4 hours but cells incubated for 6 or 8 hours could no longer 
cause an infection (table 3.4). A F, hybrid from STIB 247 x TREU 927 gave rise to a 
parasitaemia in 2 of 8 mice after 2 hours incubation in human serum but 0 of 6 mice 
after 4 hours incubation. TREU 927 infected 2 of 8 mice after either 2 or 4 hours 
incubation. The guinea pig serum negative controls all gave rise to parasitaemias 
even after 8 hours incubation.
Stock Serum
source
No. o f mice developing patent parasitaemia /  no. inoculated at 
different incubation times (hours)
12 3 4 6 8
STIB 386 HS 1 2 / 1 2 3 / 3 12 / 1 2 0 / 6 0 / 6
" GPS 4 / 4 1 / I 4 / 4 2 / 2 2 / 2
Fj 247x927 HS 2 / 8 - 0 / 6 - -
" GPS 2 / 2 - 2 / 2 - - ...
TREU 927 HS 2 / 8 - 2 / 8 - - :
" GPS 2 / 2 - 2 / 2 - -
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immunosuppressed mice for the standard in vivo HSS-assay. The mice were 
immunosuppressed with Cyclophosphamide (0.2 mg/g) given 24 hours prior to 
infection.
3.2,6 The reliability of an in vivo HSS assay under optimal conditions
The optimal assay conditions were determined as follows: purified trypanosomes 
were incubated at a concentration of 1x10’ cells/ ml with 25% human serum from a 
single donor for 4 hours and 100 trypanosomes subsequently inoculated by i.p. 
injection into two immunosuppressed mice. For each assay one control mouse was 
also used which was inoculated with 100 cells, treated exactly the same way as 
described above, apart from being incubated with guinea pig serum instead of human 
serum. The mice were than monitored for the presence of a parasitaemia at least 
every other day for 14 days (Turner et.al, 1986; Scott, e la l ,  1996). To test the 
reliability of the assay it was carried out repeatedly in the three parental stocks STIB 
247, STIB 386 and TREU 927. During six separate repeats of the assay using STIB 
386, all mice (12) developed a parasitaemia within 6 days of infection. For STIB 
247, the assay was repeated five times but none of the mice (10) become infected 
even though all of the control mice developed a parasitaemia within 7 days of 
infection. TREU 927 reacted as a semiresistant strain where in tlnee of six assays one 
of two mice became infected while in the other three assays none of the mice become 
infected.
3.2.7 The effect of human serum compared with purified TLF
To further assess the reliability of the in vivo HSS assay a comparison of the lytic 
effects of human serum and purified TLF was performed. The purified TLF was 
kindly provided by Dr. Jayne Raper at NYU Medical Centre, USA, and was prepared 
as described in Raper et.al (1996). At the time of purifying and aliquoting the TLF, 
the activity was measured as 1 unit per pi where 1 unit is the amount required to kill
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50% of human serum sensitive trypanosomes (ETatl.9) in 2 hours when incubated at 
a concentration of 1x10® cells/ml in 200 pi. To conduct this comparison purified 
trypanosomes at 1x10® cells/ml were incubated with amounts of TLF between 0.25 pi 
and 8 pi diluted in IxTBS in a total volume of 200pl for 2 hours at 37°C and 100 
cells then injected into mice. Also, the percent lysis was determined by phase- 
contrast microscopy and the data are presented in table 3.5.
%  lysis
Table 3.5. The lytic effect of purified TLF in vitro and in vivo. The lytic effect o f purified TLF was 
com pared with the lytic effect o f human serum (HS) by conducting HSS-assays both in vitro (upper 
table) and in vivo (lower table). Different amounts o f TLF was used and guinea pig serum used as 
negative control, nd, not determined.
ETatl.2 and ETatl.lO were used as biological controls, the former is human serum 
sensitive and the latter is human serum resistant. ETatl.2 were able to infect a 
proportion of the mice after incubation with TLF and the same was true for ETatl.lO. 
Incubation of STIB 386 with 4 pi TLF, which is four times the amount of TLF which 
is expected to kill 50% of the trypanosomes within 2 hours, was still able to infect 
mice. For STIB 247 none of the mice became infected after inoculation with cells 
incubated with 1 pi TLF, which was the lowest concentration of TLF used. TREU 
927 was also TLF sensitive as determined by the in vivo HSS-assay as non of the
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TLF (pi) STIB 386 STIB 247 TREU 927 E T atl.2  (S) E T atl.lO  (R) r
0.25 35 64 82 26 nd A
0.5 nd nd 79 48 1 ■ /■
1 70 60 75 43 3 ;;
2 68 77 100 44 5
4 67 100 95 60 12
8 nd nd 90 55 10
HS 52 79 76 63 7
GPS 2 1 5 4 2
No. o f mice developing patent parasitaemia / no. inoculated mice 7
TLF (pi) STIB 386 STIB 247 TREU 927 E T atl.2  (S) ET atl.lO  (R)
7
1 2 / 2 0 / 2 0 / 2 2 / 2 1 12 7
4 2 / 2 0 / 2 0 / 2 1 /2 1 /2
HS 2 / 2 0 / 2 nd nd nd
GPS 1 / 1 1 / 1 1 / 1 1 l\ I /  1
1
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mice developed a parasitaemia. In summary, TLF in vivo defines STIB 386 as 
resistant and STIB 247 and TREU 927 as sensitive but TLF does not discriminate 
ETatl.2 from ETatl.lO. Apart from the results with TREU 927 and ETat the results 
are the same as obtained with human serum.
For TLF in vitro STIB 386, STIB 247 and TREU 927 essentially show no 
difference when incubated with more than 1 pi TLF although TREU 927 and STIB 
247 are marginally more sensitive. There is a very good discrimination between the 
resistant ETatl.lO and the sensitive ETatl.2. at all concentrations. When incubated 
with 0.25 pi TLF, all five clones give similar results to the experiment in vivo.
3.3 DISCUSSION
From the experiments described in this chapter, it was concluded that an in vitro 
HSS-assay could not be used for reliable measurement of the resistance or sensitivity 
to human serum of various stocks or lines of trypanosomes and that only an in vivo 
assay could provide clear results. Previous in vitro tests used by other groups were 
either performed on metacyclic trypanosomes, using a cultui'e technique described by 
Brun & Jemii (1987), or on bloodstream cells either using a fluorescence-based assay 
originally described by Tomlinson et.al. (1995) (see section 1.4.2) or directly by 
phase contrast microscopy by counting the proportion of lysed blood stream 
trypanosomes (De Greef et.al, 1989; Hajdulc et.al, 1989; Rifldn, 1978). Since we 
were interested in human serum resistance/sensitivity in bloodstream trypanosomes, 
which possibly may be different hom resistance/sensitivity in metacyclics, the 
culture teclmique assay was not an option. Also, the assay needed to be applicable to 
a substantial number of F, recombinant progeny of genetic crosses and individual 
transmission of each of these tlnough tsetse flies would be labour intensive. The 
fluorescence-based assay, on the other hand, is virtually identical to counting live and 
lysed trypanosomes, only less laborious. One of the reasons why the research groups 
using this method have not encountered problems may be that they are working on 
‘pure’ human sermn sensitive stocks, which have heen in the laboratory for more
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than 30 years and only rarely switch between sensitive and resistant phenotypes 
which may not be the case with recently fly-transmitted stocks. This assay is not used 
for testing unknown stocks for their sensitivity to human serum but as an aid when 
studying the lytic component/s in human serimi and it is the percentage of lysed cells 
that is of primary interest. For those purposes, the in vitro HSS-assay may give 
sufficient information. The main problem with the in vitro assay is the difficulty in 
laiowing which cells are viable and infective and which cells have lost their 
infectivity. There were no morphological criteria which were able to distinguish 
infective cells from non-infective cells and which could be identified by phase 
contrast microscopy.
It was interesting to note that serum from different individuals differed in its lytic 
activity and that the main difference was the time for the onset of lysis. Differences 
between individuals have been observed previously (Rifldn, 1978; Lorenz et.al, 
1994). After 1.5 hours incubation time, lysis could vary between 12% and 56% for 
serum from two individuals while the final amount of lysis only varied between 89% 
and 97% after 4 hours. Since the lytic factor in human serum has not been clearly 
identified yet, it makes it difficult to speculate about the reasons for this difference. It 
has been suggested that haptoglobin-related protein is the toxin in the trypanocidal 
factor (Smith et.al, 1995) and that its activity can be inhibited by haptoglobin (Smith 
& Hajdulc, 1995). Differences in the onset of lysis may therefore depend on 
differences in the level of haptoglobin in the serum. A recent paper by Muranjan 
et.al (1998) however, rejects the idea of the importance of haptoglobin and argues 
that the addition of haptoglobin to TLFl does not affect the trypanolytic activity. All 
of the blood samples for serum prepai ation was unfortunately not drawn from fasting 
individuals and another explanation for the variation in lytie effect may be dietary 
vai’iation resulting in variations in the overall concentration of HDL in the serum and 
therefore in the lytic activity. It was clear that this lytic activity was much enhanced 
at 37°C compared with room temperature, possible because the trypanocidal factor 
needs to be internalised into the trypanosomes by an active process. This process also 
appears to be inhibited if the cells are placed on ice or at 4°C where they can remain 
intact in the presence of human serum for at least 24 hours (own observations).
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The trypanosome concentration in reaction tubes also affected the degree of lysis. It 
is however, reasonable to expect more lysis with higher trypanosome concentrations 
probably because of limited nutrient availability. In the absence of human serum 
there was more lysis when cells were kept at high concentrations in MEM+Earles 
salt. During these experiments, with various trypanosomes concentrations, it became 
evident that rabbit serum was a less than ideal negative control serum. The lysis 
occurring during incubation with rabbit serum could reach the same levels as lysis 
caused by hmnan serum especially as trypanosome concentrations increased. A 
comparison with guinea pig sermn clearly showed that rahbit serum caused an almost 
tenfold increasion of cell death when STIB 386 cells were used. It is not clear why 
the rabbit sermn exhibited such a trypanocidal effect, especially since other 
investigators have found that it caused very little lysis (Rifldn, 1978; Rifldn, 1984). 
The rabbit sermn I used all came from the same batch and had been prepared in the 
laboratory and no other sources were tried so it is not possible to determine whether 
this was a general featmn or specific for this particular batch of serum.
The use of dyes to assess cell viability offered no apparent improvement over 
phase-contrast microscopy and could not distinguish between cells capable of 
infecting mice and non-viable trypanosomes. There was no consistent pattern 
between different dyes. For a viability stain to be useful both lysed and live cells 
have to be stained so that the percentage can be coimted without having to change the 
field. Bis-benzimide stained dead cells very clearly but was not a good counterstain 
because it obviously can not be used on fixed cells which would have been needed if 
MitoTracker was going to be useful. Rlrodamine 123 stained tadpole shaped cells as 
live cells while acridine orange stained them as dead. When these tadpole shaped 
cells were injected into mice they were in some cases capable of causing an infection 
which would implicate that some of them should be regai'ded as live eells while 
others are dead. The only advantage with fixing the ceils before counting percentage 
lysis was the convenience of being able to count them at a later stage but in practice 
it made no difference to the accmacy of the test.
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By counting live and lysed ceils, and regarding any change in morphology as non- 
viable, it was not possible to clearly distinguish a human serum sensitive population 
from a serum resistant population. There was an overlap in the range of percentage 
lysis between the clearly resistant STIB 386 and the clearly sensitive STIB 247. It is 
possible that if time was less limiting a way of solving this problem would have been 
found but operationally the in vivo assay proved to be more reliable. Most of the 
conditions found as optimal for an in vitro assay were also used in the in vivo HSS- 
assay, only the numher of trypanosomes needed for inoculation into mice and the 
length of the incubation time had to be optimised. The number of cells for 
inoculation into mice was initially thought to be of importance because TREU 927, 
originates from a location in Kenya with no history of sleeping sickness and would 
thus generally be regarded as a human serum sensitive T.b.briicei but this stock 
behaved differently in the assay from the serum sensitive STIB 247. If, however, we 
accept the concept that TREU 927 is of intermediate phenotype, as has been 
previously reported for some field isolates (Rickman & Robson, 1980; Brun & Jenni, 
1987), the inoculum dose is less important. Even inoculation of 1x10® cells of STIB 
247 incubated with human serum for 2 hours did not result in a parasitaemia whereas 
a low inocula of STIB 386 always gave rise to parasitaemias. These data suggest that 
the in vivo assay is reliable, at least for STIB 247 and STIB 386. The incubation time 
is probably not a critical variable in that STIB 247 and STIB 386 gave reliable results 
irrespective of duration of incubation in the range of 2-4 hours.
To compare the lytic effect of whole serum upon trypanosomes with the lytic effect 
of a defined and purified component of the trypanolytic factor both in vitro and in 
vivo assays were carried out in the presence of TLF2 instead of human serum. The 
activity of TLF2 was measured as a volume required to kill 50% of human serum 
sensitive stocks after 2 hours at 37°C. No assumptions were made about how much 
activity was needed to kill 100% of cells and it was therefore necessary to assay 
using a dose titration of TLF2. There was a reasonable agreement between the results 
of the in vivo test with human serum and TLF2 again supporting the reliability of the 
in vivo assay. The only in-consistency was with the ETatl.lO tryi^anosome line 
which, in in vitro assays was clearly resistant and yet failed to infect half of the mice
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after incubation with TLF2 in the in vivo test and so could not be distinguished from 
the sensitive ETatl.2.
.03
Chapter 4 Genetic inheritance of human serum resistance/sensitivity
Chapter 4
Genetic inheritance of human serum sensitivity/resistance
4.1 INTRODUCTION
The three cloned trypanosome stocks STIB 247, STIB 386 and TREU 927 have 
previously been crossed in all pairwise combinations (Turner et.al., 1990) and a 
number of hybrid progeny identified and cloned. Progeny from these crosses were 
originally identified by screening for isoenzyme and RFLP markers for which the 
parents were different and/or showed allelic segregation. The majority of the hybrids 
used in this project have also been re-screened by PGR analysis of the polymorphic 
minisatellite markers Cram, ms-42 and Tb-292 to further confirm that they are 
recombinants. The Fi progeny show allelic segregation at loci heterozygous in one of 
the parents and recombination between alleles at different loci which is consistent 
with the occurrence of meiosis and a Mendelian segregation of alleles. Even though 
mating is not obligatory (Sternberg et.al, 1989), it is clear that it occurs and therefore 
genetic exchange may influence the development of new vimlent trypanosome strains 
with different host specificities. The availability of characterised hybrids provides the 
possibility of studying the genetic basis for human serum resistance/sensitivity. 
Recombinants can also arise by self-fertilisation (Tait et.al, 1996) and, by marker 
and karyotype analysis, four clones from STIB 247 and one clone from TREU 927 
have been identified as the products of self fertilisation. This chapter describes the 
genetic analysis and the inheritance of human serum resistance/sensitivity and 
explores the genetic basis of this trait. The main aim was to reveal important 
information about the number of loci and alleles involved and to determine the 
dominance relationships between segregating alleles. The Fi progeny of crosses 
between STIB 247 (sensitive), STIB 386 (resistant) and TREU 927 (intermediate) 
were analysed for their resistance to human serum. From the pattern of inheritance it 
has been possible to suggest a model for the inheritance of human serum resistance 
and, more importantly, refute a number of models for inheritance which are 
incompatible with the results. The parental stock TREU 927 and some of the Fi
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progeny exhibit an intermediate resistance phenotype which is defined in the assay as 
a proportion of trypanosomes surviving lysis by human serum. As a result of 
detecting Fi progeny clones of intermediate resistance, the simplest possible model is 
based on 3 alleles, a codominant sensitive and resistant allele and a recessive 
sensitive wildtype allele, all at a single locus.
4.2 RESULTS
4.2.1 Human serum resistance in the Fi progeny from crosses
Recombinant progeny from the three crosses STIB 247 x STIB 386, STIB 247 x 
TREU 927 and STIB 386 x TREU 927 were all analysed for their resistance or 
sensitivity to human serum by the in vivo HSS-assay (Chapter 3). The initial aim was 
to analyse all the available progeny and this was to a large extent achieved. Since 
TREU 927 turned out to be of intermediate resistance and difficult to score, most 
effort was concentrated on the products of the STIB 247 x STIB 386 cross. All assays 
involving STIB 247 were conducted in immunosuppressed mice to exclude 
interference of the mouse immune system with the growth of the trypanosome 
population.
Recombinants from a cross between STIB 247 and STIB 386 
A total of 28 hybrids from a cross between the resistant STIB 386 and the sensitive 
STIB 247 were analysed for resistance or sensitivity to human serum. Nine of these 
hybrids were the first bloodstream population of metacyclic clones from the tsetse fly 
while the remaining 19 were obtained by cloning trypanosomes from the bloodstream 
infections initiated by tsetse flies containing mating products. These were all diploid 
recombinants of distinct genotypes identified by marker analysis (Annette MacLeod, 
pers.comm). The results of the in vivo HSS-assay showed that thirteen of the hybrids 
were of a sensitive phenotype, eight of them of a resistant phenotype and seven of an 
intermediate, semi-resistant phenotype, as shown in table 4.1.
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Trypanosome cross STIB 386 x STIB 247
Clone No. o f mice developing parasitaemia /  
no of mice inoculated  
HS GPS
Total no. of
assays
HSRÆ1SS
Parental STIB 386 12/12 6/6 6 Resistant
Parental STIB 247 0/10 5/5 5 Sensitive
F9/45 mcl 2 4/4 2/2 2 Resistant
F9/45 mcl 7 0/2 1/1 1 Sensitive
F9/45 mcl 9 4/4 2/2 2 Resistant
F9/45 mcl 10 4/8 4/4 4 Intermediate
F9/45 mcl 11 2/2 1/1 I Resistant
F9/45 mcl 12 1/2 1/1 I Intermediate
F492/50 mcl 12 2/2 1/1 1 Resistant
F492/50 mcl 13 0/2 1/1 1 Sensitive
F492/50 mcl 24 2/2 1/1 1 Resistant
F492/50 bel 1 0/2 1/1 1 Sensitive
F492/50 bel 2 0/2 1/1 1 Sensitive
F492/50 bel 3 0/2 1/1 1 Sensitive
F492/50 bel 4 0/2 1/1 1 Sensitive
F492/50 bel 5 0/2 1/1 1 Sensitive
F492/50 bel 6 1/2 1/1 1 Intermediate
F492/50 bel 7 0/2 1/1 1 Sensitive
F492/50 bel 8 0/2 1/1 1 Sensitive
F492/50 bel 13 0/4 2/2 Sensitive
F492/50 bel 14 2/2 1/1 1 Resistant
F492/50 bel 15 0/2 1/1 1 Sensitive
F492/50 bel 16 0/4 2/2 Sensitive
F492/50 bel 17 1/2 1/1 1 Intermediate
F492/50 bel 18 2/2 1/1 1 Resistant
F492/50 bel 19 1/2 1/1 1 Intermediate
F492/50 bel 20 0/2 1/1 1 Intermediate
F492/50 bel 21 1/2 1/1 1 Intermediate
F492/50 bel 23 2/2 1/1 1 Resistant
F492/50 bel 25 0/2 1/1 1 Sensitive
Table 4.1. The results o f in vivo HSS-assays of hybrid progeny from a cross between the human 
serum resistant STIB 386 and the human serum sensitive STIB 247. The clone identification 
number is based on fly number, number of days post-infection for dissection and whether it is a 
metacyclic clone (mcl) or a bloodstream clone (bel). From a total of twenty-eight hybrid progeny, 
thirteen were sensitive to human serum, eight were resistant and seven were semi-resistant.
Intermediate resistance is defined by the ability of a trypanosome stock, after 
incubation with human serum, to cause an infection in only a proportion of the mice 
inoculated. Since the intermediate phenotype was a rather unexpected finding, most 
clones identified as possessing this phenotype were re-assayed several times to verify 
the reproducibility of the initial result (tables 4.1 and 4.2). The results were 
reproducible leading to the conclusion that that was a genuine, definable phenotype.
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FI progeny from a cross between STIB 247 and TREU 927 
Ten of the hybrid progeny from a cross between the human serum sensitive STIB 
247 and the intermediate resistant TREU 927 were screened for their resistance or 
sensitivity to human serum by the in vivo HSS-assay. Six of the hybrids were scored 
as human serum sensitive, two as human serum resistant and two as intermediate 
resistant as shown in table 4.2.
Trypanosome cross STIB 247 x TREU 927
Clone No. of mice developing parasitaemia /  
no of mice inoculated  
HS GPS
Total no. of
assays
HSR/HSS
Parental STIB 247 0/10 5/5 5 Sensitive
Parental TREU 927 3/12 6/6 6 Intermediate
F974/70 mcl 4 0/2 1/1 1 Sensitive
F532/72 mcl 1 2/2 1/1 1 Resistant
F532/72 mcl 2 0/2 1/1 1 Sensitive
F532/72 mcl 3 0/2 1/1 1 Sensitive
F532/72 mcl 4 2/2 1/1 1 Resistant
F532/72 mcl 5 2/6 3/3 3 Intermediate
F532/72 mcl 6 0/2 I / l 1 Sensitive
F532/72 mcl 7 2/4 2/2 2 Intermediate
F532/72 mcl 8 0/2 1/1 1 Sensitive
F532/72 mcl 9 0/2 1/1 1 Sensitive
Table 4.2. The results of in vivo HSS-assays of hybrid progeny from  a cross between STIB 247 
and TREU 927. Ten of the hybrid progeny from a genetic cross between the human serum sensitive 
STIB 247 and the semi-resistant TREU 927 were analysed for their resistance or sensitivity to human 
serum. Six of them were sensitive to human serum, two resistant to human serum and two of an 
intermediate resistance. All the hybrids tested were from metacyclic clones and none of them prepared 
from bloodstream clones. The results from both of the intermediate human serum resistant clones were 
repeated and confirmed.
FI progeny from a cross between STIB 386 and TREU 927 
STIB 386 has been shown to be resistant to human serum while TREU 927 has, in 
this project, proved to be of an intermediate human serum resistance. Hybrid progeny 
from a cross between the two stocks were analysed for their sensitivity or resistance 
to human serum and the results are shown in table 4.3. Of the seven hybrids tested, 
four were sensitive to human serum and three were resistant to human serum. There 
were no clones with an intermediate resistance among the tested hybrids.
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Trypanosome cross STIB 386 x TREU 927
Clone No. of mice developing parasitaemia / 
no of mice inoculated 
HS GPS
Total no. o f
assays
HSR/HSS
Parental STIB 386 12/12 6/6 6 Resistant
Parental TREU 927 3/12 6/6 6 Intermediate
F246/56 mcl 6 0/2 1/1 I Sensitive
F296/44 bel 1 2/2 1/1 1 Resistant
F296/44 bel 2 4/4 2/2 2 Resistant
F296/44 bel 3 0/4 2/2 2 Sensitive
F296/44 bel 9 2/2 1/1 1 Resistant
F296/44 bel 12 0/2 1/1 1 Sensitive
F296/44 bel 13 0/2 1/1 1 Sensitive
Table 4.3. The results from in vivo HSS-assays of 7 hybrids from a genetic cross between the 
human serum resistant STIB 386 and the intermediate human serum resistant TREU 927. Four 
of the hybrids proved to be sensitive to human serum while the other three were resistant to human 
serum.
Recombinants from self-fertilisation events 
A further five clones which previously had been characterised as selfing products 
(Tait et a l, 1996) were also tested for their sensitivity to human serum. These clones 
were identified as the products of self-fertilisation based on marker analysis. They are 
identical to one of the parental stocks used in the crosses except that they are 
homozygous for a proportion of the loci which were heterozygous in the original 
parental stock. Self-fertilisation products can be very informative when determining 
paiental genotypes as they can be used to determine if an individual is heterozygous 
or homozygous for the allele in question. Four of the selfing products were from 
STIB 247 (Tait et,ai, 1996) while one of them was identified as a TREU 927 selfer 
(MacLeod, unpublished). All four selfing products from STIB 247 were sensitive to 
human serum while the TREU 927 selfing product was of an intermediate resistance 
(table 4.4). Thus, no segregation of the sensitive phenotype of STIB 247 was 
observed nor of the intermediate resistance of TREU 927.
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Self-fertilisation products from STIB 247 and TREU 927
Clone No. of mice developing parasitaemia / 
no of mice inoculated  
HS GPS
Total no. of
assays
HSR/HSS
Parental STIB 247 0/10 5/5 5 Sensitive
F492/50 mcl 10 0/4 2/2 2 Sensitive
F492/50 mci I I 0/4 2/2 2 Sensitive
F492/50 mcl 15 0/4 2/2 2 Sensitive
F492/50 mcl 16 0/4 2/2 2 Sensitive
Parental TREU 927 3/12 6/6 6 Intennediate
F296/46 mcl 1 1/4 2/2 2 Intermediate
Table 4.4. Results o f in vivo HSS-assays of recombinants produced after self-fertilisation of 
STIB 247 and TREU 927. All of the selfing products from STIB 247 turned out to be sensitive as the 
parent and the only selfer from TREU 927 was also of the intermediate phenotype as its parental 
source.
4.2.2 Suggested models for inheritance of human serum resistance
The Fi progeny from all three crosses demonstrated segregation of the human serum 
resistance phenotype but the limited number of selfing products screened showed no 
such segregation. When analysing the inheritance pattern for the human serum 
resistance trait only the results from the genetic cross between STIB 386 and STIB 
247 were initially considered. This was mainly because a cross between a pure 
resistant and a pure sensitive clone could be more informative than a cross involving 
an intermediate resistant stock and also because a large number of hybrids had been 
cloned and were available for analysis while only a small number were available 
from the other two crosses. The results of the analysis of the STIB 247 x STIB 386 
cross show that segregation of the resistance phenotype occurs in the Fi progeny 
providing evidence that the HSR trait is genetically determined. There are a number 
of classical inheritance models which can be refuted on the basis of the three 
segregating phenotypes found (human serum sensitive, human serum resistant and 
intermediate, semi-resistant, phenotype) and the numbers in each class. The ratio of 
the numbers of progeny in each phenotypic class can be compared to theoretical 
ratios based on different models for the parental genotypes. Assumptions can be 
made about the number of alleles involved, the number of loci and the dominance
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good fit with the observed ratios of phenotypes of F, progeny but the refuted models 
can be rejected with confidence. Only the simplest models that fit the data are 
considered in tliis section. Such models can subsequently be tested against the data to 
determine whether they fit and then tested by the analysis of offspring from a 
backcross or from a Fj generation.
In order to explain the existence of an intermediate resistant phenotype there has to 
be either a specific allele coding for intermediate resistance or a codominance 
relation between a resistant and sensitive allele which would result in an intermediate 
phenotype. The simplest model that fits the data involves a codominant 8  ^ and 
allele and a recessive sensitive wildtype allele, s ’^ . For the human serum sensitive 
STIB 247 to express a sensitive phenotype under these circumstances it would have 
to be S^ s"^  and the resistant STIB 386 would have to be S^ s"*'. The potential resulting 
hybrid progeny fi:om this cross are shown in a Punnett square in figure 4.1.
P aren ts : STIB 247 STIB 386
sensitive S 's ^ resistant S**^ s'*"
G am etes: s '  and s^ S^ and s^
S^ s"" X S V
S*^ s^
s ' s '  S^ ^ s '  s'"
+ oR + +s s S s s
Fn Phenotypes Genotypes Genotypic ratio Phenotypic ratio
Sensitive s ' s '  I
. s7:s7 . ' , ■ .
2
Resistant 1 ■ 1 -
F igu re  4.1. T he simplest possible model for inheritance of the hum an serum  resistance tra it. The
model involves three alleles at a single locus, the S® and alleles being codom inant while the third 
allele is a  recessive wildtype sensitive allele, s'*". 1/2 o f  the hybrid offspring will theoretically become 
hum an serum sensitive, 1/4 will become human serum resistant and 1/4 will be o f an intermediate 
resistant phenotype. The model has a good fit with the observed phenotypic ratio as proven by a 
test which is shown in figure 4.2.
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It can be seen that four different genotypes can arise, two of them expressing the 
same phenotype, human serum sensitivity, one being serum resistant and one having 
a potentially intermediate resistant phenotype. The observed and expected numbers 
of progeny are compared with a % -^test (see calculations in figure 4.2). The 
calculated is 0.214 and the critical value from a theoretical distribution at 5% with 
d.f.=2 is 5.991. This means that tliere is no significant deviation and therefore a good 
fit with the model. A schematic picture of the proposed inheritance model is 
illustrated in figure 43,
C hi-square  test
Phenotype Observed number Expected number
Sensitive 13 (1/2) x 28 = 1 4
Resistant 8 (1/4) x 28 = 7
Intermediate 7 (1/4) x 28 = 7
Total 28 28
2  ^  y  (observed - expected)^
^  ■ expected
(13-14)^ + (8 -7 f  + (7-7)^ = 0.214
14 7 7
d.f. = 3-1=2
Table o f Chi-square 5% critical value at 2 d.f. =  5.991
F igure  4.2. Chi square  test fo r the proposed inheritance model. Comparison o f tlie observed and 
expected results from the cross between STIB 247 and STIB 386 when assuming an inheritance 
model consisting o f a codominant sensitive and resistant allele and a recessive sensitive allele. The 
model has a good fit with expected results since the calculated is significantly less than from 
table at 5% critical value and 2 degrees o f freedom.
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Parental 
generation
Possible [§s 
Fi genotypes s s
Phenotypes HSS HSS
2 :
HSR HSR/S 
1: 1
F igu re  4.3, A  schem atic view o f the  proposed genetic model fo r the inheritance o f the  hum an 
serum  resistance tra it. This is the simplest possible model which has a good fit with the observed 
distribution o f phenotypes after a  cross between a human serum sensitive stock and a human serum 
resistant stock and it can be confirmed by a %^-test.
Another model which has a good fit with the observed ratio of the phenotypes 
involves an allelic series with three alleles in the dominance hierarchy >s^ > s ,^ 
where S ' is a completely dominant allele coding for serum sensitivity and s^ is a 
partially dominant allele for serum resistance and s^  is a completely recessive allele 
for intermediate resistance. This model has as good fit as the previously suggested 
model, as defined by values and a model involving a specific allele for 
intermediate resistance might be helpful when considering the actual function of the 
gene. The model is regarded as another possibility since the precise function of 
gene/genes conferring human serum resistance/sensitivity is still unknown as 
discussed in section 4.3. The parental genotypes in this model would be for 
STIB 247 and for STIB 386 and the resulting hybrid progeny would have four 
different genotypes, two of which would express a human serum sensitive phenotype 
{S^s^ and one that would express human serum resistance (s^s^) and one that 
would express the intermediate human serum resistance phenotype (s^s^) (figure 
4.4).
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P aren ts:
G am etes:
STIB 247 
sensitive s '  s'
s '  and s'
STIB 386 
resistant s'  ^s'
and s’
S 's ' X s"'s'
F,:
s'" s'
Phenotypic ratio
s'
s'
Phenotypes
S 's '"
s's'^
Genotypes
s' s'
s 's '
Genotypic ratio
Sensitive s' s'^ . 1 2s' s'
Resistant s \ ’ 1 1 "■'
Intermediaie '*>'• .. •». 1 • Î Ï
F igure 4.4. A second possible model for the inheritance o f hum an serum  resistance tra it. The
allele combination shown here is as equally valid as the first model. It involves a single allele coding 
for an intermediate resistant phenotype and it has just as good fit as the first suggested codominance 
model, confirmed by a test.
4.2.3 Refuted inheritance models
The two models, described above, are the simplest possible scenarios that have a 
good fit witli the numbers found in each phenotypic class. As already mentioned, 
there are many more classical models which do not fit the data and which can be 
refuted on the basis of the three phenotypes identified and the segregation ratios. The 
refuted models are important because it is difficult, without backcrosses or F 2 data, to 
prove the proposed models that fit the data, however, it is much more straightforward 
to prove that other models cannot fit the data. The refuted inheritance models will be 
dealt with one at a time including discussion of the reason for them being unable to 
explain the observed inheritance pattern.
Two allele models at one locus 
All two allele models can be refuted because none of the models can ever lead to 
three classes of phenotype. This general point can be illustrated by an example where 
one of the phenotypic traits, resistance or sensitivity to human serum, is considered
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as being determined by a dominant allele. If sensitivity to human serum is a 
dominant trait then the sensitive STIB 247 could be either heterozygous (S^s^) or 
homozygous (S^S^) for this trait while the resistant STIB 386 would be homozygous 
recessive A cross between the two would result in either all sensitive hybrid
offspring or resistant and sensitive offspring in a T.l ratio as illustrated in figure 4.5.
P aren ts: STIB 247 
sensitive or
STIB 386 
resistant s'^s^
G am etes: or and
A. sS g S  X
FP Phenotypes Genotvpes Genotypic ratio Phenotypic ratio
Sensitive :
B. X
F,: Phenotypes Genotypes Genotypic ratio Phenotypic ratio
Sensitive 1 . . . 1
Resistant 1
F igu re  4.5. A genetic model fo r the cross betw een STIB 247 and STIB  386 assum ing th a t 
sensitivity  to  hum an serum  is a dom inant t r a i t  and  th a t two alleles a re  involved a t a single locus.
There are two different possibilities since the sensitive STIB 247 can have either the gametes SS or 
the gametes Ss. In the first instance, part A, all the progeny would be o f  a sensitive phenotype while 
in the second assumption, part B, half o f the F, would be sensitive and the other h alf resistant.
No two allele model could explain the results obtained since only two phenotypes 
would be possible and these phenotypes would be in a 1:1 ratio or all progeny would 
be identical. It would not make any difference if resistance was determined by a 
dominant allele instead of sensitivity. It would still only give rise to two different 
phenotypes in a 1:1 ratio or all the progeny would be resistant instead of sensitive.
The predicted outcome of the crosses would not be any different if the recessive 
allele was a null allele rather than a functional recessive allele, as considered in the 
example above. Depending on which is the dominant allele one of the phenotypes,
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resistance or sensitivity to human seium, would have to be regarded as being 
determined by a functional allele so that a lack of its expression would result in the 
other phenotype. It is therefore clear that inheritance of the human serum resistance 
trait can not be explained by simple dominant and recessive alleles but must involve 
alleles with different dominance relationships.
Another refuted two allele inheritance model involves codominance where alleles 
can express their products independently in heterozygotes so that a heterozygote will 
express an intermediate phenotype. If this was the case, a cross between a resistant 
and sensitive phenotype could give rise to intermediate, semi-resistant progeny but 
all of the progeny would be intermediate and no pure resistant or sensitive hybrids 
would be obtained. This is because the sensitive or resistant phenotype of the 
parental stock would have to be homozygous for the resistant and sensitive allele 
respectively. This model can therefore be refuted on the basis of predicting only one 
phenotypic class for the offspring.
Instead of the alleles being codominant, they could be partially dominant so that the 
Fj progeny would express botli alleles. If this was the case, and there were only two 
alleles at a single locus, then the human serum sensitive STIB 247 could be either 
homozygous for an incompletely dominant allele conferring sensitivity (S^S^) or 
homozygous for a recessive sensitive allele The human seium resistant STIB
386 would have to be either homozygous for an incompletely dominant resistant 
allele (S^S^) or homozygous for a recessive resistant allele (A -^). In both models 
all of the hybrid offspring would be semi-resistant, as in the case of codominance.
Even though there is no distinct dividing line between the outcome of codominance 
and incomplete dominance and there is no easy way to define which is involved, it 
can be concluded that none of these models would be able to explain the observed 
phenotypes since the Fj generation would consist of only one phenotype and not the 
three phenotypes observed.
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Three allele models at a single locus
In the next set of models three different alleles with two levels of dominance are 
postulated, all defining the trypanosomes reaction to human serum. Some of these 
models can be refuted because they only generate two classes of progeny and others 
because they give segregation ratios which do not agree with those observed. One of 
the models that can be postulated is the model described in figure 4.1. The possible 
number of F| genotypes with a multiple allele model is defined by the formula 
n{n+\)/2 where n is the number of alleles involved. In a three allele model this will 
mean a possible 6 different genotypes while the number and ratios of phenotypes will 
vary depending on the dominance relationships between the different alleles.
As a different example, there can be two codominant alleles, conferring resistance 
and sensitivity, and a recessive wild type resistant (U) allele (figure 4.6).
Parental genotypes
STIB 247 STIB 386 F, Phenotypes Genotypes Genotypic ratio Phenotypic ratio
r '  X R*^  R*^
r '  r '  X R*^
Sensitive ^ 1
R^R^ X Sensitive^
R^  R^
Sensitive I R E»
Sensitive '
Figure 4.6. The predicted genotypic and phenotypic outcome for a cross between STIB 247 and 
STIB 386 assuming codominance and a recessive resistant wild type allele. In this model there are 
three alleles, a recessive wild type T  allele and two codominant iF  and alleles which would result 
in an intermediate resistant phenotype. It is only the fifth allele combination that possible could give 
rise to hybrid offspring producing all three of the observed phenotypes. The ratio of these phenotypes 
can however, be used to reject the model when tested in a % -^test.
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There are two possible genotypes for the human serum sensitive STIB 247 and three 
different genotypes for the resistant STIB 386. Only one of the combinations could 
result in the three observed phenotypes in a 2:1:1 ratio, with the resistant phenotype 
being the most frequent but this model does not have a good fit with the observed 
ratio (x^  = 7.714, d.f = 2, p < 0.05)
In the alternative model, the wild type allele (s^) allele is recessive to the S^  allele 
and there is a codominance relationship between S^  and S^ . Again, there are six 
different possible allele combinations for a cross between STIB 247 and STIB 386. 
Five of them can be refuted on the basis of the number of phenotypic classes found 
(figure 4.7) but the sixth possible combination is the model shown to have a good fit 
with the observed data (section 4.2.2 and figure 4.1).
Parental genotypes
STIB 247 STIB 386 F, Phenotypes Genotypes Genotypic ratio Phenotypic ratio
X S'" s"^
X s'"
Î . . . .....Rfôistamjy, sTs
Sensitive
Figure 4.7. The possible genotypic and phenotypic outcome of a cross between STIB 247 and 
STIB 386 when assuming a recessive wild type ) allele that is recessive in relation to the two 
codominant S  ^ and S^ alleles. This assumption can lead to six different crossing combinations with 
regard to the parental phenotypes. The five combinations shown here will only result in one or two 
phenotypes in the offspring and can therefore be rejected as a model which could fit the observed 
results. There is a sixth possible parental genotype combination but since this has a good agreement 
with the results from the observed data it was discussed in section 4.2.2.
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When considering three allele models at a single locus and with two levels of 
dominance another possibility is that the third allele is an allele for intermediate 
human serum resistance {s^ ). Codominance between two of the three alleles is 
postulated but the outcome of codominance including an allele for intermediate 
human serum resistance cannot be predicted since the phenotype that would arise 
from such a cross is not known. The putative hybrid offspring might display various 
degrees of sensitivity to human serum but the in vivo HSS-assay is probably not 
sensitive enough to be able to detect this. The only codominance situations discussed 
here will, therefore, involve a codominant and allele and a recessive allele; 
on this basis STIB 247 would have to be either or and STIB 386 or 
. It has to be assumed that hybrid offspring from such a cross, which are 
expressing the intermediate resistant phenotype, could arise from two different allele 
combinations so that both the two codominant alleles and together and 
would produce intermediate resistant trypanosomes. Even under this assumption 
there is only one combination that can produce all the three phenotypes that were 
observed but the ratio of the phenotypes is not consistent with those obtained since 
the intermediate resistant phenotype is the most common in a 2:1:1 ratio (x  ^= 8.786, 
d .f= 2 , p<0.05).
Complex models
There are other more complex models that can also either explain the observed data 
or can be refuted as models for the inheritance data. These may involve two or more 
loci, more than three alleles or have several levels of dominance. These are all much 
more difficult to test and only the general points will be discussed.
If it is assumed that there are three alleles: a human serum sensitive allele 
human serum resistant allele {s^  and an. intermediate resistant allele (s^) there can 
also be three levels of resistance. These three alleles can relate to each other in nine 
different ways: s^ can be completely dominant over both the other alleles while the 
allele is dominant over sK Alternatively, the dominance relationships could be any of 
tire following: s^ > s  ^> or s^> s^>  or s^ - > > s^ or > s^ > s^ or >s^. In
addition, there can be a situation of codominance, with s^ and being two
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codominant alleles but the otlier two possibilities, where and are codominant or 
and are codominant will not be discussed since in neither case can the 
phenotype of the possible genotypes be predicted. The possible genotypes of the 
parental trypanosomes and their Fj offspring are described in table 4.5 but their 
corresponding phenotypes will depend on the relationships between the alleles and so 
cannot be defined.
Possible gam etes: , s' and s'
Possible genotypes: s® s® s® s' s' s'
s® s' s'" s'" s' s'
Possible phenotypes: HS sensitive: HS resistant; HS intermediate resistant
Possible genotypes of p aren ta l stocks w ith d ifferen t dom inance relations betw een alleles:
HSS STIB  247 H SR  STIB 386
Allele series s“ > s‘> s' S® S® or S® s'" or s' s'" s' or s' s'
Allele series s“ > s' > s' S® S* or S^  s' or S® s' s' s'
Allele series s '>  s® > s' s" s“ or s“ s' S' S' or S' s' or S' s*
Allele series s '>  s' > s® s" S' S' or S' s' or S' s“
Allele series s' > s® > s' s® s® or s® s' s' s'
Allele series s' > s '>  s® s® s® s' s' or s' s®
Codominance s® and s' S® S® or S® s' S' S 'o r S' s'
T ab le  4.5. Possible gam etes, genotypes and  phenotypes o f p aren ts  and  Fi progeny assum ing 
th re e  alleles w ith d ifferen t dom inance relationships between alleles. Six possible genotypesVan 
result from the three alleles as indicated in the top part o f the table. A cross between a sensitive and a 
resistant stock determined by these alleles could ultimately give rise to the three phenotypes; 
sensitive, resistant and intermediate resistant hybrids. The bottom part o f the figure shows the possible 
genotypes o f  the parental strains when the three alleles show the dominance hierarchy indicated to the 
left.
If the parental stocks have three alleles, 9 possible allele combinations can occur, 
three of which are homozygous and six of which are heterozygous. There are 
however only 6 different unique combinations since each of the heterozygotes 
appears twice. The next assumption is that is the dominant allele and that is 
recessive to both the and allele. STIB 247, which is human serum sensitive, 
would then have to be either or oi while the resistant STIB 386 have to 
be either or s^sK Only one of the six combinations of the assumed parental 
genotypes could possibly give rise to an intermediate phenotype. The intermediate 
phenotype could be formed if STIB 247 is assumed to be and STIB 386 and
19
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as this genetic model could potentially explain the observed results it was described 
and discussed in section 4.2.2. None of the other five possible models could explain 
the observed phenotypes in the generation.
For the second allelic series, S^>  s^> s^, the possible combinations would produce 
three possible F, phenotypes: hybrids of only the sensitive phenotype, sensitive and 
resistant phenotypes in a 1:1 ratio or sensitive and intermediate resistant hybrids in a 
1:1 ratio. The third allelic series where is the completely dominant allele, the 
partially dominant allele and the completely recessive allele, one of the possible 
parental combinations could give rise to all three observed phenotypes. The three 
classes would appear in a 2:1:1 ratio with the most frequent class being the human 
serum resistant phenotype but when comparing the numbers with the observed data 
there was a significant difference = 7.714, d.f. = 2, p < 0.05). The other 
combinations would produce only resistant offspring or resistant and sensitive 
hybrids in a 1:1 ratio. The remaining three possible allelic series cannot lead to the 
production of the three phenotypic classes observed and therefore do not fit with the 
observed results described in section 4.2.1. It is possible that human serum resistance 
is determined by alleles at more than one locus so that resistance and sensitivity aie 
inherited independently. The different loci could then either all be coding for 
sensitivity or all for resistance and an intermediate phenotype could arise when more 
than one of the alleles was inherited and expressed. Several of the possible 
combinations involving two alleles at two loci could produce the three phenotypic 
classes human serum sensitive, human serum resistant and intermediate resistant 
phenotypes but none of them in the 2:1:1 ratio that was observed. Models involving 
more than two loci are more difficult to test and with multiple alleles at each locus, 
the potential number of Fj phenotypes would be large.
4.2.4 Application o f the proposed inheritance model
The suggested model for inheritance of human serum resistance (described in figure 
4.1), which involves three alleles at a single locus; codominant human serum
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sensitive and human serum resistant alleles and one recessive sensitive wild type 
allele, can be used to predict the outcome of the other crosses. Hybrid offspring from 
STIB 247 X TREU 927 and STIB 386 x TREU 927 were analysed for their 
sensitivity or resistance to human serum and the results were given in section 4.2.1. 
Only a small number of F, from these crosses were actually analysed but if the model 
is applied it can test whether it is consistent with the available data. From the model, 
the serum resistant STIB 386 is predicted to have the genotype S^s'^ and STIB 247 
is predicted to be S^s'^. An intermediate resistant trypanosome stock, like TREU 
927, would in this model have the allele combination S^S^. A cross between STIB 
247 and TREU 927 would subsequently result in a F, generation with human serum 
sensitive, human serum resistant and intermediate resistant phenotypes in a 2:1:1 
ratio (figure 4.8).
Predicted model: 
Parents:
F,: Phenotypes
Sensitive: . Æ
STIB 247 
sensitive s^
Genotypes
TREU 927
intermediate S S 
Genotypic ratio Phenotypic ratio
Preliminary results from the 
STIB 247 X TREU 927 cross:
F,: Phenotypes Observed number Expected number Proportion
Obs. Exp.
Sensitive 0:556
Figure 4.8. Predicted model for the inheritance of human serum resistance applied to a STIB 
247 X TREU 927 cross. The model suggested in figure 4 .1 is here tested on a cross between STIB 
247 and TREU 927 assuming the genotypes predicted by the model. There is a good fit between the 
suggested model and the results obtained from a rather limited number o f hybrid progeny tested for 
their human serum resistance/sensitivity.
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The observed ratio is in fact very close to the predicted ratio of phenotypes from 
this cross (table 4.2) which is 5 sensitive, 2 resistant and 2 intermediate resistant. A 
chi-square test can confirm that there is no significant difference between the 
observed data and those expected {y  ^= 0.112, d.f. = 2, p < 0.05). There are however, 
problems with using chi-square tests with such small numbers as other ratios could 
probably still suggest agreement.
The model was also applied to the cross STIB 386 x TREU 927 where seven F, 
progeny had been tested for their reaction to human serum. The comparison of the 
predicted numbers with those observed was less similar; the observed results were 3 
resistant hybrids and 4 sensitive hybrids while the predicted result is human serum 
resistant, human serum sensitive and intermediate human serum resistant offspring in 
a 2:1:1 ratio (figure 4.9).
Predicted model: 
Parents: STIB 386 
resistant s^
TREU 927 
intermediate
F,: Phenotypes Genotypes Genotypic ratio Phenotypic ratio
$
Sensitive T "  1
Preliminary results from the 
STIB 386 X TREU 927 cross:
F,: Phenotypes Observed number Expected number Proportion
Obs. Exp.
Sensitive ki 0.571 0.250
m
Figure 4.9. Application o f a proposed model for inheritance o f human serum resistance with 
progeny from STIB 386 x TREU 927. The inheritance o f human serum resistance/sensitivity trait in 
a cross between STIB 386 and TREU 927 is tested by comparing the predicted results from the 
proposed model (figure 4.1) with observed results. There is not a good fit with the model but 
reservations must be made for the small number o f  progeny tested for this cross.
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The main point is however, not how good the fit to the model is for these crosses, 
since the number is too small for such conclusions, but that the model for this trait 
can be used to predict the outcome of a cross which can then be tested 
experimentally. If further progeny were generated and scored for their HSS 
phenotype, the predicted segregation could be tested.
4.3 DISCUSSION
The results in this chapter have been presented without considering the actual 
function of the gene or genes that determine human serum resistance. The aim was to 
approach the subject from a genetic perspective and determine the inheritance of this 
trait. It is clear from the inheritance data in this chapter that resistance to human 
serum is inherited as a stable trait and that genes determining human infectivity are 
transmitted to approximately 25% of the offspring from the STIB 247 x STIB 386 
cross. This can have serious implications in the field and even though there is some 
debate about the frequency of sexual reproduction in natural populations (Tait, 1980; 
Cibulski et.al., 1988; Tibayrenc & Ayala, 1991; Hide et.al, 1994), a rare event can 
still be important and result in tlie generation of new human infective strains in an 
area.
Most research on the reaction of T.brucei with human serum has focused 
specifically on the resistance trait. Here a mechanism is proposed involving not only 
resistance to human serum but also sensitivity to human serum as a functional 
process. It is not only a lack of resistance that makes a trypanosome strain sensitive 
to human serum but there is a specific gene product that confers sensitivity. In the 
proposed model for inheritance of resistance/sensitivity to human serum there are 
three different alleles at a single locus, two of these potentially translate into 
polypeptides which confer sensitivity while the third allele codes for resistance. One 
of the sensitivity alleles, s~^ , is recessive to the other two alleles, and S^, which 
are codominant when expressed together. This is a simple model to explain the 
occurrence of the intermediate resistant phenotype since codominance implies an
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independence of allele function so that a hybrid product would express a phenotype 
which is a mixture of the two alleles, in this case intermediate in their resistance. The 
only proposed mechanism of resistance of T.b.rhodesiense to human serum was 
described by Hager & Hajduk (1997) and involves the presence of cell-surface 
receptors which bind and internalise TLF, transport it to lysosomes and lead to their 
disruption resulting in complete cell lysis. Both the human serum resistant and 
human serum sensitive trypanosomes were shown to bind TLF in the flagellar pocket 
but the resistant trypanosomes failed to endocytose the TLF and therefore could 
avoid lysis. Assuming that this model is correct and that a specific receptor is 
responsible for the endocytosis that leads to resistance and sensitivity to human 
serum, a functional explanation of the inheritance model can be suggested. If the 
receptor is present and fully functional it would have the capacity to uitemalise a 
toxic factor leading to cell lysis i.e. the trypanosome would be human serum 
sensitive. The receptor would, in this case, be the result of one of the genotypes S^s’^  
or . A non-functional receptor would, on the other hand, be the gene product of 
allele combinations or S^s  ^ and the combination might result in an 
unstable gene product and a receptor which is not fully functional or a lower affinity 
receptor which leads to lower levels of lysis The second possible inheritance model, 
outlined in figure 4.4, could be explained in very similar terms so that is coding 
for the presence of a fully functional receptor, for a non-functional receptor and 
for a receptor which is present but has partially lost its function. An alternative model 
with identical functional consequences is that the gene product of the locus is a 
molecule required for internalisation of the TLF complex with the receptor present 
on both resistant and sensitive cells. The described SRA-gene (DeGreef & Hamers, 
1994) however, cannot be a receptor as it does not have the appropriate sequence for 
membrane insertion. A critical question that arises from this model is how to unravel 
the true nature of the intermediate resistant phenotype. An intermediate phenotype 
was defined as a trypanosome isolate that after incubation with human serum was 
able to infect a proportion of mice in a group. TREU 927 was shown to express the 
intermediate resistant phenotype and it is worth considering a few other observations 
about this strain. There was a difference in the outcome of the in vivo HSS-assay 
when 50, 100, 1000 or 1x10^ cells were injected into mice after exposure to human
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serum in that when a higher number of cells were injected more of the mice 
developed a parasitaemia. The length of the incubation in human serum before 
inoculation did not affect the outcome of the in vivo assay ; the results were the same 
after 15 minutes, 30 minutes, 1 hour, 2 hours or 4 hours incubation. Conceivably, 
there could be two mechanisms involved in determining intermediate resistance; 
either there are differences in expression of resistance within the population so that 
individual cells are either resistant or sensitive, and thus some aliquots contain only 
sensitive trypanosomes while others contain one or more resistant trypanosomes. 
However, as it is not known how sensitive the in vivo HSS assay is and whether it 
would be able to detect only one remaining trypanosome among a number of lysed 
cells. Alternatively, each individual trypanosome has the ability to be either resistant 
or sensitive. To my knowledge, there have been no experiments that have addressed 
this question and it would indeed be hard to image how this could be done since not 
even single cell experiments would be able to tell the two events apart. The data 
presented in this chapter, together with the above observations are, however, 
compatible with the second explanation i.e. each cell may be either resistant or 
sensitive to human serum. If this is considered in light of the proposed receptor 
mediated uptake model by Hagar & Hajduk (1997), intermediate resistant cells may 
have a partially dysfunctional receptor for the toxic serum factor and the source of 
the toxin may be of importance. It has been suggested that the toxin in normal human 
serum is human haptoglobin-related protein which has been found both in TLFl and 
TLF2 (Tomlinson & Raper, 1998), so that a TLF receptor would have to have a low 
affinity in order to bind both of these molecules. An intermediate resistant phenotype 
might have receptors with even lower affinity due to being a variant or it might be 
unstable so that it sometimes manages to bind and internalise the toxic factor but 
other times fail to complete this process.
When discussing a three allele system with two codominant alleles there were two 
parental genotypes which were deliberately not included because their existence 
cannot be tested for in the assay used. These genotypes both involved an intermediate 
resistant allele, which was codominant with either a sensitive allele or a 
resistant allele (S^). Only speculation about the resulting phenotypes from such a
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cross can be made since the in vivo HSS assay would not be sensitive enough to 
separate these phenotypes. Likely phenotypes would include a grading of sensitivity 
to human serum so that some progeny are more resistant than other resistant stocks 
and some sensitive isolates more sensitive than other sensitive stocks. The idea does 
not fit with the proposed model since in order for the allele to be expressed at least 
one of the parental strains must have this allele but both STIB 247 and STIB 386 are 
very clearly sensitive and resistant respectively. It is however, interesting to note that 
among the hybrid offspring there were clones that most certainly were more resistant 
than other resistant clones from the same cross in that they established a patent 
parasitaemia after 2-3 days while most resistant strains were not detected until after 
5-6 days, implying that differences in numbers of infective organisms amongst the 
hybrids of resistant phenotype. Tliis was not confined to single experiments but could 
be repeated and the trypanosomes still showed the same growth pattern. 
Unfortunately, the in vivo HSS-assay is not sensitive enough to be able to pick up 
minor differences in resistance but it would not be surprising if there was some 
grading of sensitivity. The allele combination might be more resistant than 
and S^S^movQ sensitive than A +  in the model described in figure 4.1. Even 
when a completely sensitive strain is incubated with human serum tliere are 
individual cells that seem morphologically intact and may differ in their response to 
the toxic factor in human serum and, similarly, among the resistant STIB 386, 10-20 
% of the cells were usually lysed in contact with human serum. What is important in 
this discussion is that there are not only strains which are clearly sensitive or resistant 
to human serum but there are also strains which exliibited at least one level of 
intermediate resistance to human serum.
The refuted models are in a way more important than the actual suggested model in 
that they can be rejected with a great deal of certainty while the suggested model, as 
stressed earlier, should be seen only as the simplest possible explanation of observed 
results. There are more complex models in which more than one locus is involved 
and where more than three alleles are involved. Models can be proposed with 2 
alleles at two different loci, which can be postulated to control two different 
receptors, both necessary to confer sensitivity or where one locus codes for resistance
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and the other for sensitivity and there are combinations which can give rise to ali 
three observed phenotypes. None of these combinations would however give a 2:1:1 
ratio with human serum sensitive as the most abundant segregant but the intermediate 
phenotype, in all cases, would be the most frequently observed.
The most direct way to test the proposed model of inlieritance, would be to attempt 
a series of backcrosses. A cross between an F, hybrid and one of the parental types 
could be used to determine whether the parent is homozygous or heterozygous for a 
certain allele and the predicted results compared with the observed results. 
Backcrosses in T.brucei have been achieved (Gibson et.al., 1995), which implies that 
hybrid genotypes are sexually competent and that backcrosses can be obtained. In a 
planned backcross experiment, which unfortunately was delayed because of problems 
with the tsetse fly colony and lack of time, one of the human serum resistant F, from 
the STIB 247 x STIB 386 cross would be crossed with the parental STIB 247. If the 
model is correct tlien the resistant F, progeny would be of the genotype s'^ and 
the backcross progeny would segregate as sensitive, resistant and intermediate 
resistant in a 2:1:1 ratio (figure 4.10).
Predicted results from a backcross 
between the parental STIB 247 and 
a HSR Fj progeny
Parents: STIB 247 
sensitive
Fj progeny 
resistant
Fj: Phenotypes Genotypes Genotypic ratio Phenotypic ratio
Sensitive
Resistant
Figure 4.10. Suggested approach for confirming the proposed genetic model by conducting a 
backcross between one of the parents and a hybrid offspring. The outcome o f  such a testcross can 
be predicted and subsequently compared with observed results to show the probability o f the model. 
A proposed backcross to confirm or reject the proposed inheritance model in figure 4.1 is outlined.
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There are five human serum resistant F, offspring which could be used 'fo r a 
backcross. The locus identified by the microsatellite marker JS-2 could be used to 
detect tsetse flies with mixed infections and half of the progeny clones would be 
genotypically distinct from both STIB 247 and the F, progeny clones used in such a 
cross. Backcrosses would also be extremely informative when investigating TREU 
927’s intermediate phenotype in that its proposed genotype can be tested i.e. a cross 
between TREU 927 and one of the intermediate resistant hybrid progeny would 
result in only intermediate resistant recombinants. It was hoped that the self­
fertilisation test of STIB 247 would be useful in confirming its genotype. A 
heterozygous genotype would have segregated into three genotypes in which 50% of 
the progeny would be homozygous for one allele or the other. But as the proposed 
genotype of STIB 247 is ss, all segregants would be sensitive and so non informative. 
The four products of self-fertilisation from STIB 247 were sensitive which is 
consistent with the proposed genotype. TREU 927 sellers however, would be 
informative as there would be a segregation into intermediate, sensitive and resistant 
phenotypes. Unfortunately, only one TREU 927 selfer was available so no 
conclusion could be made.
As STIB 386 does not express the SRA gene (Chapter 5), the locus identified by the 
genetic analysis is unlikely to be the SRA gene. This leads to the conclusion that 
there are several different genes that can determine human serum resistance. The 
genetic approach illustrated here, can be very useful in identifying loci as it makes no 
assumptions about the mechanism of human serum resistance. Genetic mapping of 
the human serum resistance trait could be undertaken to determine the chromosomal 
region(s) that differ between human serum sensitive and resistant trypanosome lines. 
Work is under way to identify a complete set of universal chromosomal markers for 
the T.brucei genome (Melville et.al, 1998; Dan Masiga, pers.comm., 1998) and 
when a genetic linkage map has been fully established, the inheritance pattern of 
specific markers could be compared with observed inheritance pattern of the human 
serum resistance trait. This could subsequently lead to the actual localisation of the 
human serum resistance locus, if the map position is determined and a single gene 
determines human serum resistance. Once a specific region on the genetic map had
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been identified, closely linked physical markers could be used to clone the region 
identified.
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5.1 INTRODUCTION
Chapter 5
SRA gene expression and its lack of correlation with serum
resistance in T ,b r u c e i
1
In a number of stocks the human serum resistance trait in Tb.rhodesiense is I
unstable. Resistant populations can be transformed to become sensitive and :i
resistance can be selected in sensitive populations by exposing them to human serum 
in small doses (Rifkin et.al, 1994; Rickman & Kolala, 1980). Several attempts have
•i'ibeen made to explain the resistance trait and since a change in serum sensitivity was 
often associated with a change in the expressed VSG, it was thought that the VSG 
was involved in mediating resistance. Rifkin et.al. (1994) compared human serum 
resistant and human serum sensitive T.b.rhodesiense clones expressing the same 
VSG but could find no differences in structure or biochemical properties of the VSG 
in the two clones. Similarly, De Greef et.al. (1989) studied differences in cDNA §
sequences of VSG genes from sensitive and resistant forms and the relative 
abundance of VSG molecules but could not correlate resistance to any difference in 
VSG expression.
One approach used to investigate the molecular basis for human serum resistance 
was by subtractive hybridisation to identify RNAs differentially expressed between 
serum sensitive and serum resistant isogenic lines expressing the same VSG. This 
method was employed by De Greef et.al. (1989) who found a 1.5 kb transcript which 
was present only in the resistant forms. This resistance-specific transcript was found 
in four T.b.rhodesiense clones which all were derived from the ETat repertoire and in 
one uncloned stock from Tanzania. It was, however, not expressed in one |
Tb.gambiense isolate or in one T.b.brucei isolate tested. Southern blot analysis 
indicated that the Serum Resistant Associated (SRA) gene was present in the 
sensitive T.b.rhodesiense line but not expressed. In a subsequent paper, four 
uncloned T.b.rhodesiense isolates from Zambia, two T.b.brucei isolates, two
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T.b.gambiense isolates, one T.evansi and one T.equiperdum isolate were analysed 
and all of the Zambian samples shown to express the SRA gene while sequences 
related to the SRA-transcript were present, but not expressed, in the other members 
of the Trypanozoon subgenus (De Greef et.al, 1992). The SRA-transcript was later 
shown to code for a protein that has homology with VSG. The best homology was 
found in the carboxy-terminal part of the molecule which is the domain with the 
highest degree of sequence conservation between VSG genes. The N-terminal leader 
sequence, forming the elongated structui'e of VSG genes, was however, missing in 
the SRA gene. The genomic clone, isolated by probing genomic libraries with the 
SRA c-DNA clone, was shown to contain a pseudogene since no open reading frame 
could be found but belonged to the same gene family (De Greef & Hamers, 1994).
This chapter describes the investigation of the presence and expression of the SRA 
gene in seven different T.brucei clones including the three genetically competent 
stocks used in the inheritance studies (Chapter 4). The objectives of this study were 
to, firstly, investigate whether the SRA gene was present in STIB 247, STIB 386 and 
TREU 927 and, if so, whether it was expressed. Secondly, to determine whether 
expression of SRA was associated with human serum resistance in these stocks and 
thirdly, to potentially follow the inheritance of SRA presence/expression into the F, 
to investigate whether it co-segregated with the serum resistance phenotype. The 
presence of the SRA gene was investigated both by PCR and by Southern blotting. 
Sequences related to the SRA gene were detected in all clones tested by Southern 
analysis. However, sequencing of the PCR product suggested a degree of sequence 
variation at the site of one primer so that in one stock no PCR product could be 
obtained at all and in another case only the 3’end of the fragment could be amplified 
with primers designed for the SRA gene sequence. The expression of the SRA gene 
was studied by Northern hybridisation and by RT-PCR and it was established that its 
expression could not be correlated with human serum resistance in the clones studied 
here. From those data, it can be concluded that resistance to human serum is 
determined by more than one mechanism which may differ between isolates from 
different areas and that the inlieritance of the serum resistance/sensitivity phenotype 
described in Chapter 4 does not involve differences in SRA expression.
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5.2 RESULTS
5.2.1 Analysis of the SRA gene by PCR
Total genomic DNA was isolated from bloodstream forms of STIB 247, STIB 386, 
TREU 927 and ETat 1.2 and used as DNA templates for PCR analysis of the SRA 
gene as described in 2.15. The ETatl.2 trypanosome line was derived from the 
stabilate bank in Glasgow. It was used as a positive control because SRA was 
originally identified from ETatl.2 from the stabilate bank in Antwerp. Typically 20 
ng DNA was used in each 10 pi reaction. The published SRA gene sequenced was 
accessed in the GenBank™Data Bank, accession number Z37159, and four sets of 
oligonucleotide primers were designed from this sequence. The sequences of the 
eight primers are shown in table 5.1 and the positions of the sequences in the 
published sequence are shown in figure 5.1.
Oligo name Oligo sequence No. of bases
M HT 5 ’ > CAA AAG CAG CAA CCA TAT TCA G < 3 ’ 22
MHS 5 ’ > TAG CAA GGC GAA CCG AAA G < 3 ’ 19
2SRA1 5’ > CGA ACG AC A GTT A AC GTA AC A < 3’ 21
2SRA2 5’ > AGC CAA TTT CAT ATC CAC AAG < 3 ’ 21
SRA5 5 ’ > CGC TTT GAC GAA GAG CCC GTC AAG < 3 ’ 24
SRA6 5’ > CCT TCC CAT TCG TAT TCT TGT G < 3 ’ 22
SRA7 5 ’ > ATT CTG CAG CAG GCG TCA C < 3 ’ 19
SRA8 5 ’ > TTC CGC ATT ATA TGT GCA C < 3 ’ 19
T IM A 5 ’ > GCG TAG TGG CCT CCA CCT TTG TTC < 3 ’ 24
T IM E 5’ > A AC ACC CCC TAT TGT TTC CTC TCC < 3 ’ 24
T IM E 5’ > TGC CGT TGA GTG GGT GAA GAT AGC < 3 ’ 24
T ab le  5.1. O ligonucleotides used as p rim ers for SRA gene analysis. Eight different primers were 
designed for PCR analysis o f  the SRA gene and used in various combinations. Their names and 
sequences are outlined above. Primers for the TIM gene were used as positive controls for the PCR 
reactions.
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Z37159 Length: 1395
1 CGCTATTATT AGAACAGTTT CTGTACTATA TTGACACACC TCTAAGAATC
51 ACAATAGCAA G G CQ A A CCO a AAGCGAACGA CAGTTAaCGT AACAGCA*ATG
101 CCCCGAAATT CGGGCCGGAC AACAAGTACC TÏGGCGCTCC CTGGCCCTAA
151 AGCTGCTGGC AGTGCCTGTA TCGCCCAGTG GCAC CGCSTT GACGAAGAGC
201 CCGTCaAGAA GGTTTGCAAA GTAGAAAAAA ACTTAGCAGA CGÏCGCAGGA
251 ATCGCTTTGG CCAAAATAAA CAACCTGATA AAACAAGTAT CGGCAGCAAC
301 CGAAGCGCAA GCAAGAATGA CCTTGGCCGC CGCAAGCACA GACCACAGCA
351 ACATCTCAGC GCTTTATGCC GCGGCGTCAA ACATAGTGAC AAGATGCGTA
401 CTCAACGCAG TCCACGCTCT TACAAGTCTT GCGCCAATAG CGTTAACTGC
451 AGCGTCCAAC GGAGCCAAAA CCAGTGGGCA CATCTCAGAA GTAATCGACA
501 TTCTGCAGCA GGCGKCAC AA GGTAAGACAG AAGGAAAGTG CATAGTGAAA
551 AGCGGCGGCG GTACAACAAC AGTAGCAATA AGGCAACTTT ACAACAAAAT
SOI AGGGGACCTA GAAAAACAAA CGACCAACAA CTGCGGCACC AGCGTGACCG
651 AAGTACTCGA ACACATTCTA AAACAAGAAG CGCTCAAGGA AGCGCTACTT
701 TCAATCGTGA AAAAACCAAA AGGGGCœCA GACAAAACAG CAGCAGATGA
751 ATTGGÏCACC GCGCTAATCA ACGGCGTGGT GCCAAACAGC ACAGCACAGA
801 CCCAAAAATT AAAGGAGAAA ATTCTAAACA CCTTGGTCCC CAAGCTTGTG
851 GAAGGCTCAA AAAGCCAAGT AAAACTAAGG ATTCTGAAGT ACCCGGGAAA
901 AATACAGAAA AGCAAACTCG TATCAATCCA AGAGTTAAAA ACCCGAGTGG
951 AGCCTGAATC TAGCACTGAA AGCTGCAAGC AGCAGGTCGC CACCAACCAG
1001 GCACAGGAGG CATTTTGTAA CGCAATTGGC GACGACAAAG ACAAGTGTAA
1051 CAATGAGACA CGAÏGCAGTT ACGATGACAG CAAAGGCTCA GACAAAAA
1101 AAA GCAGAAGCAA ATGGGGCACC TGCAACGCAA
1151 CCTCAAGGGG GAGTGAACGA AGCAACAACA GGAAATTGTA AAGGGAAACT
1201 GGAACCCGGA TGCACCAAGG C nCRAG ASiTA C G A & TSG G AR eSAAAAGAAT
1251 CCAAAGATTC AAGTTTTCTT G T aS tiX J iT G A n jiT T c s a c T C T aA a.T A T G G T X
1301 G C T G C TTU TG TGGCCTTTCT g t t t * t a a t t t  t c a c c t c t t t  t g a a a g a a c t
1351 TTGCTGTTTC ATATACTTTA ACACATTTTC ATGAATTTGT GAAAA
Primer MHS 
Primer 2SHAI 
Primer SRA5 
Rimer SRA7
Primer (complementary) 
Rimer SRA6 (complementary) 
Rimer 2SRA2 (complementary) 
Rimer MHT (complcmentaiy)
Figure 5.1. The published SRA sequence for E T atl.2  and primers designed for PCR. The SRA
sequence o f  ETatl.2 (GeaiBank accession number Z37159) indicating the positions o f  sequences used 
to design primers for PCR analysis o f  the presence o f  the SRA gene hi other stocks. A  total o f  eight 
different primers were designed for the published SRA gene and used both for PCR analysis and for 
sequencmg reactions. The stop- and start-codon are marked with *.
Initially, oligonucleotides MHS (5’ TAG CAA GGC GAA CCG AAA G 3’) and 
MHT (5’ CAA AAG CAG CAA CCA TAT TCA G 3’),which flank the coding 
region, were tested on the four clones but annealing temperatures between 55°C and 
70C° typically produced several DNA fragments of sizes ranging between 0.5 kb and
1.2 kb when separated on 1% agarose gel, stained with ethidium bromide and 
visualised by ultm violet transillumination (figure 5.2). For ETatl .2 a single specific
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band of the predicted size was produced at annealing temperatures reaching 70°C but 
for STIB 386 and STIB 247 there were several bands apparent even at higher 
annealing temperatures. TREU 927 produced a single band at higher temperatures 
but of a smaller than expected size (0.9 kb).
1.3 kb 
0.9 kb-
ETatl.2
M70*C <   60* C
STIB 386 
M70*C < ----------- 60* C
2.0 kb- 
0.9 kb-
STIB 247 TREU 927
55* C ------------------- ► 65* C M 7Cf C <-------------------------  6(T C M
1.3 kb 
■ 0.9 kb 0.9 kb
Figure 5.2. PCR amplification using a range of annealing temperatures with primers MHS and 
MHT designed from sequences flanking the SRA gene. PCR products were separated on a 1% 
agarose gel and visualised by UV transilluminator. PCR amplification with SRA primers for ETatl.2 
DNA produced a major band 1.2 kb in size but there were also several smaller fragments being 
amplified even at 65°C annealing temperature. The same primers, when used with STIB 247, 
amplified a DNA fragment o f approximately 1.2 kb in size and smaller fragments were only produced 
at annealing temperatures lower than 55°C. For TREU 927 and STIB 386 there was a range of, 
predominantly smaller, fragments being amplified with this primer combination even at higher 
annealing temperatures.
PCR amplification of the SRA locus was subsequently carried out using nested 
primers. Typically, reactions were first carried out with primers MHS and MHT 
under the following cycling conditions: 96°C for 50 s, 55°C for 50 s and 70°C for 2 
min for a total of 24 cycles. A 1 pi sample of the product was transferred to a fresh 
tube and subjected to a second PCR amplification using primers 2SRA1 (5’ CGA 
ACG ACA GTT AAC GTA ACA 3’) and 2SRA2 (5’ AGC CAA TTT CAT ATC 
CAC AAG 3’) (see figure 5.1) under the same conditions, or with an annealing 
temperature at 52°C, for a further 30 cycles. Nested PCR amplification with the 
described primers resulted in a strong specific band of 1.2 kb in size from ETatl.2 
and STIB 247 as shown in figure 5.3. The size of the resulting PCR product from
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TREU 927 was slightly larger, approximately 1.5 kb in size and no product could be 
obtained from STIB 386. Control PCR was carried out using primers flanking the 
TIM locus to confirm that no PCR inhibitors were present in DNA isolated from 
STIB 386 and this gave rise to a fragment of expected size (figure 5.3b). Primers 
2SRA1 and 2SRA2 eould alone give rise to PCR produets from all DNA samples 
mentioned apart from STIB 386 (data not shown).
A. IM ET atl.2 STIB 386 STIB 247 TREU 927
1.5 kb 
1.0 kb
0.5 kb
M ETatl.2 STIB 386
Figure 5.3. PCR amplification of tbe SRA gene locus using nested primers. (A) DNA from 
ETatl.2, STIB 247, STIB 386 and TREU 927 was isolated and used for PCR amplification with 
nested primers, MHS and MHT followed by 2SRA1 and 2SRA2. The products were separated on a 
1% agarose gel, stained with ethidium bromide and visualised by ultraviolet illumination. M, I kb 
DNA marker. (B) TIM primers E and B were used in control PCR to verify the quality o f  DNA 
isolated from STIB 386 since PCR amplification with primers designed for the SRA gene failed.
To investigate further the presence of a sequence similar to the SRA gene in STIB 
386 other primer combinations were used. Primers SRA5 (5’ CGC TTT GAC GAA 
GAG CCC GTC AAG 3’) and SRA6 (5’ CCT TCC CAT TCG TAT TCT TGT G 3’) 
produced two separate bands of 1.2 kb and 1.4 kb respectively in ETatl.2 but there 
was a complete absence of any product from STIB 386 (figure 5.4). A possible 
reason for the second band is the presence of a second sequence homologous to the 
primers used.
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E T atl.2 STIB 386
1.5 kb- 
1.0 kb-
70°C 4  60°C 70°c 4
Figure 5.4. PCR amplification of the SRA gene sequence using primers SRA5 and SRA6. Primer 
combination SRA5 and SRA6 was used to amplify SRA related sequences in ETatl.2 and STIB 386 
in order to investigate the presence o f a SRA gene in STIB 386. Fragments were amplified from 
ETatl.2 gDNA but not from STIB 386 gDNA. The DNA preparation was the same as that used for 
the TIM control reaction in figure 5.3
Primer combination SRA7 (5’ ATT CTG CAG CAG GCG TCA C 3’) and SRA8 
(5’ TTC CGC ATT ATA TGT GCA C 3’) were also tested in order to find sequence 
homology with the published SRA gene. Annealing temperatures between 55°C and 
68°C were tested and this produced one or several segments in ETatl.2 at all 
annealing temperatures tested but no produet could be detected from STIB 386 (data 
not shown).
PCR analysis of the SRA locus in STIB 247, STIB 386, TREU 927 and ETatl.2 
suggested that a sequence related to the published SRA gene was present in ETatl.2, 
STIB 247 and TREU 927 but that the sequence was either absent from STIB 386 or 
sufficiently divergent that the primers designed from the ETatl.2 sequence were 
unable to prime. To investigate which explanation was more likely. Southern blots 
were performed with DNA from the cloned stocks used for PCR analysis.
5.2.2 Analysis of the SRA gene by Southern hybridisation
The probe used for Southern analysis was the purified product from the nested PCR 
reaction of ETatl.2 SRA (section 5.2.1) labelled with fluorescein. Southern 
hybridisation was conducted as described in section 2.13 using digested genomic
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DNA derived from ETatl.2, STIB 386, STIB 247 and TREU 927 and hybridising 
sequences were detected in all four eloned stocks (figure 5.5).
A. E T a tl.2 ST IB  386 ST IB  247 T R E U  927
1.0 kb
0.75 kb 
0.5 kb
B.
Figure 5.5. Southern hybridisation of restriction digested genomic DNA from four trypanosome 
stocks with the SRA gene probe. (A) Southern blot analysis o f Igg o f genomic DNA digested with 
TaqI from ETatl.2, STIB 386, STIB 247 and TREU 927 with the fluorescein labelled PCR product 
purified from ETatl.2 after a nested amplification using primers MHS and MHT followed by 2SRA1 
and 2SRA2. (B) Ethidium bromide stained gel prior to Southern blotting which reveals some DNA to 
have been only partly digested, particularly in ETatl.2 and STIB 247.
The pattern of hybridising fragments was however, not identical for the four cloned 
stocks when probed with the SRA gene probe. Apart from hybridisation with DNA 
left in the wells and with undigested DNA at around 20 kb, strong hybridisation can 
be seen with two DNA fragments. For ETatl.2 and STIB 247 the size of these 
fragments are 0.75 kb and 0.5 kb respectively. For STIB 386 and TREU 927 the size 
of hybridising bands are 0.95 kb and 0.8 kb. The restriction enzyme Taql is expected 
to cut twice within the published SRA gene resulting in three fragments of the 
lengths 495 bp, 61 bp and 824 bp. The 61 bp fragment is probably too small to result 
in strong binding with the probe although a very faint band of a small size is Just
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s r a  GTACTCAACG CAGTCCACGC TCTTACAAGT CTTGCGCCAA TAGCGTTAAC TGCAGCGTCC AACGGAGCCA AAACCAGTGG
E t a t  1 .2  GTACTCAACG CAGTCCACGC TCTTACAAGT CTTGCGCCAA TAGCGTTAAC TGCAGCGACC AACGGAGCCA AAACCAGTGG
2 4 7 s r a  GTACTCAACG CAGTCCACGC TCTTACAAGT CTTGCGCCAA TAGCGTTAAC TGCAGCGACC AACGGACCCA AAACCAGTGG
9 2 7 s r a    CAATT TTAGCGACAG CAGGMGAAAC AGCGATC AA ACCCATG
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visible in the lanes of TREU 927 and STIB 386 DNA. The hybridisation pattern is 7
thus as expected for ETatl.2 and STIB 247 while for STIB 386 and TREU 927 one 
of the fragments is considerable larger than expected. The simplest explanation for I
this is that a modification has occurred at the 5’end of the gene since the fragment 
size at the 3’end is unchanged compared with the control ETatl.2. For the published 
SRA gene, more bands were detected after Southern blot analysis than expected on 
the basis of a restriction map (De Greef & Hamers, 1994). The authors explained this 
with the existence of several related sequences. In summary, it appears that the 
described SRA gene is present in ETatl.2 and in STIB 247 and that a sequence 
related to the SRA gene can be found in STIB 386 and TREU 927.
5.2.3 Sequence analysis of the PCR products from the SRA locus
In order to verify the identity of PCR products obtained in ETatl.2, STIB 247 and f
TREU 927, when using primers designed for the published SRA gene, the 
amplification products were cut from the agarose gel, purified and sequenced. Only 
single pass sequencing was conducted for most of the PCR fragment so some level of 
variation from the published SRA gene sequence was expected. From the band 
recovered from ETatl.2, 1050 bp were successfully sequenced and this showed an 
overall 98% identity with the published SRA gene which has a total length of 1230 
bp within the open reading frame (figure 5.6).
s r a  CGCTATTATT AGAACAGTTT CTGTACTATA TTGACACACC TCTAAGAATC ACAATAGCAA GGCGAACCGA AAGCGAACGA
E t a t l . 2     GTACAA 3*
2 4 7 s r a  ..................................................................................................................................................................................................................................................
92 7  s r a  ..................................................................................................................................................................................................................................................
s r a  CAGTTAACGT AACAGCAATG CCCCGAAATT CGGGCCGGAC AACAAGTACC TTGGCGCTCC C ..T G G C C C T  AAAGCTGCTG
E t a t l . 2  ..GTTAACGT AACAGCAATG CCC.GTAATT CGGGCCGGTC AACAAGTACC TTGGCGCTCG CGCTGGCCCT AAAGCTGCTG -
2 4 7 s r a   TNTG CCC.GAAATG CCGGCNGGAC AACAAGTAC. TTGGCGCTCG CGCTGGCCCT AAAGCTGCTG
9 2 7 s r a    AACAAGTAC. TTGGCGCTCG CGCTGGCCCT AAAGCTGCTG i1-s r a  GCAGTGCCTG TATCGCCCAG TGGCACCGC. TTTGACGAAG AGCCCGTCAA GAAGGTTTGC AAAGTAGAAA AAAACTTAGC
E t a t l . 2  GCAGTGCCTG TATCGCCCAG TGGCACCGCC TTTGACGAAG TGCCCGTCAA GAAGGTTTGC AAAGTAGAAA AAAACTTAGC
2 4 7 s r a  GCAGTGCCTG TATCGCCCAG TGGCCCCGCC TTTGACGAAG AGCCCGTCAA GAAGGTTTGC AAAGTAGAAA AAAACTTAGC
9 2 7 s r a  GCAGTGCCTG TANCGCCCAG TGGCACCGCC TTTGACGAAG AGCCCGTCAA GAAAGTTTGC AAAGTATAAA AAAACTTATC
s r a  AGACGTCGCA GGAATCGCTT TGGCCAAAAT AAACAACCTG ATAAAACAAG TATCGGCAGC AACCGAAGCG CAAGCAAGAA
E t a t l . 2  AGTCOTCGCA GGAATCGCTT TGGCCAAAAT AAACAACCTG ATAAAACAAG TATCGGCAGC AACCGAAGCG GAAGCAAGAA
2 4 7 s r a  AGACGTCGCA GGAATCGCTT TGGCCAAAAT AAACAACCTG ATAAAACAAG TATCGGCAGC AACCGAAGCG GAAGCAAGAC
92 7 s r a  AGACGTCGCA GGAATCGCTT TGGCCAAAAT AAACAACCTG ATAAAACAAG TATCGGCAGC AACCGACGCG GAAGCAAGAA
e r a  TGACCTTGGC CGCCGCAAGC ACAGACCACA GCAACATCTC AGCGCTTTAT GCCGCGGCGT CAAACATAGT GACAAGATGC t
E t a t l . 2  TGACCTTGGC CGCCGCAAGC ACAGACCACA GCAACATCTC AGCGCTTTAT GCCGCGGCGT CAAACATAGT GACAAGATGC '5
2 4 7 s r a  TGACCTTGGC CGCTGCAAGC ACAGACCACA GCAACATCTC AGCGCTTTAT GCCGCGGCGT CAAACATAGT GACAAGATGC .i-?
9 2 7 s r a  TGACCTT.................................. C A C ................................................................................................................................................................................
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s r a  CGGCGGTACA ACAACAGTAG CAATAAGG.C AACTTTACAA CAAAATAGGG G . ACCTAGAA AAA. CAAACG ACCAACAACT
E t a t l . 2  ..............TACA ACAACAGTAG CAATAAGG.C AACTTTACAA CAAAATAGGG G . ACCTAGAA AAA. CAAACG ACCAACAACT
2 4 7 s r a   GTACA ACAACAGTAG CAATAAGGGC AACTTTACAA CAAAATAGGG GGACCTAGAA AAAACAAACG ACCAACAACT
9 2 7 s r a    AAATGGATGG CCGAATTGGA GGACCTAGCA GAAACAATGG A AACAAAA
E t a t l . 2
2 4 7 s r a
9 2 7 s r a
E t a t l . 2
2 4 7 s r a
9 2 7 s r a
E t a t l . 2
2 4 7 s r a
9 2 7 s r a
E t a t l . 2
2 4 7 s r a
9 2 7 s r a
E t a t l . 2
2 4 7 s r a
9 2 7 s r a
E t a t l .2  
2 4 7 s r a  
9 2 7 s r a
E t a t l .2  
2 4 7 s r a  
9 2 7 s r a
E t a t l . 2
2 4 7 s r a
9 2 7 s r a
E t a t l . 2
2 4 7 s r a
9 2 7 s r a
E t a t l . 2
2 4 7 s r a
9 2 7 s r a
GCGGCACCAG CGTGACCGAA GTACTCGAAC ACATTCTAAA ACAAGAAGCG CTCAAGGAAG CGCTACTTTC AATCGTGAAA
GCGGCACCAG CGTGACCGAA GTACTCGAAC ACATTCTAAA ACAAGAAGCG CTCAAGGAAG CGCTACTTTC AATCGTGAAA
GCGGCACCAG CGTGACCGAA GTACTCGAAC ACATTCTAAA ACAAGAAGCG CTCAAGGAAG CGCTACTTTC AATCGTGAAA
GCCGCGGCGG C.TG .CCG CA  GTAGCC CG C CTAAACTTAC AAT TA
AAACCAAAAG GGGCGCCAGA CAAAACAGCA GCAGATGAAT TGGTCACCGC GCTAAT.CAA CGGCGTGGTG CCAAACAGCA
AAACCAAAAG GGGCGCCAGA CAAAACAGCA GCAGATGAAT TGGTCACCGC GCTAAT. CTA CGGCGTGGTG CCTCATAGC.
AAACCAAAAG GGGCGCCAGA CAAAACAGCA GCAGATGATT TGGTCACCGC GCTAATNCTA CGGCGAGGAG .........................
AAAACAAAAG AAACAGCC GCGCA GGTCGCCA TT AAGAAAGA
CAGCACAGAC CCAAAAATTA AAGGAGAAAA TTCTAAACAC CTTGGT CCCCAAGCTT G TGGAAGG CTC AAAAA
................................................TTG TTGGAGACA. TTNTAAACAC CTTGGT CCCCAAGCTT G TGGAAGG CTC AAAAA
  AAATTT TTTNAAACAC CTTNGTTTCC CCCAAAGCTT TGTTGGAAGG TTCKAAAAAA
AAAAAC ATTTG CAGCT
GCCAA GTAA AACTAAGGA TTCT GAAG TACCCGGG A AAAATACA G AAAAGCAAAC TCG TATCA AT CCAAGAG
GCCAA GTAA AACTAAGGA TTCT GAAG TACCCGGG T AAAATACA G AAAAGCAAAC TTG TATCA AT CCAAGAG
GCCAAAGTAA AATTAAAGGA TTTCTHGGAG TACCCGGGGA AAAATACAAG AAAAGCAAAC TNTGTTATCA ATTCCAAGAG 
 ACA TTCCC AGC CCCAGC
TTAAAAACCC GAGTGGAGCC TGAATCTAGC ACTGAAAGCT GCAAGCAGCA GGTCGCCACC AACCAGGCAC AGGAGGCATT
TTAAAAACCC GAGTGGAGCC TX3AATTTAGC ATTGAAAGTT GCAAGCAGCA GGTCGCCACC AACCAGGCAC AGGAGGCATT
TTAAAAACCC GAGTGGAGCC TGAATCTAGC ACTGAAAGCT GCAAGCAGCA GGTCGCCACC AACCAGGCAC AGGAGGCATT
ACCC GT AGTC CA GCCAACACCA A ACC AA GGAAAA AGGAGGCATT
TTGTAACGCA ATTGGCGAC GACAAAGACA AGTGTAACAA TGAGACACGA TGCAGTTACG ATGACAGCAA AGGCTCAGAC
TTGTAACGCA ATTGGAGAC GACAAAGACA AGTGTAACAA TGAGACACGA TGCAGTTACG ATGACAGCAA AGGTTCAGAC
TTGTAACGCA ATTGGCGAC GACAAAGACA AGTGTAACAA TGAGACACGA TGCAGTTACG ATGACAGCAA AGGCTCAGAC
TTGTAACGCA ATTGGCGACC GACAAAGACA AGA.TAACAA TGAGACMCGA TGCAGTTACG ATGACAGCAA NGGTTCAGAC
AAAAAGTGCA CATATAATGC GGAAAAAGCA GAAGCAAATG GGGCACCTGC AACGCAACCT CAAGGGGGAG TGAACGAAGC
AAAAAGTGCA CATATAATGC GGAAAAAGCA GAAGCAAATG GGGCACATGC AACGCAACCT CAAGGGGGAG TGAACGAAGC
AAAAAGTGCA CATATAATGC GGAAAAAGCA GAAGCAAATG GGGCACCTGC AACGCAACCT CAAGGGGGAG TGAACGAAGC
GAAAAGTGCA CATATAATGC GGAAAAAGCA GAAGCAAATG GGCCACATAC AACGCAACTT GAAGGGGNAG TGAACGAANC
AACAACA.GG AAATTGTAAA GGGAAACTGG AACCCGGATG CACCAAGGCA CAA. GAATAC GAATGGGAAG GAAAAGAATC
AACCACA.GG AAATTGTA.............................................................................................................................................................................................
AACAACA.GG AAATTGTAAA GGGAAACTGG AACCCGGATG CACCAAGGCA CAA.GAATAC GGATGGGAAG GG......
ANCAACANGG AATTTGTAAA GGGAAACCGG AACCCGAATG CACCAAGGCT CCCTGAATGC AAATTGGAAA GTGAGCAATG
CAAAGATTCA TGGATATGAA ATTGGCTCTG AATATGGTTG TTTTAA TTTT
CGGCAGTTTA NATTTNCAA. CGCCN.
GAAAGAACTT TOCTGTTTCA TATACTTTAA CACATTTTCA TGAATTTGTG AAAA
Figure 5.6. Comparison of the published SRA gene sequence and the sequence of PCR derived 
SRA fragm ents from  E T atl.2 , STIB 247 and TREU 927. A direct comparison with the DNA 
fragment produced by nested amplification of SRA related sequence from ETat 1.2 and the published 
SRA gene sequence within the open reading frame showed 98% identity with the published gene. A 
line up with the PCR amplified product from STIB 247 and the published SRA gene show a 98% 
identity between the sequences across the 1080 bp sequenced. Nested PCR was also used to produce a 
fragment related to the SRA gene in TREU 927 and alignment with the published SRA gene sequence 
revealed a good homology at the 3’end of the sequence, close to 95%, but a comparison between the 
5 ’ends of the sequences show much more divergence. Dots indicate missing sequence while gaps 
indicate gaps in sequence alignment. Start and stop codons are marked with *.
Similarly, the PCR product recovered from STIB 247 showed 98% identity with the 
published SRA gene sequence when 1076 bp of the PCR product were sequenced 
(figure 5.6). This is convincing evidence that the fragments obtained from PCR 
amplification using primers for the SRA gene in Etatl.2 and STIB 247 are true 
homologues of the SRA gene. The sequence obtained from TREU 927 showed major 
differences at the 5’end compared with the published SRA sequence while a stretch 
starting from the 3’end and ending at bp 992 show 95% identity with the SRA gene 
(figure 5.6), As discussed earlier, the 3’end of the SRA sequence has high homology
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with the carboxy terminal part of sequenced VSG genes (De Greef and Hamers, 
1994) and it is also at this end of the gene that TREU 927 show the best fit with the 
SRA gene.
5.2.4 Analysis of the expression of SRA by Northern hybridisation
Having established the presence of a SRA gene in STIB 247 and ETat 1.2, identified 
a closely related sequence in TREU 927 and a homologue (by Southern 
hybridisation) in STIB 386, it was important to test for expression of the gene in 
these stocks to investigate the possibility of a correlation between SRA expression 
and resistance to lysis. RNA was isolated from the human serum sensitive line of 
ETat 1.2, from ETatl.lO which is a human serum resistant line, and from STIB 386 I:(human serum resistant), STIB 247 (human serum sensitive) and TREU 927
V ' -(intermediate resistant). RNA was then separated by gel electrophoresis on agarose f
gels before blotting. The ETatl.lO RNA preparation was a kind gift from Etienne 
Pays and used as a control since this was the trypanosome line from which the SRA 
gene had originally been described. Initially, a PCR product comprised of the major 
part of the SRA open reading frame from ETat 1.2 (primers MHS and MHT followed 
by 2SRA1 and 2SRA2) was used to probe the Northern filter. This resulted in strong 
hybridisation with an approximately 1.4 kb RNA fragment in the lanes of the human 
serum resistant ETatl.lO in addition, with a slightly larger fragment in a clone of A
STIB 247 which had been passaged in mice for approximately 80 times (STIB 
247x80) but not in ETatl .2(8). STIB 386, STIB 247 or TREU 927 (figure 5.7).
STIB 247x80 was tested for human serum sensitivity by the in vivo HSS-assay used 
in this study and found to be serum sensitive. A SRA homologue was not present in 
any of the other stocks tested.
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A.
B.
ETatl.lO R  ET atl.2S STIB 386 STIB 247 STIB 247 TREU 927
)assaeed
Figure 5.7. Northern hybridisation of mRNAs with the SRA gene probe. (A) Spg o f total RNA 
was separated by agarose gel electrophoresis in the presence o f formaldehyde/form amide, blotted 
onto Hybond N  ^ membrane and hybridised to SRA PCR product derived from ETat 1.2. (B) Tubulin 
was used as control probe to verify the presence and quality o f RNA in each lane.
It was suspected that the hybridising fragment in the passaged line of STIB 247 could 
be a VSG gene on the basis that the SRA gene has some homology with the VSG 
gene family and the band is the approximately correct size for a VSG gene transcript. 
This possibility was tested by indirect immunofluoresence using VAT-specific 
antisera. It was confirmed that STIB 247x80 was expressing the GUTat 8.1 VAT 
which was not expressed in any of the other lines but labelled 99% of the 
trypanosome population in STIB 247x80 (data not shown). PCR with a miniexon 
primer and a specific VSG primer designed to base-pair with a conserved region in 
the 3’ untranslated region of VSG mRNAs (Carrington et.al., 1991) further verified 
the expression of a single gene of the size expected for a VSG gene (figure 5.8).
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M STIB 247 
passaged x 80
2.0 kb- 
1.5 kb
Figure 5.8. RT-PCR amplified VSG gene expressed in a passaged line o f STIB 247. The fragment 
hybridising with STIB 247x80 RNA was suspected to be a VSG gene and the resulting RT-PCR 
product using miniexon primer (5’ AAC GCT ATT ATT AGA ACA GTT TCT G 3’) and VSG 
specific primer (5 ’ GTG TTA AAA TAT ATC A 3 ’) is shown above. The following conditions were 
used: 96°C for 5 min followed by 30 cycles o f 96°C for I min, 42°C for 1 min and 70°C for 2 min 
and an additional extension time o f 5 min at 70°C.
A comparison of the sequences close to the C-terminal ends of SRA and VSG genes 
show particular high homology in the last 200 bp of the translated region and to test 
if this region alone was responsible for hybridisation PCR products, which lacked 
this region, were generated from ETat 1.2 to be used as a probe in Northern blots. The 
prediction was that this PCR product could generate specificity of hybridisation to 
the SRA gene and less cross reactivity to the putative GUTatS.l VSG gene. Primers 
SRA5 and SRA8 were combined in reactions together with purified SRA from 
ETat 1.2 as DNA template. This was predicted to generate a 900 bp product which 
would be 200 bp shorter at the 3’end compared with the previous probe. The 
amplified fragment was subsequently run on an agarose gel, purified and used in 
Northern hybridisation experiments. The SRA gene probe lacking the 3’end no 
longer bound to RNA derived from the passaged line of STIB 247 but hybridisation 
still occurred with a 1.4 kb size fragment in the human serum resistant line ETatl .10. 
Again, no hybridisation could be observed in any of the other trypanosomes clones 
used (figure 5.9). Hybridisation of this probe was also observed to RNA of a human 
serum resistant ETat 1.2 clone (kindly provided by Etienne Pays) (data not shown). 
Northern blots and hybridisations, both with the whole SRA gene and with the SRA 
gene minus its C-terminal end, were repeated several times, each showing identical 
results. It can be concluded that, of the trypanosome stocks tested, only the human
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serum resistant ETatl.lO and ETat 1.2 expressed the SRA gene and not the human 
serum resistant STIB 386, the human serum sensitive STIB 247, the passaged line of 
STIB 247 or the intermediate resistant TREU 927.
ETatl.lO R ET atl.2S STIB 386 STIB 247 STIB 247 TREU 927
passaged
A.
B.
Figure 5.9. Northern blot analysis o f mRNAs probed with the SRA specific PCR probe lacking 
its C-term inal end. (A) Total RNA derived from both human serum resistant and human serum 
sensitive trypanosome stocks were probed with PCR amplified SRA gene after approximately 200 bp 
had been removed from its 3 ’end. (B) P-tubulin from T.brucei was again used as positive control 
probe.
5.2.5 Analysis of the SRA gene by RT-PCR
RT-PCR was used as an additional tool for evaluating the expression of the SRA 
gene in human serum resistant and human serum sensitive cloned stocks of 
trypanosomes. The same set of primers were used as for the other PCR analyses 
described in section 5.2.1. To ensure the quality and integrity of RNA and 
synthesised cDNA, a control reaction with primers for the TIM locus was always 
performed for each batch of cDNA prior to any experiment. Primers TIM A and TIM 
B were routinely used for the control to produce a 1.1 kb PCR product. Control 
reactions with primer combination TIM E and TIM B, resulting in a 0.4 kb fragment.
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were initially used but it was observed that the cDNA was sufficiently intact to 
produce the smaller product but failed to provide an adequate template for the 1.1 kb 
amplification product in two of five cDNA preparations (figure 5.10). Using primers 
for the larger fragment therefore provided a more rigorous control of cDNA quality.
M ETatl.2 ETatl.lO  STIB 386 STIB 247 TREU 927
1.0 kb 
0.5 kb-
Figure 5.10. Example of positive control o f the quality of cDNA prior to use in RT-PCR. cDNA 
synthesised from RNA derived from cloned trypanosome stocks was tested with TIM primers prior to 
use in RT-PCR experiments. Two sets o f primers were used, TIM E and TIM B which was expected 
to produce a 0.4 kb band and TIM A and TIM B expected to produce a 1.1 kb band. In each pair o f  
tracks the first shows the result using primers E and B and the second, the results using primers A and 
B. M, 1 kb DNA ladder (13 bands). PCR conditions were as follows: 96°C for 50 s, 64°C for 50s and 
72°C for 2 min for a total o f 30 cycles.
RT-PCR was performed on cDNA derived from the human serum resistant ETat 1.2 
and ETatl.lO, from human serum sensitive ETat 1.2, STIB 386, STIB 247 and TREU 
927 and the results obtained are shown in figure 5.11. Only the human serum 
resistant ETatl.lO and ETat 1.2 gave an ethidium bromide stained fragment of 1.2 kb 
but none of the other clones tested gave rise to an amplified product even though the 
same batch of cDNA could produce the 1.1 kb band using TIM A and TIM B 
primers. Primer combinations MHS/MHT and 2SRA1/2SRA2 were also tested in a 
nested amplification and both sets of primers produced DNA fragments for the 
human serum resistant ETat 1.2 and ETat 1.10 only (data not shown).
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IM ETat ETat ETat STIB STIB TREU  
I.IOR 1.2R 1.2S 386 247 927
1.5 kb
1.0 kb
Figure 5.11. RT-PCR amplification of the SRA locus from RNA isolated from cloned stocks of 
trypanosomes. Ethidium bromide stained agarose gel separation o f  the RT-PCR amplified products 
obtained from cDNA using the primers 2SRA1 and 2SRA2. RT-PCR was performed under the 
following cycling conditions: 96°C for 50 s, 50°C for 50 s and 72°C for 2 min for a total o f 30 cycles.
5.3 DISCUSSION
Genomic analysis of the SRA gene has shown that it is present in STIB 247, 
ETat 1.2, ETatl.lO and that a similar sequence can be found in TREU 927 and in 
STIB 386. The expression of the SRA gene has previously been confirmed in the 
ETat repertoire of T.b.rhodesiense which all are descendants of a strain isolated from 
G.pallidipes in Uganda in 1959.
SRA gene expression was clearly not associated with human serum resistance in the 
genetically competent stocks investigated in this study. An SRA homologue was 
identified in all three stocks but it was expressed in none of them, including the 
serum resistant stock STIB 386. STIB 386 was isolated from a man in Ivory Coast 
and initially characterised by Mehlitz et.al. (1982) as a group 2 T.h.gambien.se 
because it was observed to be more virulent in mice than other T.b.gambiense 
isolates but it was also shown to be highly resistant to human serum whereas other 
group 2 T.b.gambiense isolates are usually subresistant or even sensitive to human 
serum (Mehlitz et.al., 1982). Richner et.al. (1989) did however, find variable 
resistance in human serum resistance tests on STIB 386 metacyclic forms. Further 
evidence for STIB 386 being a group 2 T.b.gambiense comes from its ability to be
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passaged thi’ough tsetse flies in the laboratory (Jenni et.al, 1986) since this has not 
been achieved with group 1 T.b.gambiense isolates. Data from Hide et.al (1990, 
1991, 1994, 1997) suggests that groups of T.b.rhodesiense isolates from different 
parts of Africa are very distinct and that they may have originated independently. 
This observation provides credibility to the suggestion that more than one 
mechanism conferring human serum resistance in T.brucei may exist. Human serum 
resistance could be determined by the expression of SRA in stocks from East Africa 
but not those from West Africa and so might not be responsible for himiaii serum 
resistance in either group 1 or group 2 T.b.gambiense. Another mechanism may 
therefore determine resistance in STIB 386 and it is possible that multiple 
mechanisms for human serum resistance has evolved in different areas of Africa. The 
lack of SRA gene expression in STIB 247 and TREU 927 is what would be expected 
given that these stocks are sensitive to human serum.
It is clear from the sequencing data that the SRA locus identified in ETat 1.2 
(Glasgow line) and STIB 247 are both homologous to the published SRA gene 
sequence. It is however, less clear what the implications of the variation in sequence 
found in XREU 927 would have on the resulting gene product. The related gene in 
TREU 927 is larger than the SRA gene and the highest degree of similarity is found 
at the 3’end which is the part of the SRA gene that show strong homology with 
published VSG gene sequences. It is a possibility that the PCR product obtained 
from TREU 927 is a VSG gene. Findings that would support this suggestion are the 
size of the fragment, which is in the same size range as described for VSG genes, the 
Southern blots that show hybridisation of the SRA gene with DNA from TREU 927 
only when the 3’end is present (data not shown) and the fact that sequence analysis 
showed some divergence from the SRA gene sequence. The related SRA sequence in 
STIB 386 was not analysed because of time constraints. Since no PCR product could 
be obtained from this stock, other methods would have to have been adopted to clone 
SRA gene homologues. De Greef & Hamers (1994) proposed the presence of SRA 
pseudogenes which are no longer transcribed and which show differences in 
sequence from the actively transcribed gene. The same group also detected more 
bands in Southern blot analysis than expected on the basis of the restriction map of
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the cDNA clone and suggested the presence of several related sequences. The 
Southern blots performed on DNA from ETatl.2, STIB 386, STIB 247 and TREU 
927 did not however, reveal the existence of any bands in addition of those expected 
from the restriction map of SRA. The extra bands identified by De Greef & Hamers 
(1994) could also be alternative functional forms of a gene family. Further analysis 
of the SRA homologues in the stocks studied here would have included sequencing 
of the entire open reading frame (in both directions) and analysis to determine gene 
copy number but in view of the lack of association of SRA gene expression with 
human serum resistance in these stocks it was decided not to give priority to this area 
of the project.
The importance of the SRA gene in conferring human serum resistance in the ETat 
repertoire and some other uncioned stocks of T.b.rhodesiense from East Africa has 
now been confirmed by transfection of SRA from ETatl.lO(R) into a serum sensitive 
stock, Antatl.8 (Van Xong et.al, 1998). The SRA gene was inserted into the 
ribosomai locus of the T.b.brucei clone and this transformed the population from 
human serum sensitive to human serum resistant without changing VSG expression. 
These authors have also presented evidence that the SRA gene is an ESAG in the 
ETatl.lO expression site and that this expression site is only active in human serum 
resistant clones. This could explain the earlier observations of a potential correlation 
between the change in expression of human serum resistance/sensitivity and VSG 
switching (Van Meirvenne et.al, 1976). If the change in VSG expression is by gene 
conversion i.e. there is no change in expression site, then the SRA will not change 
and so the resistance/sensitivity will remain the same. But if there is a switch to 
another expression site, lacking an SRA-ESAG, the switch in VSG will be associated 
with a change from resistance to sensitivity. The localisation of the SRA gene to an 
expression site could have implications for the epidemiology of trypanosomes 
capable of causing an infection in humans. The trypanosomes would be limited to 
expression sites containing SRA genes as any trypanosomes (in hmnans) expressing 
non SRA-containing expression sites would be lysed by serum. Antigenic variation 
in trypanosomes is usually brought about by gene conversion of the VSG gene in an 
active expression site or switching between expression site. If trypanosome infections
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in humans would be limited to a subset of expression sites containing SRA, and 
lacking ES AGs 1-5, this may have quantitative consequences for the number of 
VSGs the trypanosomes can use. However, the suggestion that SRA genes are only 
expressed in VSG expression sites has yet to be formally proven.
If expression of the SRA genes turns out universally to be expressed in 
T.b.rhodesiense but not in T.b.gambiense and T.b.brucei it could potentially be used 
as the first definitive marker to distinguish between T.b.gambiense and 
T.b.rhodesiense.
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in humans would be limited to a subset of expression sites containing SRA, and 
lacking ES AGs 1-5, this must have quantitative consequences for the number of 
VSGs the trypanosomes can use. However, the suggestion that SRA genes are only 
expressed in VSG expression sites has yet to be formally proven.
If expression of the SRA genes turns out universally to be expressed in 
T.b.rhodesiense but not in T.b.gambiense and T.b.brucei it could potentially be used 
as the first definitive marker to distinguish between T.b.gambiense and 
T. b. rhodesiense.
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Chapter 6
Genes isolated by differential display RT-PCR as potentially 
important in human serum resistance
6.1 INTRODUCTION
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Human serum resistance in T.brucei is believed to be mediated by the SRA gene 
described by De Greef and Hamers (1994) which encodes a VSG like protein. But f
while this may be the case with some T.b.rhodesiense isolates it is not necessarily a y
universal means of conferring human serum resistance in T.brucei as discussed in 
Chapter 5 in this thesis. Other mechanisms, which also result in trypanosomes 
expressing resistance to human serum, may have evolved separately in various parts 
of Africa. In principal it could be postulated that cells expressing resistance express a 
specific gene sequence that confers resistance on cells that would otherwise be 
sensitive or alternatively, one could postulate the converse i.e. that cells are resistant 
but only rendered sensitive by the specific expression of a gene determining 
sensitivity. The ability to obtain sensitive parasite lines by rodent passage of some 
resistant stocks suggests that the expression of any gene determining sensitivity or 
resistance can also vary in its expression during the course of vegetative growth in a 
non-immune host.
One approach available to try and identify differentially expressed genes is RNA J
display which can be used to identify differences at the level of messenger RNA. |
RNA display is a tecluiique in which random small fragments of expressed sequences 
from two different populations are compared in order to identify sequences expressed f
in only one of the populations (Liang & Pardee, 1992). A schematic representation of 
differential display is illustrated in figure 6.1. The success of the method is 
dependent on the expressed RNA being exactly the same in the two populations apart I
from the trait being studied.
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»
Total RNA extraction of selected HSS and HSR trypanosome lines 
expressing the same VSG
Reverse transcription with A-, C- or G- 
anchored oligo dT primers
First strand cDNA
ACUGGGUAGCCAAAAA
G'FTTTT
ACUGGGUAGCCAAAAA 
^  CCCATCGGTTTTT
PCR with anchored primer and an arbitrary 
primer, incorporating
Double stranded cDNA fragment ACTGGGTAGCCAAAAA
TGACCCATCGGTTTTT
Gel electrophoresis on 6% denaturing polyacrylamide gel 
followed by autoradiography
Differentially expressed bands displayeda
Cut out differentially 
expressed bands 
Extract DNA and reamplify
Clone
Confirm differential expression by Northern blotting
(RT-PCR or probe library to obtain complete cDNA)
Sequence, screen databases to identify genes
Figure 6.1. Schematic representation of differential display RT-PCR used for identifying 
possible HSR/HSS genes. Total RNA from two different populations o f trypanosom es (A and B) are 
reverse transcribed using an anchored oligo-dT primer to produce single stranded DNA. A second 
primer, random in sequence, is then used in combination with the anchored primer to amplify a range 
o f mRNAs from their 3 ’end. These cDNA fragments are displayed on a DNA sequencing gel. A DNA 
band o f  interest can be cut from the gel, amplified by PCR, cloned and sequenced. Finally, its 
sequence can be compared with sequences in data banks directly or used as a starting point for RT- 
PCR to obtain a longer cDNA fragment before DNA sequence analysis.
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A complication when using bloodstream form T.brucei is that the trypanosomes 
used for analysis need to be expressing the same VSG gene (as well as being Î
isogenic) otherwise the majority of differentially expressed transcripts would be the 
result of differences in VSG gene expression. The aim of this study was to identify a 
cDNA fragment that is expressed in only the serum sensitive or serum resistant 
trypanosomes lines. This was based on the assumption that human serum resistant 
trypanosomes express a transcript that human serum sensitive trypanosomes do not 
express or vice versa. To achieve this, a trypanosome line that was capable of 
expressing differences in human serum resistance phenotype was chosen and clones 
expressing the same VAT were selected. Total RNA was isolated from the expanded 
populations of these clones and analysed with the RNAimage^'^system (GenHunter).
A total of nine differentially expressed fragments were identified from the 
approximately 10 000 expressed fragments analysed. These fragments were isolated, 
cloned and rescreened on Northern blots. These cloned inserts which were confirmed 
as being differentially expressed were sequenced and analysed for potential sequence 
homology with previously identified DNA sequences. Cloning of the nine bands 
resulted in sixteen different cloned fragments of which four showed expression 
patterns associated with human semm resistance or sensitivity. Three of these were 
specifically expressed in human serum sensitive trypanosomes and one was 
specifically expressed in human serum resistant trypanosomes. Two of the sensitive 
specific clones were related to EST sequences from a cDNA library of a cloned 
T.b.brucei bloodstream population. These sequences have not yet been fully 
characterised and time did not permit further investigation into the structure and iffunction of these genes/gene fragments. The third sensitive specific clone was a
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fragment of a gene for ribosomai RNA. The resistance specific clone was unrelated j'
-to any other sequences in the database and attempts to obtain a longer sequence, 
which would aid identification, have not been successful.
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6.2 RESULTS
6.2.1 Selection of a trypanosome line expressing differences in human serum 
resistance phenotype whilst expressing the same VAT
A crucial requirement for differential display RT-PCR to be successful was to 
produce trypanosome lines which differed in their expression of human serum 
resistance but were identical in all other respects. The human serum resistant stock 
STIB 386 was examined because it had been found, while screening clones for their 
resistance/sensitivity to human serum, that some of the clones derived from an 
extensively mouse-passaged line of STIB 386 (GUP 2944) no longer expressed the 
resistant phenotype and had become sensitive to human serum. One of these human 
serum sensitive subclones (GUP 3179) had been cloned at the second peak of 
parasitaemia and characterised as expressing the GUTat 9.2 VAT while another 
subclone from GUP 2944, which had been cloned at the first peak of parasitaemia 
and previously shown to express the GUTat 9.1 VAT, retained complete resistance to 
human serum (figure 6.2). This series of clones and subclones had been made prior 
to my arrival in the laboratory (Turner et.al., 1991).
STIB 386 
Huma» serum resistant
STIB 386 passaged x 49 
human serum resistant/sensitive
Subclones expressing different VATs:
GUTat 9.1 HSR
GUTat 9.2 HSS Sub-sub clones:
GUTat 9.3 HSR GUTat 9.1 HSS
GUTat 9.4 HSS/R others HSS
GUTat 9.5 HSS others HSR
Figure 6.2. Selection o f trypanosome stocks for differential display RT-PCR. A passaged line o f 
STIB 386 was chosen as the starting material for differential display RT-PCR and clones from this 
screened for their human serum resistance/sensitivity until a stable resistant and a stable sensitive 
clone was found. These were selected to express the same VAT, GUTat 9.1. HSR; human serum 
resistant, HSS; human serum sensitive, HSS/R; human serum sensitive/resistant.
152
Chapter 6 Genes isolated by Differential Display RT-PCR as potentially important in human serum resistance
The two clones were thus ideal candidates for differential display RT-PCR if they 
could be selected to express the same VSG. Antibody mediated complement lysis 
assays and IFATs using rabbit anti-9.1 antiserum confirmed that 95 % of the cells of 
GUP 2979 expressed GUTat 9.1. The serum sensitive GUP 3179 was however, 
shown by both IF AT and antibody mediated complement lysis to consist of a mixture 
of trypanosomes expressing different VATs of which approximately 40% were 
expressing the GUTat 9.2 variant and, encouragingly, 10% still expressing GUTat 
9.1. To produce a serum sensitive population expressing the GUTat 9.1 VSG, GUP 
3179 was incubated with rat anti-9.2 antiserum so that trypanosomes expressing this 
VSG were lysed and the remaining cells used for cloning. Trypanosomes derived 
from the clones were again screened for their VAT expression by IF AT and their 
sensitivity/resistance to human serum until a clone positive for GUTat 9.1 but still 
sensitive to human serum was identified. In vivo HSS-assays and IF AT were repeated y
three times with identical results using a clone negative for both GUTat 9.1 and 
GUTat 9.2 as a negative control. To prepare RNA from each of the HSR and HSS 
subclones of GUTat 9.1 trypanosomes populations were expanded in mice and rats, 
checking by IF AT after each step and by HSS-assays in vivo before purifying the 
cells on DE-52 cellulose columns and isolating RNA as described in section 2.8.
6.2.2 Preparation of starting material
The integrity of isolated RNA was checked by running a sample on an agarose gel |
before use which also permitted detection of any contaminating chiomosomal DNA.
The isolation of intact RNA that is free of DNA is crucial for the success of the 
differential display methodology as the subsequent randomly primed PCR will 
amplify DNA. All samples were treated with DNase I to ensure that the inRNA 
preparations were free of DNA since DNA contamination of RNA preparations 
isolated using the Trizol method was frequently observed. The DNase treated RNA 
preparations were reverse transcribed using three different one-base anchored oligo- 
dT primers and the resulting cDNA checked in a PCR reaction using primers for the
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TIM gene as positive control for the quality of the cDNA. Only samples that gave 
rise to amplification products longer than 500 bp were used in the RT-PCR that 
followed. By using different sets of primers it has been calculated that most of the 
genes expressed in a cell may be systematically detected (Liang et.a t, 1994). 24 
different arbitrary primers were used in conjunction with the tliree different oligo-dT 
primers resulting in 72 RT-PCR reactions for each sensitive and resistant population.
The total number of PCR amplified fragments for each of the sensitive and resistant 
populations was estimated to be approximately 10 000. If the size of the diploid 
nuclear genome in Tbrucei is estimated to be 54 Mb (Melville et.a t, 1998) and it is 
assumed that 10-15 % of the genome is expressed at a given time, this represents a 
total of 5.4 kb of mRNA. Since the size of the amplified fragments varies between 50 
and 350 bp the sum of the length of fragments amplified by each primer-combination 
is ai’ound 10 kb which would theoretically mean that the majority of niRNAs in the 
genome should be represented even if some redimdancy occurs. The coverage of the 
majority of mRNAs can also be argued on the hasis of the size of the fragments 
amplified. If we assume an average size of 3 kb per mRNA and know that RT-PCR 
only amplifies 2-10% of the total length of any mRNA; an amplification of 10 kb of 
sequence would represent at least 100 kb of mRNA. Similarly, if one assumes that j
each cell expresses 5-10 000 different mRNAs, the sampling of 10 000 fragments is a f
reasonable sample size. The major potential problem with these arguments is the r
different levels of abundance of different mRNAs leading to more abundant mRNAs 
being better represented than low abundant mRNAs.
The arbitrary primers are only 10 nucleotides in length and so require a low 
annealing temperature (40®C) for priming. This low temperatme may create, some 
spurious products that are not reproducible and could lead to false positives. To avoid 
this, all RT-PCR reactions were undertaken in duplicate using two different RNA 
preparations run side by side on the sequencing gel. Only bands which were 
differentially expressed in both pairs of lanes were considered as potential 
differential display products. Since the use of different thermostable DNA 
polymerases under the same PCR conditions have been shown to amplify different 
cDNA populations (Haag & Raman, 1994), the same Taq DNA polymerase was used
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throughout the experiments. The amplified subset of mRNA 3’ termini from the 
cDNA preparations were then displayed on 6% denaturing polyacrylamide gels 
similar to those used for DNA sequencing.
6.2.3 Band separation and retrieval
DNA sequencing gels were used in order to obtain high resolution of a large 
number of amplified cDNAs and routinely 100 - 120 bands were separated in each 
lane on the gel. Because ^^P-dATP had been incorporated into the PCR reaction, the 
bands could be visualised after drying the gel and autoradiography. The 
autoradiographs were carefully studied and a total number of nine differentially 
expressed band were identified as shown in figure 6.3. Only those differentially 
amplified products that appeared in both lanes of the two separately isolated RNA 
samples were considered for fuither analysis. It was interesting to note that 
differentially expressed bands were found originating both from the human serum 
resistant and the human serum sensitive population. Bands 001, 002, 003, 004 and
008 were all produced from the serum sensitive population while 005, 006, 007 and
009 came from trypanosomes expressing the human serum resistant phenotype (table 
6.1).
:e
Band Oligo-dT anchored 
primer
Arbitrary primer Size o f fragment 
(bp)
Origin o f the band
001 H -T ,rC H-AP-26 300 sensitive
002 H -T,,-C H-AP-26 app. 200 sensitive
003 H -T h-G H-AP-25 app. 200 sensitive
004 h -t „ -g H-AP-25 413 sensitive
005 H-T,,-G H-AP-8 app. 100 resistant
006 H -T„-G H-AP-9 app. 300 resistant
007 H -T„-G H-AP-9 160 resistant
008 H -Th-G H-AP-15 224 sensitive
009 H-T„-G H-AP-13 188 sensitive
Table 6.1. The generation of nine differentially displayed cDNA fragments in a comparison of 
human serum sensitive and resistant trypanosom e lines. The cDNA fragments were found to be 
differentially displayed on polyacrylamide DNA sequencing gels. The original primer combinations 
used for generating these bands, their approximate size and their origin from human serum resistant or 
human serum sensitive trypanosome RNA are shown.
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R S R S R
001 -002 " 006
Figure 6.3. Examples o f differential display RT-PCR products including the nine differentially  
displayed bands. Two independent RNA preparations were made from a human serum sensitive (S) 
and two from a human serum resistant trypanosome population (R) which were isogenic and 
expressing GUTat 9.1 before being subjected to RT-PCR with 24 different arbitrary primers coupled 
with three different one-base anchored oligo-dT primers. dATP was incorporated into the PCR 
reaction so that the products could be visualised on a denaturing gel after autoradiography. All nine 
differentially displayed bands (001-009) that were found during the experiment are shown in the 
examples above.
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Each of the nine bands was cut from the gel, reamplified by PCR using the original 
primer combination and the products separated on agarose gels. This allowed the 
sizes of the fragments to be more accurately measured (figure 6.4 and table 6.1)
M 001 002 003 004 IM 005 006 007 009
O.Skb-^
0 .25k b -^ .. ;
IM 008
Figure 6.4. Recovered and reamplified differentially displayed DNA fragments. The nine 
differentially displayed bands were cut from the sequencing gel, reamplified by PCR and are shown 
after separation on a 1% agarose gel stained with ethidium bromide. M, 1 kb DNA ladder (13 bands).
The nine bands were each recovered from the agarose gel and cloned into a pUCl 8 
vector. Some of the original fragments gave rise to cloned products with more than 
one insert size. Even though great care was taken only to cut out the specific 
differentially displayed band from the original sequencing gels, without touching the 
edges of the next, it is possible that DNA from adjacent bands may have 
contaminated the reactions. The bands may also overlap each other on the gel and it 
is therefore impossible to avoid contamination with DNA from other fragments. It 
was therefore necessary to screen several clones with different sized inserts for each 
differential display fragment to determine which one corresponded to the 
differentially expressed sequence. Midiprep samples of the cloned bands were either 
digested with suitable restriction enzymes to cut out the insert, or direct PCR 
amplification of plasmid inserts was performed to identify clones with inserts (figure 
6.5).
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M IE 2D 3D 4B 4D M 7B 7G 8B 8F 9F 9C
A.
l.Okb
0.5kb
IM 5G 5HC.
o.5kb_#.«#^ m  
0.25kbH
D.
5E 51 6A 6C
Figure 6.5. Different sized inserts identified in cloned fragments isolated from differential 
display. The presence o f multiple DNA fragments present in some excised bands gave rise to plasmid 
inserts o f different sizes as shown in the pictures above. Panel (A) is the result o f midiprep digest 
where the top bands correspond to the plasmid and the lower bands are the plasmid inserts. Panels 
(B), (C) and (D) are the results o f direct PCR screening o f colonies and the bottom bands here are 
primer dimers. The number and letter refer to clone names for the colonies that where picked. 
Unlabelled tracks are either the products from colonies lacking an insert or contain inserts o f identical 
size to colonies that have already been picked. Band 004 produced clones o f two different sizes, band 
005 three different sizes and band 006 two different sizes. The other recovered fragments, 001, 002, 
003 , 007, 008 and 009, resulted in inserts o f a single size. M, I kb DNA ladder (13 bands).
A single size insert was found in clones from bands 001, 002 and 003 (IE, 2D and 
3D, figure 6.5a) but two insert sizes were obtained from fragment 004 (4B and 4D, 
figure 6.5a). Three different sizes were found from fragment 005 (5B, 5E and 51, 
figure 6.5d). Clone 5G and 51 were later shown to originate from the same fragment 
and clone 5H and clone 5B also had a common origin. Two different sizes were 
found from 006 (6A and 6C) but a successful recovery was only achieved with clone 
6C. From the recovered and reamplified fragments 007, 008 and 009 only one size of 
insert was found.
6.2.4 Screening differentially displayed bands
cDNA fragments which are apparently differentially expressed on a differential 
display gel require checking to distinguish differential display products from PCR
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artefacts. This is usually carried out by Northern blotting before cloning to establish 
whether the cDNA represents a true difference in expression between samples tested.
Since the number of bands to be examined was rather low however, and in order to 
have a larger quantity of DNA for use as probes, the cDNAs of interest were cloned 
before screening. The screening was conducted using two approaches. Firstly, 
amplified inserts from each cloned fragment were used as probes onto Northern blots 
prepared from total RNA isolated from the human serum resistant and the human 
serum sensitive trypanosomes populations. Unfortunately, this approach proved 
umeliable because of limits in the sensitivity of detection of signals, presumably 
because of low abundance of the mRNAs. Secondly, bands were screened by 
Northern slot blots which allowed larger amounts of RNA to be concentrated in 
smaller areas and thus increase the chance for detecting signals. The integrity and 
level of RNA on slotblots and Northern blots was controlled by hybridising the filters 
with a trypanosome (3-tubulin gene probe as a positive control. A summary of the 
results of screening each clone is provided in table 6.2. The clones originating from 
band 004 (004B),003 (003D) and 009 (009G) hybridised strongly with RNA from 
both the human serum resistant and the human serum sensitive trypanosomes using 
both approaches and these clones were therefore excluded from finther analysis.
Similarly, clone 002D, clone 0051 (same size as 005G), clone 005B (same size as 
005H) and clone 006C all hybridised with the two different RNA preparations when 
examined by slot blot hybridisation even though no signal could be detected after 
standard Northern blotting. Two clones, of the same size, obtained from band 007 
(007B and 007G) both failed to give rise to any signal at all by either Northern or slot 
blot analysis. The expressed fragment from this band could have been potentially 
interesting to follow up, but further analysis was difficult because of time constraints 
and the most obvious explanation is that they result from a PCR artefact and are 
therefore of no interest.
59
Chapter 6 Genes isolated by Differential Display RT-PCR as potentially important in human serum resistance
cDNA clone origin Northern blot 
HSR HSS HSR
Slot blot
HSS
OOIE HSS - - - +
002D HSS - - -t- +
003D HSS + + + +
004B HSS + + + +
004D HSS - + - +
005G HSR - - + +
005H HSR nd nd + +
005B HSR nd nd + +
0051 HSR nd nd + +
005E HSR - - + -
0060 HSR nd nd + +
007B HSR “ - - -
007G HSR - - -
008B HSS - - nd nd
008F HSS - - - +
009G HSR + + + +
Table 6.2. Summary o f screening o f clones originating from differentially displayed fragments 
by Northern and Northern slot blot analysis. Sixteen clones were produced from the nine 
differentially displayed bands excised from the DDRT-PCR gel and screened for their expression in 
human serum sensitive (HSS) and human serum resistant (HSR) trypanosome populations. (+) signal
present, (-), no signal could be detected. Sequencing o f the clones later showed that clone 005G and 
clone 0051 were from the same fragments and so were clone 005H and 005B, 007B and 007G and 
008B and 008F. nd, not determined.
I
The clones 00IE, 004D, 005E and 008F (same size as 008B) all showed clear 
differences in their hybridisation pattern between the RNA derived from human 
serum resistant and human serum sensitive trypanosome populations as shown in the 
representative slot blot data in figure 6.6. Clones 00IE, 004D and 008F show high 
expression in HSS trypanosomes but little or no expression in HSR trypanosomes 
while clone 005E shows increased expression in the HSR trypanosomes. Northern 
slot blotting was repeated for all four clones with similar results. Clone 004D and 
00IE occasionally produced a faint signal in the slot containing human serum 
resistant trypanosome RNA but the signal was always stronger with the slot 
containing RNA from the serum sensitive trypanosome population. The signal 
produced in slots probed with clone 008F were consistently rather faint but no signal 
was ever detected with RNA from serum resistant trypanosomes. Hybridisation with 
clone 005E always produced a strong signal with the human serum resistant RNA 
and no signal could be seen in the RNA from serum sensitive trypanosomes. Further
I
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analysis of these four clones was subsequently undertaken with the aim of 
establishing their relationship to human serum resistance/sensitivity.
Clone specific probe
Resistant Sensitive
I  5E
Tubulin control
Resistant Sensitive
I I
4D
s IE
8F
Figure 6.6. Screening o f differentially displayed fragments by Northern slot hybridisation.
Sixteen clones were screened for hybridisation with Northern slot blots with total RNA from serum 
sensitive and serum resistant trypanosome populations. The four blots shown above produced a 
significant difference in intensity o f signal for one o f the populations whereas the remaining clones 
either produced a signal for both o f the blots or failed to produce a signal altogether. Trypanosome 13- 
tubulin was used as a positive control.
6.2.5 Characterisation of differentially displayed clones
The four clones, each derived from a differentially amplified product, were tested to 
determine whether they were transcripts of T.brucei DNA on Southern blots, 
sequenced and analysed for database similarities.
Southern blot confirmation
Genomic DNA isolated from ETatl.2, STIB 386, STIB 247, TREU 927 together 
with DNA from the human serum resistant and human serum sensitive derivatives of 
STIB 386 and mouse was digested with TaqI, run out on an agarose gel, transferred 
to a nylon filter and hybridised with the purified insert of clone 004D. This resulted 
in strong hybridisation with trypanosome DNA in all lanes whereas no signal could 
be detected in the lanes of mouse DNA (figure 6.7a). There are two common bands 
of approximately 1.2 kb and 0.8 kb in size in all stocks apart fi'om the lanes
16:
Chapter 6 Genes isolated by Differential Display RT-PCR as potentially important in hitman serum resistance
containing ETatl.2 DNA where only the 0.8 kb band is present. It is possible that the 
hybridising sequence in ETatl.2 is slightly different and no Taql site is present in the 
genomic region covered by the probe or there could be two genes with a high degree 
o f  sequence homology present o f  which only one copy is present.
Clone OOIE was used to probe filters with genomic DNA digests with EcoRI and 
Taql from two different trypanosome stocks, TREU 927 and ILtatl.2 (data not 
shown) and with DNA from STIB 386 digested with Pstl, BamHI and Taql which all 
resulted in specific hybridisation with two DNA fragments (5.0 kb and 4.5 kb for 
PstI, 6.0 kb and 4.0 kb for BamHI and 0.75 kb and 0.2 kb for Taql, figure 6.7b). 1 he 
trypanosome origin o f  the clone 008F was also confirmed since it clearly hybridised 
with genomic DNA isolated from STIB 386 cut with Pstl and BamHI (figure 6.7c). 
Hybridisation o f clone 005E onto filters containing DNA from TREU 927 and 
ILtatl.2 digested with Taql and EcoRl was however, only just detectable (data not 
shown) probably because this insert was only 56 bp in size. The data suggests that 
the three clones OOIE, 004D and 008F represent different genes and also confirms 
that they are o f  trypanosome origin.
Etat 386 247 927 GUTat9.1 
R S
Mouse
B.
S.Okb.
4.5kb‘
0.75kb-
0.2kb-
386 
Pst Bant Taq
386 
Pst Bam
004D OOIE 008F
Figure 6.7. Southern blot analysis o f DNA from trypanosome isolates probed with three 
differentially displayed fragments. Three different Southern blots were prepared with Ipg DNA 
isolated from various trypanosome clones and probed with three o f the cloned differentially displayed 
fragments. (A) genomic DNA from ETatl.2, STIB 386, STIB 247, TREU 927 and the GUTat 9.1 
human serum sensitive (S) and human serum resistant (R), used for RT-PCR differential display, were 
digested with Taq I for Southern blot analysis and probed with the tluoroscein labelled 004D clone. 
(B) genomic DNA from STIB 386 was digested with three different restriction enzymes, Pstl, BaniH! 
and Taq! and analysed by Southern blotting probed with the ^^P-labelled OOIE clone. (C) genomic 
DNA prepared from STIB 386 was digested with P stl and BamHI, blotted and probed with the ^^ P- 
labelled 008F clone.
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Sequence analysis of the differentially expressed fragments 
Fragments amplified with random primers and detected on differential display gels 
are usually rather short and the four products that were sequenced here ranged from 
50 bp to 413 bp in length. Each of the four clones was sequenced in both dir ections 
and sequencing quality checked by comparing both strands using GCG BESTFIT. 
Each pail* of sequences showed >99% identity. Each of the four sequences was then 
used for FAST A and BLAST searches but because of the short length of clone 005E 
(50 bp, figure 6.8a) the results of these searches were not meaningful for this clone.
005E Length: 50
5’ 1 AAGCTTTTACCGCGCCGTTATATCTTGTTCTTACCXAAAA AAAAAAt ;C i r 3’
OOIE Length: 300
5’ 1 AATTCGAGCT CGGTCACCAA GCTTGCCATG GCAGGNAAOG AÆAGCTGGG
51 GCTGCl'GAGG TACGTCGGCG TGTGGCAGCA CAGAGGÏCGT TTGTGCQGGA 
101 TGTGCAGTTA CAATGGGGAG CAAAACTCGA TTGACAGÏCA TGGAGGTGGA 
151 CATTACATGTGTi'ACTGGTGTGGCTCTGTTTl’AGGTGATG CCCTGCACCC 
201 TTTTCATTGC ACAGTGTGCA AAAGAGI GAT ATTTTTCAGG TACTGCTGTT 
251 GTTATTGTTG TTCCGCTATG GAIFGAGTGC TTGTGAAAAA A AA A A AG G  F i 3’
004D Leiigtli: 413
5’ 1 AAGCTTTCCT GGAGCGGGGAViqATI*TCGT GCCAACGGCA CTCGTACACG
51 AGTTGTTCGG TCACTGAGCA CAACGTTACA CCGTTTTGTT AGGAAAGTGA 
101 AGGTGGTCGG CGCACTTCTC CCTTTTTTGG GGTTTGTGTG TTTTACCGGC 
151 TTATCTGAAA AGGGGCAACA GAgAACCTGG GATGATATTC CAAAAAAAAA 
201 AAGCTTAAGC TTTCCTGGAG CGGGGAAGGA TTTCgTGCCA ACGGCACTCG 
251 TACACGAGTT GTTCGGTCACTGAGCACAAC GÏTACACCGT TTTGTl'AGGA 
301 AAGTGA AGGT GGTCGGCGCA CTTCTCCCTT TTITGGGGTT TGTGTGTTTT 
351 ACCGGCTTAT CnGAAAAGG GGCAACAGAg AACCTGGGAT GATATTCCC\ 
401 AAAAAAA.\A\ Gl I 3'
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D . 008F Length: 224
5’ 1 AGAGCTTACO AAACGCAACG ATaTNCGCAA GCGGCACCCT TCGGCTTCAT 
51 CCTGTGTACG A AG CATC AAA CAACAAATAT TACGTGA GTC CTGTGGTGCA 
101 TGTGTCAATG CCCACAGGGA ACTCTACCTGTGA TCACA TAA TTTtTNCAT 
151 NAGGGGAAAA TACNGTTtCC CTtGGCGTgc CTTCACTCAT GTaTATCTAT 
201 CCGCTCCCC\ AAAAAAAAAA CCI I 3'
Figure 6,8. Sequences o f d on e 005E , clone OOIE, clone 004D and clone 008F.(A) Both strands o f  
clone 005E was sequenced using M-13 forward and reverse primors for the pUC18 vector and the 
sequence o f  the entire vector insert obtained. There are no putative stop codons within the short 
sequence. (B) Sequence o f  clone OOIE after automatic sequencing in both directions. (C) Sequm ce o f  
clone 004D. An open reading frame can be found between the start codon and stopcodons at bp 263, 
305 and 365, douÙe underlined. The stop codon at bp 298 is in another reading frame. (D) Sequence 
o f  clone 008F insert including three possible stop codons.
The region complementary to the sequence o f  the anchored oligo-dT primer, possible stopcodons and 
start codons are underlined.
The insert in clone OOIE was 300 bp in length (figure 6,8b). As expected, the 
sequence complementary to the oligo-dT anchored primer is present at the 3 ’end and 
several possible stop codons in all three reading frames can be identified. F AST A 
searches in the GenEMBL database did not reveal any similarity to other sequences 
in the database with the best score being Human DNA sequence fiom PAC 79C4 but 
with only 63% identity over a 105 bp region. BLASTN and BLASTX searches in the 
African Trypanosome DNA database found at the Parasite Genome Blast Server 
(http://www.ebi.ac.uk/parasites/parasite_blast_server.html) showed that the 
expressed sequence fragment from clone OOIE was 99% identical to T.brucei cDNA 
from bloodstream forms of ILTatl.l over a 250 bp region (figure 6.9). This 
transcript has unfortunately not been further characterised but is a result of randomly 
sequenced ESTs from T.brucei. A map of the sequence reveals two Taql restriction 
sites, one at position 4 and another at position 127. This is consistent with the 
genomic Southern blot using clone OOIE (figure 6.7b) which shows hybridisation 
with two different fragments, approximately 1.1 kb and 0.4 kb in size for STIB 386 
digested with Taql, demonstrating two Taql restriction sites. The third fragment is 
too small to result in detectable hybridisation.
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EMBL:TBA16319 AA016319 T3554 Bloodstream form of serodeme ILTatl.l Trypanosoma brucei brucei cDNA 5'.
(343.7 bits), Expect = 2.Oe-100, P = 2.0e-100
250/252 (99%), Positives = 250/252 (99%), Strand = Minus / Plus
286 TCACAAGCACTCAATCCATAGCGGAACAACAATAACAACAGCAGTACCTGAAAAATATCA 227 I ! I I I I  I I I II ! ! I I I I I I I I I I I  I I  I I I I I I I I I I I I  I  I I I I I I I I  I  I I I  I I  II I I  I I  20 TCACAAGCACTCAACCCATAGCGGAACAACAATAACAACAGCAGTACCTGAAAAATATCA 7 9
CTCTTTTGCACACTGTGCAATGAAAAGGGTGCAGGGCATCACCTAAAACAGAGCCACACC 167 I I I I I I  I I I  I  I  I I I I I I I I I I I I I  I  I I I I I  I  I I I I I I I I I  I  I I I I I I I I I I I  I I  I I I I  I I  CTCTTTTGCACACTGTGCAATGAAAAGGGTGCAGGGCATCACCTAAAACAGAGCCACACC 139
ACTAACACATGTAATGTCCACCTCCATGACTGTCAATCGAGTTTTGCTCCCCATTGTAAC 107I I I I I I I I I I I  I  M I  1  I I I I I I I I I I I I  I I I  I I I I I I I I  I  I 1 1  I I I I I I I M I I  I  I I I MACTAACACATGTAATGTCCACCTCCATGACTGTCAATCGAGTTTTGCTCCCCATTGTAAC 199
TGCACATCCCGCACAAACGACCTCTGTGCTGCCACACGCCGACGTACCTCAGCAGCCCCA 47 I I I I I I I I I  I I  I  I I I  I  I I I I I I I I I I I I  I I I  I I I I I I I I  I I I I  I I I I I I I I I I I  I  I I I  I I TGCACATCCCGCACAAACGACCTCTGTGCTGCCACACGCCGACGTACCTCAGCAGCCCCA 25 9
GCTATTCCTTNC 35 I I I I I I I I I  I  I
Length = 471Minus Strand
Score = 1244
Identities =
Query:
Sbjct:
Query: 226
Sbjct: 80
Query : 166
Sbj c t : 140
Query: 106
Sbj c t : 200
Query: 46
Sbjct: 260
Figure 6.9. Alignment o f the insert of clone OOtE and a randomly sequenced EST from 
bloodstream T.brucei IL T a tl.l. The insert o f  clone OOIE (query) showed 99% identity with T.brucei 
cDNA from bloodstream forms o f IL T a tl.l (subject) over a 250 bp region, starting at nt 35 and 
ending at nt 286 as defined in figure 6.8b.
The insert of clone 004D was 413 bp in length (figure 6.8c). The best scores in 
GCGs PASTA search in the GenEMBL database was T. brucei small ribosomal RNA 
with 96.5 % identity over a 200 bp region. The same region is also 96% identical to 
another 200 bp stretch of T.brucei large ribosomal subunit (figure 6.10).
EMBL.'TBRRNA X14553 Trypanosoma brucei gene for ribosomal RNA large subunit Length = 4511 Plus Strand HSPs:
Score = 937 (258.9 bits), Expect - 1.9e-74, Sum P(2) = 1.9e-74
Identities = 193/200 (96%), Positives = 193/200 (96%), Strand = Plus / Plus
Query: 
Sbjct: 
Query: 
Sbjct: 
Query; 
Sbj c t : 
Query: 
Sbjct:
7 TCCTGGAGCGGGGAATGATTTCGTGCCAACGGCACTCGTACACGAGTTGTTCGGTCACTG 6 6 I I I I I  I  I  I I I  I I I I I I I I I I I I I  I  I  I I II I I I I I I I I  M I I I I I  I I I I  I I I M I II I  I 165 8 TACTGGAGCGGGGAAGGATTTCGTGCCAACGGCACTCGTACACGAGTTGTTCGGTCACTG 1717
67 AGCACAACGTTACACCGTTTTGTTAGGAAAGTGAAGGTGGTCGGCGCACTTCTCCCTTTT 126 
1111111111111111111111111111111111111111111111111 1111111111 1718 AGCACAACGTTACACCGTTTTGTTAGGAAAGTGAAGGTGGTCGGCGCACATCTCCCTTTT 1777
127 186TTGGGGTTTGTGTGTTTTACCGGCTTATCTGAAAAGGGGCAACAGAGAACCTGGGATGAT 
111111111111111111111111111111111111111111111111111111111111 1778 TTGGGGTTTGTGTGTTTTACCGGCTTATCTGAAAAGGGGCAACAGAGAACCTGGGATGAT 1837
187 ATTCCAAAAAAAAAAAGCTT 206 1111111111 III II I 1838 ATTCCAAAAAGAAATTGCAT 1857
Figure 6.10. Sequence comparison o f the insert of clone 004D and the T.brucei gene for large 
subunit ribosomal RNA. The cloned insert o f 004D (query) showed 96% identity with a T.brucei 
gene for ribosomal RNA (accession number X I4553) (subject) over 200 bp.
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There is a similar* percent identity with other T.brucei ribosomal RNA sequences 
over the same region and a high degree of sequence homology with ribosomal RNA 
from other organisms (other Trypanosoma species, Leishmania species and Crithidia 
fasciculata among others). BLASTX searches in the SWISSPROT database showed 
a tentative sequence mateh with a putative galactose-1 -phosphate uridylyltransferase 
in the translated 5’ region of the fragment but it is most likely that the insert in clone 
004D is the product of contaminating ribosomal RNA. The start codon has not been 
identified with complete eonfidence and it is possible that the open reading frame 
identified within the sequence is not the correct one as even the smallest ribosomal 
RNA gene is at least 700 bp long compared with the 413 bp of clone 004D.
The amplified cDNA product 008F was again relatively short (224 bp) (figure 
6.8d). Using the African trypanosome DNA database this clone was found to be 93% 
similar to a fragment randomly sequenced from a sheared genomic library from 
T.b.rhodesiense (expressing M-VAT 4) over 110 bp at the 3’end (figure 6.11).
EMBL:TBB352 B07352 G432T3 MVAT4 sheared genomic library Trypanosoma brucei
rhodesiense genomic clone G432.
Length = 336 
Plus Strand HSPs:
Score = 544 (150.3 bits), Expect = 3.le-71, Sum P(2) = 3.le-71
Identities = 110/112 (98%), Positives - 110/112 (98%), Strand - Plus / Plus
CGAAACGCAACGATATNCGCAAGCGGCACCCTTCGGCTTCATCCTGTGTACGAAGCATCA 6( II I I I I I I I I I I I I I I  I !  [ II I II II I I I I I I I I [ I  I !  1  II I I I I I I I I II I! I I I I I
I I  I I I I I I I I I I I I I I I I I I I I  I  I I I I  I I I I  I  I I I I I I I I I I  I I I I I I I I I I
Figure 6.11. Sequence aiigiimeut o f the insert o f clone 008F and an EST identified in 
T.b.rhodesiense expressing M-VAT4. Clone 008F showed 98% identity with a randomly sequenced 
fragment in T.b.rhodesiense (accession number B07352) over a 112 bp region.
This was also confirmed for the translated sequence resulting from a BLASTX 
search again in the African trypanosome DNA database. Table 6.3 summarises the 
information about the four differentially expressed clones identified in this study.
Query: 9
Sbjct: 102
Query: 69
Sbjct: 162
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with information regarding the size of the fragments, the database matches and 
expression.
Clone Expression Size
(bp)
Identification or homology Ace. no. o f 
homology
Length- 
% identity
OOIE HSS 300 EST from T.brucei ILTat 1.1 T3554 250-99
bloodstream forms
OOIRT HSS 506 EST from T.brucei ILTat 1.1 T3554 220 - 98
bloodstream forms
005E HSR 50 Unknown
005RT HSR 476 Unknown repeat sequence
004D HSS 413 T.brucei gene for ribosomal X14553 1 9 3 -9 6
RNA large subunit
008F HSS 224 EST from T.b.rhodesiense M- B07352 1 1 0 -9 8
VAT4
008RT HSS 364 EST from T.brucei \ifï?A  1.1 T3551 7 4 - 9 8
bloodstream forms, cDNA 5 ’
Table 6.3. Summary o f data on clones derived from differential display RT-PCR products and 
from putative full length open reading frames. Clones with the putative ORFs are denoted RT and 
length-% identity is the percent identity over the length o f region (bp). The expression column 
indicate whether the clone is specifically expressed in the serum resistant (HSR) or the serum 
sensitive (HSS) trypanosomes population.
Obtaining fu ll length cDNA sequences 
The cDNA sequences resulting from differential display RT-PCR were in general 
rather short and, since they were all produced using one-base anchored oligo-dT 
primers, only the 3’ end of each transcript was amplified. Even though the 
untranslated region at the 3’end in T.brucei is relatively short and there is a lack of 
introns in the T.brucei genome, the cloned cDNA fragments were clearly not long 
enough to generate sequence data that could be fully informative in terms of 
identifying open reading frames or homologues in the database. Consequently, there 
were elear potential advantages to be gained from obtaining longer sequences of 
coding regions. One approach available to obtain longer fragments is by RT-PCR 
using the presence of a conserved spliced leader sequenee at the 5’end of every 
trypanosome mRNA. This 39 nt spliced leader sequence, or mini-exon sequence, is 
common in all mature trypanosome mRNA molecules but was first identified when 
studying VS G genes (Borst, 1986) and has since been used in conjunction with
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primers for a conserved region at the 3’end to amplify VSG genes by PCR 
(Carrington et.al, 1991). A primer for the spliced leader sequence together with 
specific primers designed from each clone sequence of the 3’end of each cDNA 
fragment was used to amplify the full length cDNA. The primers used for RT-PCR 
of differentially sequences of clones OOIE, 008F and 005E are listed in table 6.4.
P rim er Length Sequence (S’ - 3 ’)
Miniexon 25 AACGCTATTATTAGAACAGTTTCTG
Miniexon-2 21 TACTATATTGGTATGAGAAGC
lE-1 21 TCACTCTTTTGCACACTGTGC
lE-2 23 GCAATGAAAGGGTGCAGGGGATC
lE-3 20 CACCACTAACACATGTTATG
8F-1 21 GGCATTGACACATGCACCACA
8F-2 21 GGATGAAGCCGAAGGGTGCCG
5E-1 21 GAACAAGATATAACGGCGCGG
5E-2 19 AACGGCGCGGTAAAAGCTT
T able 6.4. L ist of p rim ers used fo r R T -P C R  am plification of d ifferentia lly  expressed cDNA 
fragm ents.
Clone 004D was not pursued any further because it appeared to encode ribosomal 
RNA. All newly synthesised cDNA was quality controlled before use by RT-PCR 
amplification with primers for the TIM locus and only cDNA where the 1.0 kb 
fragments could be amplified were used in fruther RT-PCR experiments.
Nested RT-PCR reactions using the miniexon primer and a clone OOIE specific 
primer lE-1 followed by the primers miniexon-2 and lE-3, consistently amplified a 
500 bp fragment from the eDNA obtained from the human serum sensitive STIB 386 
whereas this fragment was not amplified from serum resistant trypanosomes (figure 
6.12a).
168
Chapter 6 Genes isolated by Differential Display RT-PCR as potentially important in human serum resistance
M HIM TIM HSR HSS M HSR HSS M HSS
F igure 6.12. R T -PC R  products am plified from  RNA isolated from  hum an serum  sensitive o r 
resis tan t trypanosom es. Primers were designed for three o f the differentially displayed fragments, 
005E, OOIE and 008F, and used together with the miniexon sequence to amplify the expressed 
sequence from the cDNA. The resulting RT-PCR products were run on a 1% agarose gel and stained 
with ethidium bromide. Primers for the TIM gene were used as positive control reactions for RNA 
isolated from the human serum resistant (HSR) and human serum sensitive populations (HSS) o f 
GUTat 9.1. (A) 001E. (B) 005E. (C) 008F.
RT-PCR using a range of annealing temperatures with the miniexon primer and the 
5E-1 primer (specific for clone 005E) repeatedly resulted in several amplification 
products from both a human serum resistant cDNA template as well as from a serum 
sensitive cDNA template (results not shown). This problem was overcome by a 
further amplification step using nested primers, miniexon-2 and 5E-2, which resulted 
in a 0.9 kb product and a 0.6 kb product exclusively in lanes from human serum 
resistant cDNA (figure 6.12b).
Two fragments were amplified from cDNA derived from human serum sensitive 
trypanosomes using primer combination miniexon and 8F-1 followed by miniexon-2 
and 8F-2. The primer combination only produced a product from cDNA isolated 
from the human serum sensitive trypanosomes population (figure 6.12c). It is 
possible that amplification of two different size products, instead of the expected 
single product from 005E and 008F, reflects the diploid state of T.brucei so that the 
two products represent transcripts of different lengths from two alleles of the same 
gene. STIB 386 would then be interpreted as being homozygous for the sequence in 
clone OOIE and heterozygous for the sequences in clone 005E and clone 008F. There 
is also the possibility that there are two copies of the gene or multiple transcript of a 
single gene. The overall impression of the size of the products that were amplified by
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RT-PCR, is that they are all rather short compared with the average size of mRNAs 
which is around 3 kb.
Apart from RT-PCR, another approach used in an attempt to obtaining full gene 
sequences from the short cDNA fragments was the use of 5’RACE. With this method 
cDNA synthesis is carried out starting from a gene specific primer at the 3’end and 
after capping the transcripts with dATP at the 5’end, PCR with a second gene 
specific primer and an oligo dT-anchored primer would ultimately result in a full 
cDNA sequence. The 5’RACE method was tested with primers specific for the three 
sequences identified in clones OOIE, 005E and 008F but despite several trouble 
shooting attempts the PCR reactions never produced anything other than long smears 
of DNA products.
The PCR products differentially amplified from cDNA using primers specific for 
OOIE, 008F and 005E were produced in larger amounts, purified and prepared for I
cloning. Unfortunately, cloning of the entire 0.9 kb amplification product from clone 
005E was unsuccessful despite several attempts whereas cloning of the 
approximately 0.6 kb fragment resulted in a 476 nt long plasmid insert. The sequence 
of this insert (005RT) revealed that the cloned RT-PCR product consisted of a series 
of repeats of the primer sequence coupled to the 5’ miniexon sequence. Sequencing 
from both directions showed a 98% similarity between the strands and the 5’end of |
the original clone 005E sequence can be found at the 3’end of the 005RT transcript 
(figure 6.13).
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005RT Length: 476
5’ 1 G AGAAGCTTT TACCGCGCCG TT ACAAGCTT TTACCGCGCC GTT ACAATCT
51 TTTACCGCGC CGC r  ACTATA TTCXITATGAG AACX' TTTTAC CGCGCCGTT _A 
101 CAAGCTTTIWCCGCGCCGCT ACAAGCTTTT ACCGCGCCGT T ACAAGCTTT 
151 TACCGCGCCG TT ACAAGCTT TTACCGCGCC GTT ACAAGCTITTACCGCGC 
201 CGTT ACAAGC TTTTACCGCG CCGTT ACAAG CTTTTACCGC GCCGTT ACAA 
251 GCTTTTACAG CGCCGTT ACG CTTTTACCGC GCCGTT ACGC TTTTACCGCG 
301 CCGTT ACGCT TTTACCGCGC CGTT ACGCTT TTACCGCGCC GTT ACGCTTT 
351 TACCGCGCCG TT ACGCTTTT ACCGCGCCGT T ACGCTTTTA CCGCGCCGTT 
401 ACGCTTTTAC CGCGCCGTTA CGCTTTTACC GCGCCGTTAC GCTTTTACCG 
451 CGCCGTT ACG CTTTTACAGC GCCGTC; 3’
Figure 6.13. Sequence o f the R T-PCR  product o f  clone OOSRT.The RT-PCR product amplified 
with a specific primer for the differential display firagment clone 005E and a miniexon sequence was 
subject»! to automatic sequencing . The miniexon primer and the 005E clone sequence found within 
the insert are both undo’lined in red and the repeat units are underlined in black.
None of the restriction enzymes Pstl, BamHI or Taql, cuts within the sequence but 
all three digests nevertheless hybridised with the 005RT clone as two different bands 
(6.0 kb and 3.5 kb for Pstl, 7.0 kb and 5.0 kb for BamHI and 2.0 kb and 0.9 kb for 
Taql) (figure 6.14b). It is possible that 005RT is a PCR artefact resulting from 
dimérisation of one primer and the miniexon but it is also possible that it is a genuine 
sequence of a minisatellite with the repeat being within a gene or in the 3’ UTR. The 
observation of two product of different size in the RT-PCR (figure 6.12b) and two 
bands in the Southern blot (figure 6.14b) could then be explained by two alleles 
with different numbers of repeats. To be able to tell if this is a polymorphism in a 
minisatellite repeat a genomic clone would need to be isolated and sequenced and the 
0.9 kb band would also need to be cloned and sequenced.
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Pst Bam Taq P st Bam Taq
S.Okb
4.0kb M 6 .0 k b >  g m g #3.5kb >  # # # #
# ■2.0kb■0.9kb 4 #  ^ 0 .9 k b
-4- 0.25kb
A. OOIRT B. 005RT
Figure 6.14. Southern blot analysis o f two extended differential display products. DNA was
prepared from STIB 386 and digested with the three enzymes Pstl, Bam H I and Taql before Southern 
blot analysis. (A) shows the filter hybridised with labelled clone 005RT while (B) depicts the
Southern blot filter hybridised with clone OOIRT.
The insert derived from the cloned RT-PCR product of clone OOIE (OOIRT) was 
506 nt long and both the miniexon primer and the specific primer sequence could be 
identified within the sequence. The 5’end of the original cDNA fragment OOIE can 
also be found within clone OOIRT at its 3’end (figure 6.15). Wlien the OOIRT clone 
was used to probe a Southern blot filter of Pstl, BamHI and Taql digested genomic 
DNA from STIB 386, two restriction fragments were detected in each of the digests 
(figure 6.14a). Only the restriction enzyme Pstl cuts within the sequence and it is 
possible that the lai'ger fragment in the Pstl digest consists of two bands. The 
hybridisation pattern is the same as the one observed after probing an identical 
Southern blot with the smaller fragment OOIE (figure 6.7b) apai’t from an extra band 
for Taql which could be explained by the probe hybridising with a larger fragment of 
the gene. The Southern blots strongly suggests that OOIE and OOIRT are part of the 
same gene.
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OOIRT Length: 506
5' I AACTR 1 A i l A f 1 .UiAACAG f T tT TG TACTA TATTGTGATA CCTAACTCCT 
51 CTCGGTACCA GAGGCCGCAC TCACGTCTGC ACACGGGTTG TGGTGCAATG 
101 GTGAACCTGC Alt; AGCTGGG AGGGAAGCAA GGCTGCGGGG GACCTCAATT 
151 TACTCCTGTG GGAGTGTCGT TGACACCGCT GTTGCAGTAT Tl’CTCGCTGC 
201 TCGTTCATGT AGTTGGAAAG CTACCCGGAT TTGCTGCCGG GTrTGTGACC 
251 GTGTGGCTAG TTTACATTAT GTTTATAGGG CGTGATGTGC TTTTGAACAC 
301 GTGCGTTCCT GTTGCTGGGT TCCACATTAC TGCACTGTTA CTGCTGCGTG 
351 AACTATTGAC ACCATGGCAc GAAGGAATAN CTGGGGCTGC TGCAGGTACG 
401 TCCGCGTGTG GCAGCACAGA AGTCGTTTGT GCGGGATGTG CAGTTCAATG 
451 GGGGAACAAA ACTCCAT I GA CAGTCATGGA AGTGGACA l AA CATGTGTTA
501 CTGGTG 3’
Figure 6.15. Sequence o f the R T-PC R  product o f clone OOlRT.An RT-PCR product was obtained 
by combining a specific primer for the differentially displayed fragmoit clone OOIE and a miniexon 
primer. The amplified produet was cloned and both strands sequenced. The original fi-agments OOIE 
(miderlined, bold), the miniexon primer, a start codon (bp 111-113) and two possible stopcodons (bp 
467-470 and 487-490) are miderlined.
A FAST A search in the GenBank database with OOIRT sequence only results in 
one hit, a D.melanogaster fsh membrane protein, with 62% identity in a 155 bp 
overlap. A BLASTN seai’ch in the African trypanosome DNA database at the 
Parasite Genome Blast server site, does result m a nearly perfect sequence match 
(98% over 220 bp) with the 5’ end of an anonymous T.brucei cDNA from the 
bloodstream stage of serodeme ILTatl.l (accession number T3554). This transcript 
is the result of random sequencing of ESTs and has not been further characterised. 
The cDNA from the database does not include the miniexon sequence which would 
have started 153 bp upstream from the end of the sequenced fragment when 
compared with OOIRT (figure 6.16). Amino acid alignment iu all 6 open reading 
frames similarly identified the serodeme ILTatl.l 5’ end cDNA as the best match. 
There are two possible open reading frames within the sequence, both with the same 
start codon but with two different stop codons resulting in a 127 aa or 120 aa 
Uanslated sequence respectively.
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EMBL:TBA16319 AA016319 T3554 Bloodstream form of serodeme ILTatl.l Trypanosoma 
brucei brucei cDNA 5'.
Length = 471 Minus Strand HSPs;
Score — 1075 (297.0 bits). Expect — 6.8e-124, Sum P(2) = 6.8e-124 
Identities = 217/220 (98%), Positives = 217/220 (98%), Strand = Minus / Plus
CAGCAGCCCCAGNTATTCCTTCGTGCCATGGTGTCAATAGTTCACGCAGCAGTAACAGTG 313
I I ! I  I  I I I I I I I I I I I I  I  I  I  I  M  M  I I I I I I I I I  M  I I  I  I M  M  I I I 1 1  I  I I I  I M  M  CAGCAGCCCCAGCTATTCCTTCCTGCCATGGTGTCAATAGTTCACGCAGCAGTAACAGTG 308
312 CAGTAATGTGGAACCCAGCAACAGGAACGCACGTGTTCAAAAGCACATCACGCCCTATAA 253II I  1  1 I II I I I I I I II I 1 1 1  I  I I I I I I  II I I I I I I I  I  1 1 1 I  I I I I III I 1 1 1  I I 1  1 I  I 1 1 309 CAGTAATGTGGAACCCAGCAACAGGAACGCACGTGTTCAAAAGCACATCACGCCCTATAA 3 68
252 ACATAATGTAAACTAGCCACACGGTCACAAACCCGGCAGCAAATCCGGGTAGCTTTCCAA 193 I I I 1  1 I I I I I I I I I I I I 1 1 1 I  I  I  I I I I I I I I I I I I I  1  1 1  1 I  I I I I I I I I 1 1  1 I  I I  1 1  I 1 3 69 ACATAATGTAAACTAGCCACACGGTCACAAACCCGGCAGCAAATCCGGGTAGCTTTCCGA 428
192 CTACATGAACGAGCAGCGAGAAATACTGCAACAGCGGTGT 153 
1 1 1  1 I  I I I I  I I I I I I I I I I I I 1 1 1 1 1 1 I I I I I I I I I I I I I 429 CTACATGAACGAGCAGCGAGAAATACTGCAACAGCGGTGT 4 68
I L T a t l . l  (T3554). The cloned RT-PCR product OOIRT showed a 98% sequence identity over 220 bp 
with a randomly sequenced cDNA fragment from T.brucei expressing ILTat 1.1.
Sequencing of the RT-PCR product obtained from human serum sensitive 
trypanosome cDNA using miniexon primer and specific primers for the 008F 
transcript resulted in a 364 nt long sequence (008RT). Sequencing of both strands 
confirmed the quality of the sequence with 99% identity over the entire insert
Query: 372
Sbjct: 249
Query;
Sbjct:
Query:
Sbjct:
Query:
Sbjct:
F igure 6.16.
between the complementary strands. The miniexon primer and the primer for the
008F fragment cannot be identified with certainty within the sequence (figure 6.17).
008RT Length: 364
1 ACCTATCTCA GCGATCTGTC TATTTCGTTC ATCCATAGTT GCCTGACTCC 
51 CCGTCGTGTA GATAACTACG ATACGGGAGG GCTTACCATC TGGCCCCAGT 
101 GCTQCAATQA TACCGCQAGA CCCACGC TCA CCGGCTCCAG ATTTATCAGC 
151 AATAAACCAG CCAGCCQGAA GGGCCGAGCG CAGAAGTGGT CCTGCAACTT 
201 TATCCGCCTC CATCCAGTCÏ ATTAATTGTT GCCGGGAAGC TAGAGTAAGT 
251 AGTTCGCCAG TTAAÏAGÏTT GCGCAACGTT GTTGCCATTG CTACAGGCAT 
301 CGTGGTGTCA CGCTCGTCGT TTGGTATGGC TTCATTCAGC TCCGGTTCCC 
351 AACGATCAAG GCGA
F igure 6.17. Sequence of the R T -P C R  p ro d u ct 008RT. An RT-PCR product was obtained from the 
HSS population o f trypanosomes by using a specific primer for the differential display fragment 008F 
and a miniexon primer. The resulting clone 008RT was sequenced in both directions.
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It is a concern that the full sequence of the 008F clone cannot be found within the
:r
008RT sequence. But whereas clone 008F shows similarity at its 3’end with a 
sequence identified in a sheared genomic library from T.b.rhodesiense expressing 
metacyclic VAT-4, clone 008RT is basically identical to a T.brucei cDNA 5’end 
from bloodstream form of serodeme ILTatl.l (figure 6.18).
A .
EMBL:TBB352 B07352 G432T3 MVAT4 sheared genomic library Trypanosoma brucei
rhodesiense genomic clone G432.Length - 336 
Plus Strand HS P s :
Score = 544 (150.3 bits). Expect = 3.le-71. Sum P(2) = 3.le-71
Identities = 110/112 (98%), Positives = 110/112 (98%), Strand = Plus / Plus
Query; 9 CGAAACGCAACGATATNCGCAAGCGGCACCCTTCGGCTTCATCCTGTGTACGAAGCATCA 68
M I I I I I I I I I I I I I  I  II I I I I I I I I I  M I  M I  I I I I I  I I I I I I I I I ! I I I M I I  I  I I  Sbjct: 102 CGCAACGCAACGATATTCGCAAGCGGCACCCTTCGGCTTCATCCTGTGTACGAAGCATCA 161
Query: 69 AACAACAAATATTACGTGAGTCCTGTGGTGCATGTGTCAATGCCCACAGGGA 120
I  I I I I I I I I I I I I I  I  I I  I I I I  I I I I I I I  I I I  I I I I I I II I I I  I  I I I I I I I I I Sbjct: 162 AACAACAAATATTACGTGAGTCCTGTGGTGCATGTGTCAATGCCCACAGGGA 213
B . ■S
E M B L :TBA52885 AA052885 T3551 Bloodstream form of serodeme ILTatl.l Trypanosoma 7brucei brucei cDNA 5'.Length = 275 
Plus Strand HSPs:
Score = 361 (99.8 bits). Expect = 9.8e-28, Sum P(2) = 9,8e-28 
Identities = 73/74 (98%), Positives = 73/74 (98%), Strand = Plus / Plus
Query: 428 CGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTC 4 87
I I I I I I  I  I  I I I I I I I I I I I I I  I  I  I  I  I  I  I I I I I I I I  I  I  I  I I I I I I I I I I I I I I  I I I I I I I I Sbjct: 178 CGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTC 237
Query: 488 GCCAGCTGGCGTTA 501
I I I I I I  I  I I I  I I I Sbjct: 238 GCCAGCTGGCGTAA 251
Figure 6.18. Sequence alignment of the cDNA produced from differential display fragment 008.
(A) The cloned insert 008F (query) showed 98% identity with a cDNA fragment sequenced from 
T.b.rhodesiense (accession num ber B07352) (subject) over a 112 bp region (B) the RT-PCR product 
which stemmed from the same fragment (query) showed 98% similarity over 74 bp with an EST 
sequenced from T brucei expressing IL T a tl.l (accession number T3551) (subject).
This sequence is not the same as that showing homology with clone OOIRT and 
therefore represents a distinct gene. A BLASTX search in the African trypanosomes 
DNA database also matches the 008RT translated sequence with the 5’ cDNA 
sequence identified in T.brucei ILTatl.l. Table 6.3 lists the clones analysed with
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information regarding the origin, the size of inserts obtained and any database 
matches.
6.2.6 Characterisation of genes potentially important in human serum resistance
From the original nine differentially displayed bands that were identified and the 13 
different cloned inserts derived from them, four proved to be of interest regarding 
human serum resistant/sensitive trypanosome lines. Two of the resulting clones from 
these cDNA fragments, OOIRT and 008RT, showed a high degree of identity with 
ESTs which had been generated from clones randomly selected from a cDNA library 
of T.brucei ILTatl.l. Unfortunately, both of the sequences generating high scores 
with the differentially expressed clones had not been characterised and had not been 
shown to be related to any other sequences in the database. From the high homology 
found with the sequences in the database, both when comparing either nucleotide or 
translated sequences, it can be concluded that each pair of sequences are identical. 
Clone OOIRT and clone OOIE, from which OOIRT is derived, are both clearly the 
same as T3554. The other clone, 008RT, which is the RT-PCR product derived from 
clone 008F, is identical to the 5’ region of T3551 whereas the V  end is very similar 
to a genomic sequence in B07352. The sequence of clone 004D matches the 
sequence of various trypanosome ribosomal genes, especially T.brucei ribosomal 
DNA for the small ribosomal sub-unit. It is difficult to envisage how ribosomal gene 
products might determine resistance or sensitivity to human serum. Clone 005E itself 
was too short to give any indication concerning the likely homologues and a longer 
sequence of clone 005E was not obtained since the cloned RT-PCR product for this 
fragment most likely was the result of mispriming during PCR although the 
possibility that this represents a real transcript camiot be totally excluded
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6.3 DISCUSSION
The decision to use RT-PCR differential display to investigate differences in 
expressed sequences was taken since, at the time, it seemed to be the method that 
would yield the most interesting results in a limited time and had the potential to a?
identify sequences unique to the serum resistant and/or serum sensitive trypanosome 
population by covering the majority of expressed genes as well as being sensitive 
enough to pick up rare mRNAs. Other methods such as subtractive hybridisation, 
differential screening, representational difference analysis and RADES-PCR have 
been used successfully by other groups in other contexts (De Greef et.al, 1989;
Zhang et.al, 1996; Lisitsyn, 1995; Murphy & Pelle, 1994; Stevens & Tibayrenc,
1994) but these methods all have limitations and drawbacks not found in DDRT- 
PCR. This is not to say that DDRT-PCR has weaknesses as well as strengths. The 
principal drawback is that it makes an assumption that the phenotype is determined 
by differences at the transcriptional level. If the human serum resistance trait was 
determined at, for example, a post-translational level, then DDRT-PCR would not be 
able to detect it. Other drawbacks are the large number of primer combinations 
required in order to cover a wide representation of mRNAs, the high numbers of false 
positives identified and the short size of the differential display fragments. The high 
number of false positives is often caused by the presence of more than one product in 
a particular excised band but there may also be other reasons such as mispriming and /
competition for the PCR primers. It is recommended that screening of the excised 
and re-amplified fragment is carried out directly by Northern blotting (Liang &
Pardee, 1995) but if the excised fragments contain other overlapping bands of non 
differentially expressed sequences this could result in an ambiguous result with 
Northern blotting. On this basis it was decided to clone the fragments before /
screening. In hindsight, it would have been better to have screened the fragments I
with a reverse Northern blotting procedure instead of screening the fragments one by 
one. If the cDNA fragments from differential display had been dot blotted onto 
duplicate filters and probed with labelled cDNA made from RNA samples from the 
resistant and sensitive trypanosomes it would have saved both a lot of time and much 
less RNA would have been needed. It is often claimed that DDRT-PCR is a very J
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sensitive method of detecting low abundance mRNAs (Liang et.al., 1995; Bauer 
et.al., 1993) but these transcripts are the most difficult to screen for. Northern blots 
containing 5 pg total RNA per track were in some cases insufficiently sensitive to 
produce a signal when hybridised with the differentially displayed fragment and even 
slot blots with the same or higher amounts of RNA produced only faint signals and in 
one case failed to produce a signal altogether. It is likely that these clones correspond 
to rarer mRNAs. If time had permitted a quantitative reverse transcriptase-PCR, 
could have been used to verify if the clones are expressed at lower levels. The 
number of false positives encountered was however, not a major problem in these 
experiments when compared with other published results where sometimes very 
large number of clones have to be screened to separate out the false positives (Wang 
& Feuerstein, 1997; Callard et.al, 1994; Utans et.al., 1994). In this study, the major 
drawback was the short size of the differentially displayed fragments and, as the 
reverse PCR primer is anchored next to the poly(A) tail, most of the differentially 
displayed products probably correspond to 3’ untranslated regions. This is less useful 
than coding sequence for comparison against EST or gene sequence data since these 
usually do not contain the untranslated 3 ’ sequence. Besides, even homologous genes 
often differ to a large extent in their untranslated region compared with their coding 
region so that sequence comparisons may be potentially misleading until longer, 
preferably full length sequences have been obtained.
The use of the miniexon primer in order to obtain full-length cDNA fragments was 
chosen mainly because no full-length cDNA libraries were available and time was 
too short to produce a new library. The RT-PCR products that resulted from these 
amplifications were also comparatively short when compared with the average 
mRNA size in T.brucei. This could imply either that the miniexon was mispriming to 
another sequence or that the gene products determining resistance/sensitivity are 
small in size. Another issue that has been problematic is the reproducibility of the 
differential display autoradiographs. While it was rather straight forward to identify 
bands that were reproducible in repeat reactions in lanes next to each other, it turned 
out to be more difficult to reproduce the same banding pattern when the same primer 
combination was used again and run on a separate gel. When comparing
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autoradiographs from two such repeat experiments it was easy to identify the major 
bands while a lot of the weaker bands could not be found on the repeat gel indicating 
that bands corresponding to rare mRNAs may be less reproducible. This would then 
lead to lack of detection of some less abundant transcripts which may well be as 
imporiant as genes with a high level of expression.
Of the four cDNA fragments that passed the screening steps tlnee were specific for 
the serum sensitive population and one was specific for the resistant population. But 
without more information about the four clones, it is difficult to speculate about the 
fmietion of the genes/gene fragments. Clone 004D, which has a 200 nucleotide long 
stretch in common with a T.brucei ribosomal gene, seems an unlikely candidate to be 
determining human serum sensitivity even though it seems to be differentially 
expressed in the two populations. Clone 008RT and clone OOIRT are both identical 
to ESTs randomly sequenced from Tb.brucei and the possibility cannot be excluded 
that they ai'e part of the same gene since it is likely that the RT-PCR product 008RT 
contains more 5’end sequence than OOIRT. Homologue of 008 is also to a 
T.b.rhodesiense EST but to my knowledge the trypanosome clone used for making 
the cDNA library has not been tested for its resistance or sensitivity to human serum 
so it is possible that this cloned stock of T.b.rhodesiense also is PISS. It is 
mifortunate that these ESTs have not been further characterised and that a cDNA 
library was not available. It is however, encouraging that these two clones were 
found to be specific for the serum sensitive trypanosomes since Tb.brucei by 
definition is a human serum sensitive sub species. The resistant specific clone 005E 
was initially very interesting since it hybridised specifically with RNA from the 
serum resistant population and not at all with RNA from the sensitive population. 
Attempts to produce a longer sequence were first thought to be successful but 
subsequently it was shown that the amplified sequence only contained primer repeats 
most likely caused by the primer priming itself! It is therefore still uncertain what 
role the 005E fragment may have in human serum resistance. However, further 
investigation of this transcript is worth following given the Southern blot data which 
argue against the RT-PCR product being an artefact.
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The finding of differentially displayed eDNA fragments from both human serum 
sensitive and hiunan serum resistant origin is in agreement with our genetic 
interpretation of the inlieritance data (Chapter 4). A preliminary interpretation of this 
is that both sensitive and resistant phenotypes can result from the presence of a 
transcript and not only the lack of a transcript. However, it would require further 
analysis to examine whether the phenotype of the F, progeny clones correlated with 
the expression of the RNA display fragments.
Further work with the three clones OOIRT, 005E and 008RT would have involved 
continued attempts to obtain the 5’end of the genes especially since the RT-PCR 
products amplified here were suspiciously short. Ideally, the cloned cDNA probe 
would be used to screen a cDNA library made from human serum resistant and 
sensitive STIB 386 niRNA. The 5’RACE method should also be suitable for 
recovering the 5’ upstream sequence of the gene fragments if more effort was put 
into trouble shooting the procedure. If full gene sequences could be obtained it would 
simplify Northern blot experiments since probes would be longer. RNA from several 
different human serum resistant and serum sensitive isolates could be hybridised with 
the gene to determine its significance in human serum resistance. A genetic test 
would also be useful to further investigate if the three clones 008RT, 005RT and 
OOIRT are responsible for conferring resistance or sensitivity to himian serum. 
Parental trypanosomes and F, progeny could be screened either by RT-PCR or by 
Northern hybridisation to look for co-segregation with phenotype. Initial experiments 
by Northern hybridisation were undertaken but the results were ambiguous and 
difficult to interpret. The intensity of the bands on the resulting autoradiographs 
seemed to suggest that clone OOIRT is expressed at higher levels in the serum 
sensitive clones than in the serum resistant clones and also that 008RT is 
overexpressed in the serum sensitive trypanosome clones. The experiments were 
carried out with the parental STIB 386, STIB 247, TREU 927 and with five hybrid 
trypanosome clones, two of which were human serum sensitive in an in vivo HSS- 
assay and three which were scored as serum resistant. However, if the 
autoradiographs were exposed for a long time (>5 days) a signal could be detected in 
all of the lanes regai'dless of whether the RNA was derived from a serum sensitive or
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a serum resistant clone. It would be interesting to carry out quantitative RNA ;
analysis for the expression of these clones in order to establish if there are real
differences in RNA expression between the serum resistant and the serum sensitive 
trypanosome populations. In addition, a genomic library from STIB 386 could have
obtain full length genomic sequences.
v:been made and used to screen with the differential display fragments in order to -4.
Identification of the biological functions for any differentially expressed genes 
would be the most interesting next step. This could be based on two approaches. |
Firstly, by expressing the encoded protein and analysing the gene product in resistant 
and sensitive cells and secondly, by using transfection to demonstrate whether the 
resistant or sensitive phenotype was determined by the identical gene. A third 
approach could be by identifying homologues with genes of known function in the 
database but as human infectivity is likely to be specific to trypanosomes rather than 
a common feature of many organisms, this is perhaps the approach least likely to be 
successful.
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Human African trypanosomiasis was almost extinct and under control by the 1960’s 
but today there is a serious resurgence of the disease in sub-Saharan Africa. Large 
areas of central Africa, the southern Sudan and Uganda, Congo-Zaire and Angola, 
are suffering from resurgence and epidemics of trypanosomiasis (Smith et.al, 1998). 
The reasons for the re-emergence include widespread civil unrest and wai's, poor 
health financing, lack of control programmes and insufficient advances made in 
diagnosis, treatment and vector control.
A basic requirement for trypanosomes to be able to infect humans is that they can 
survive and replicate in the hostile environment of human blood and withstand lysis 
by a trypanosome toxic factor found in human serum. The mechanisms involved in 
determining whether a trypanosome strain is human serum resistant or sensitive are 
not fully understood but more laiowledge in this area could aid in finding new ways 
of blocking infection by human infective trypanosomes. The emphasis of this study 
was to determine if, and how, human semm resistance is inherited and to initiate 
studies on identifying the gene/s involved in determining the resistance/sensitivity 
trait.
The trypanolytic factor for serum sensitive trypanosomes is contained within the 
HDL fraction of human serum (Rifkin, 1978; Hajduk et.al, 1989; Tomlinson et.al, 
1995; Gillet etMl, 1991; Seed & Seehelski, 1989) but their is still some controversy 
about the precise nature of the lytic factor. Hajduk et.al purified TLFl from a minor 
subclass of HDL, which are large, high density particles with a molecular mass of 
500 kDa and later defined the lytic component within TLFl as haptoglobin-related 
protein (hpr). Raper et.al (1996) opposed this suggestion since their experiments 
showed that the lytic activity of TLFl was inhibited by haptoglobin present in the 
NHS and concluded that another lytic factor, TLF2, was the main trypanolytic factor. 
TLF2 has however, recently been shown to also contain hpr (Tomlinson & Raper,
182
Chapter 7 General Discussion
1998) and it now seems likely that hpr is the major trypanolytic factor and whether it 
is part of TLFl or TLF2 becomes less important. The experiments showing that hpr 
in TLFl was inliibited by haptoglobin were undertaken in vitro but experiments in 
vivo, involving injecting trypanosomes together with haptoglobin into mice, show a 
much less dramatic effect (S. Hajduk, pers.comm., 1998). Haptoglobin levels may 
however, be important for differences in trypanolytic activity seen between sera from 
different individuals so that the greater the ratio of hpr to haptoglobin, the greater the 
resistance against trypanosome infection. In addition, African Americans have, when 
compared to Caucasians, lower levels of haptoglobin and higher levels of hpr (Smith 
et.al, 1995) which would offer better protection against tiypanosomiasis. This 
research area requires further investigation to firmly establish whether haptoglobin 
has an antagonistic effect on trypanosomes by hpr.
The difference between the subspecies T.b.brucei and T.b.rhodesiense is subtle 
since they are separated solely on their susceptibility to human serum and the 
assumption that trypanosomes can be neatly classified as either resistant or sensitive 
to hmnan serum should be abandoned. The development of a reliable assay for 
measuring sensitivity and resistance to human serum highlighted this issue since it 
was not possible to distinguish human infective and human non-infective 
trypanosomes clones only by their morphological appeai'ance when exposed to 
human serum. It was difficult to determine which cells were viable and infective and 
which ones had lost their infectivity using phase contrast microscopy observations 
alone. Not all cells appeared to respond to the lytic factor in human serum at the 
same time and there were always some cells that appeared more resistant than others. 
It is possible that there is a grading of susceptibility to TLF within T.brucei and this 
would explain why there was a significant spread in the percentage lysis between 
individual assays. Another possibility is that the phenotype of the trypanosomes is 
unstable so that the resistance, or sensitive phenotype is rapidly being switched on 
and off. This would be a reasonable explanation if the resistance/sensitivity trait was 
in a VSG expression site, as suggested for the SRA gene (Van Xong, 1998) since 
VSG switching also occiu'S at a high rate. The reason for the successful application of 
in vitro assays by other groups is probably because they are working on trypanosome
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strains that have been adapted to a laboratory environment and have become 
inadvertently selected for more homogenous expression of the HSS phenotype 
whereas STIB 386, STIB 247, TREU 927 and the hybrid progeny produced from 
them, have all recently been transmitted tlnough tsetse flies.
The in vivo HSS assay proved to be a more reliable test for distinguishing between 
serum sensitive and serum resistant clones since there could be no ambiguity to 
whether the trypanosomes were able to cause a parasitaemia or not and the results for 
the par ental clones gave identical results when repeated a large number of times. For 
TREU 927 a proportion of mice became infected during each assay and this, together 
with the inheritance data, led to the conclusion that intermediate resistance to human 
serum is a specific phenotype. Further evidence for this was the observation that if 
the number of cells injected into mice was increased an infection was established in 
all mice. This result implies that a proportion of the trypanosomes are viable. 
Intermediate resistance was a finding which has been mentioned, but not explained, 
in several reports (Geigy et.al, 1975; Rifkin, 1984; Gibson & Mizen, 1997). The 
sensitivity of the in vivo HSS assay has not been measured but it may reasonably be 
assumed that if there was only one intact trypanosome remaining, it could still give 
rise to a patent parasitaemia. A single trypanosome is capable of producing an 
infection as demonstrated when conducting optical cloning of trypanosome stocks 
where only one trypanosome is injected into mice although cloning efficiency is 
usually around 50-60%. Based on the in vivo HSS-assay, this would imply that 1/100 
trypanosomes resist lysis in TREU 927 while 0/100 resist lysis in STIB 247 and > 
I/lOO resist lysis in STIB 386. This could further be tested by adding various ratios 
of STIB 386 cells to STIB 247 cells during an in vivo HSS-assay and investigate 
whether this would result in resistance.
In conclusion, there is still much work that needs to be done before we have a full 
understanding as to why some trypanosomes resist lysis by human semm while 
others do not. The basic requirement to be able to test trypanosomes for their 
sensitivity and resistance was carried by the in vivo assay described in Chapter 3. It 
would however had been an advantage if the in vitro test could have been enhanced
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and made more sensitive and reliable. It is possible the MitoTracker dye in 
combination with counter staining with DAPI could have been optimised but since it 
is likely that human serum resistance exhibits a continuum of relative susceptibility, a 
more sensitive assay would have been required. In a broad sense, in vitro tests will 
measure the behaviour of the vast majority of cells in a strain while the in vivo 
infectivity assays will also measure the presence and behaviour of a small minority of 
resistant cells. At present, an in vivo assay is the best way to define the line between 
resistance and sensitivity in recently fly-transmitted trypanosomes. In terms of the 
mechanism of intermediate resistance, one could consider two testable models. First 
that TREU 927 binds the lytic factor less effectively than STIB 247 or second, that 
internalisation of the postulated TLF receptor complex occurs more slowly and 
leading to less lysis in a given time period.
A possible problem that can arise with the reliability of the in vivo HSS assay is that 
when scoring the Fi progeny there is a risk of over-scoring the number of sensitive 
progeny. Progeny that can cause a parasitaemia are clearly resistant but there is a 
possibility that clones which fail to infect in one test could have resulted in infection 
if a larger number of mice had been used. For some of the intermediate resistant F fs , 
the assay were repeated with identical results but a few intermediate resistant clones 
were sensitive in a second assay. Thus as intermediate resistance sometimes could be 
scored as sensitive this would lead to an over estimate of the number of sensitives. 
Since this is likely to affect only a few of the progeny scored, it would not alter the 
ratio significantly. However, given that the ratio of sensitive to intermediate resistant 
progeny is critical, all F; progeny clones should be tested using a larger number of 
mice.
The SRA gene expression, which was demonstrated by DeGreef & Hamers (1994) 
to coincide with human serum resistance in the ETat repertoire, was not expressed in 
the serum resistant line, STIB 386. Milner et.al. (1997) have also identified a 
resistant specific transcript which has 92% homology with the SRA gene. This 
transcript was isolated from a different T.b.rhodesiense strain isolated in Tanzania 
whereas the ETat strains originate from Uganda. Thus, both of these come from areas
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in East Africa which are not far apart while the STIB 386 was isolated from a man in 
the Ivory Coat and has been characterised as a group 2 T.b.gambiense (Mehlitz et.al., 
1982) even though Hide et.al. (1990) found it to be indistinguishable from East 
African T.b.rhodesiense or T.b.brucei stocks. The results suggest that the mechanism 
of human serum resistance found in STIB 386 does not involve the SRA gene and 
therefore that resistance can be conferred by more than one mechanism. It is possible 
that gene/s involved in human serum resistance have evolved independently at 
different locations in Africa and that several different mechanisms are present. The 
strain responsible for sleeping sickness in the Busoga area in Uganda was shown by 
Hide et.al. (1994, 1996) to have been the same from at least the 1960s until today so 
that this human infective strain has arisen only once and is very stable in the Busoga 
focus. Human infective strains in the Zambian focus are very similar to each other 
but markedly different from those in Busoga suggesting that human infectivity has 
arisen more than once and that the mechanisms conferring resistance are likely to 
differ.
Since the SRA gene is not responsible for resistance in the clones used in this study 
it would be of much interest to find the gene/s which are involved in conferring 
resistance and sensitivity in these stocks. Initial studies to identify the genes were 
undertaken by DDRT-PCR and at least two fragments were identified as specific for 
the human serum sensitive population. The next step would have been to obtain the 
full length gene sequence from which these fragments were derived, either by 
continued efforts to make that 5’RACE method work, by PGR walking, by designing 
new primers to optimise the RT-PCR approach or, more directly, by screening a 
genomic library with the cloned RT-PCR products obtained. A full gene sequence 
could verify that the fragments really are differentially expressed since probing 
Northern blots with a full gene sequence would result in stronger, more defined 
hybridisation. In addition, a database search with the full gene sequence would 
possibly identify homology with genes from other organisms which might give clues 
about the function of the gene. At a later stage, the encoded protein could be 
expressed and the gene product analysed in sensitive and resistant trypanosome
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populations or the gene used to transfect resistant cells and screen for changes in 
sensitivity/resistance expression.
It was shown in Chapter 4 that human serum sensitivity was inherited in a 2:1:1 
ratio of sensitive: resistant: intermediate resistant in the F, progeny when a resistant 
and a sensitive strain were crossed. A model for inheritance was proposed which 
involves tlri'ee alleles at a single locus; a codominant sensitive and resistant allele and 
a recessive sensitive allele. This model was suggested because it is the simplest 
model that fits the inheritance data and it can also account for the finding of 
intermediate resistance. There are several ways to further test the proposed 
inheritance model and the first would have involved conducting a series of 
backcrosses as discussed in section 4.3. Another way would have been to cross F, 
progeny of different resistance phenotype to produce a Fg generation. The phenotypes 
of such a cross could then be compared with the expected ratio of phenotypes. 
Crossing hybrid progeny with a sensitive phenotype would be less informative since 
the model suggests two different genotypes for this phenotype. The identification of
a larger number of TREU 927 selfer products could also aid in testing the model.
.TREU 927 sellers would be informative because they are predicted to segregate into 
intermediate, sensitive and resistant phenotypes in a ratio which would be predicted 
by the proposed genotypic model.
The suggested inlieritance model is also consistent with a functional model. Hager 
& Hajduk (1998) demonstrated that TLF resistant trypanosomes can bind TLF in 
their flagellar pocket but that they fail to internalise it whereas sensitive 
trypanosomes can both internalise and deliver TLF the lysosome where it acts to 
destroy phagolysosome integrity. Conflicting data, however, suggests that resistance 
to TLF is the result of retention of TLF in a prelysosomal compartment and that 
internalisation of TLF is the same in resistant and sensitive trypanosomes (Coppi & 
Raper, 1997). Which of these conclusions is correct is not of major importance for 
the model presented here since a receptor that binds TLF or a molecule that aids in 
delivering the TLF to the lysosome can be considered as equivalent in terms of 
providing a model. Taking into account the suggested codominance and that STIB
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386 would have to have a sensitive recessive allele, functional models in which the 
product of the locus is a single polypeptide or where there is an absence of this single 
polypeptide and which results in internalisation/no internalisation or alternatively, 
delivery to lysosomes/no delivery to lysosonies cannot explain the proposed 
genotypes and phenotypes of the inheritance model. Instead, a model based on 
different receptor affinities might explain the genetic results. A single polypeptide 
could have two binding sites with different affinities for internalisation or binding of 
TLF. If both of the sites are bound by TLF with high affinity lysis would occur 
(STIB 247) but if only the low affinity binding site was present (as for STIB 386) the 
result would be only partial lysis. If instead the high affinity binding site was present 
this would again result in partial lysis but this would be more than for STIB 386, i.e. 
as for the intermediate resistant phenotypes. Another model suggests a dimeric 
receptor or delivery molecule where the resistant receptor has a very low affinity. 
Again, the presence of one of each or two of the same of the higher affinity receptors 
would result in lysis whereas the presence of one resistance and one low affinity 
receptor would result in resistance (STIB 386) and an intermediate resistant
phenotype would arise when an allele for the high affinity receptor was present 
together with the very low affinity receptor. These models could be tested by 
examining the affinity of the parental and Fj progeny clones for human serum and the 
rate of internalisation of the receptor complex. The identification of the ligand/s and 
receptor/s for TLF will aid our understanding of the mechanisms of trypanosome 
resistance to human serum.
It is clear that human serum resistance can be inlierited into previously human 
serum sensitive trypanosome lines, as shown in Chapter 4, and this raises the 
question of how important this is in the epidemiology of human trypanosomiasis as 
the human infective genotype may spread to non human-infective trypanosomes by 
genetic exchange. As discussed in Chapter 1, it has been shown that genetic 
exchange does have a role in the generation of diversity of trypanosome populations 
even though both clonality and genetic exchange can be detected in different 
populations (Hide et.al, 1997; Stevens & Tibayrenc, 1996; Tibayrenc, 1997). A 
study by Hide et.al (1994) suggested that the human infective population and the
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non human-infective population had different levels of genetic exchange so that the 
non human-infective population was more clonal than the human infective group 
which showed evidence of frequent genetic exchange. This may however, be 
explained by the theory proposed by Maynard Smith et.al (1993) which involves an 
epidemic population structure in which there is frequent recombination within all 
members of the population but with occasional epidemics when a highly successful 
individual arises and reproduces rapidly to produce an epidemic clone. A complex 
genetic system may however, exist since both triploidy and self fertilisation events 
have been described in T.brucei (Gibson, 1989; Tait et.al, 1996) and genetic 
exchange between human and non human trypanosomes in the field has not been 
directly observed. There might be some natuial reasons for why sex in trypanosomes 
has not been observed more often. Genetic exchange is thought to take place in the 
tsetse fly and for this to occui' the fly needs to be infected with at least two 
trypanosomes strains. Since tsetse flies mainly become infected during their first 
blood meal (Maudlin & Welburn, 1988) the fly would have to feed on a host with a 
mixed infection. This might not be as unlikely as has been thought (Gibson, 1995) as 
a recent study in the Ivory Coast revealed that approximately 40% of all trypanosome 
infections were mixed and that there was a significantly higher prevalence of mature 
T.brucei infections than had previously been reported (Masiga et.al, 1996).
Further investigation into the inheritance of human serum resistance and the genes 
involved, as well as enhancing our understanding of T.brucei genetics, should help to 
clarify the mechanism of human serum resistance and may provide insight into new 
areas of preventing human infection.
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